US20070300327A1 - Plant enzymes for bioconversion - Google Patents
Plant enzymes for bioconversion Download PDFInfo
- Publication number
- US20070300327A1 US20070300327A1 US11/796,503 US79650307A US2007300327A1 US 20070300327 A1 US20070300327 A1 US 20070300327A1 US 79650307 A US79650307 A US 79650307A US 2007300327 A1 US2007300327 A1 US 2007300327A1
- Authority
- US
- United States
- Prior art keywords
- sesquiterpene
- germacrene
- plant
- synthase
- chicory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title abstract description 134
- 108090000790 Enzymes Proteins 0.000 title abstract description 134
- 238000000034 method Methods 0.000 claims abstract description 31
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 94
- 230000015572 biosynthetic process Effects 0.000 claims description 70
- 241000196324 Embryophyta Species 0.000 claims description 58
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 claims description 48
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 claims description 47
- QEBNYNLSCGVZOH-NFAWXSAZSA-N (+)-valencene Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CCC=C21 QEBNYNLSCGVZOH-NFAWXSAZSA-N 0.000 claims description 44
- WCTNXGFHEZQHDR-UHFFFAOYSA-N valencene Natural products C1CC(C)(C)C2(C)CC(C(=C)C)CCC2=C1 WCTNXGFHEZQHDR-UHFFFAOYSA-N 0.000 claims description 44
- 239000001890 (2R)-8,8,8a-trimethyl-2-prop-1-en-2-yl-1,2,3,4,6,7-hexahydronaphthalene Substances 0.000 claims description 29
- HMTAHNDPLDKYJT-CBBWQLFWSA-N amorpha-4,11-diene Chemical group C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(C)=C)[C@H]21 HMTAHNDPLDKYJT-CBBWQLFWSA-N 0.000 claims description 26
- GFNWRKNVTHDNPV-UHFFFAOYSA-N 2alpha-hydroxyvalencene Natural products C1CC(C(C)=C)CC2(C)C(C)CC(O)C=C21 GFNWRKNVTHDNPV-UHFFFAOYSA-N 0.000 claims description 24
- HMTAHNDPLDKYJT-UHFFFAOYSA-N amorphadiene Natural products C1=C(C)CCC2C(C)CCC(C(C)=C)C21 HMTAHNDPLDKYJT-UHFFFAOYSA-N 0.000 claims description 24
- GFNWRKNVTHDNPV-UXOAXIEHSA-N beta-nootkatol Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)C[C@H](O)C=C21 GFNWRKNVTHDNPV-UXOAXIEHSA-N 0.000 claims description 24
- YMBFCQPIMVLNIU-UHFFFAOYSA-N bergamotene group Chemical group CC(C)=CCCC1(C)C2CC1C(C)=CC2 YMBFCQPIMVLNIU-UHFFFAOYSA-N 0.000 claims description 20
- 239000002253 acid Substances 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 241000208838 Asteraceae Species 0.000 claims description 18
- 101710093888 Pentalenene synthase Proteins 0.000 claims description 17
- 101710115850 Sesquiterpene synthase Proteins 0.000 claims description 17
- PLQMEXSCSAIXGB-SAXRGWBVSA-N (+)-artemisinic acid Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(=C)C(O)=O)[C@H]21 PLQMEXSCSAIXGB-SAXRGWBVSA-N 0.000 claims description 14
- 230000009261 transgenic effect Effects 0.000 claims description 12
- 229930101531 artemisinin Natural products 0.000 claims description 11
- JYGAZEJXUVDYHI-DGTMBMJNSA-N dihydroartemisinic acid Chemical compound C1CC(C)=C[C@@H]2[C@H]([C@@H](C)C(O)=O)CC[C@@H](C)[C@@H]21 JYGAZEJXUVDYHI-DGTMBMJNSA-N 0.000 claims description 10
- 108030003566 Valencene synthases Proteins 0.000 claims description 9
- LZMOBPWDHUQTKL-RWMBFGLXSA-N artemisinic acid Natural products CC1=C[C@@H]2[C@@H](CCC[C@H]2C(=C)C(=O)O)CC1 LZMOBPWDHUQTKL-RWMBFGLXSA-N 0.000 claims description 7
- PLQMEXSCSAIXGB-UHFFFAOYSA-N artemisininic acid Natural products C1=C(C)CCC2C(C)CCC(C(=C)C(O)=O)C21 PLQMEXSCSAIXGB-UHFFFAOYSA-N 0.000 claims description 7
- JYGAZEJXUVDYHI-UHFFFAOYSA-N dihydroartemisininic acid Natural products C1CC(C)=CC2C(C(C)C(O)=O)CCC(C)C21 JYGAZEJXUVDYHI-UHFFFAOYSA-N 0.000 claims description 5
- JGINTSAQGRHGMG-SCSKSZFBSA-N (e)-5-[(1s,5s)-4,6-dimethyl-6-bicyclo[3.1.1]hept-3-enyl]-2-methylpent-2-en-1-ol Chemical compound C1[C@@H]2C(CC\C=C(CO)/C)(C)[C@H]1CC=C2C JGINTSAQGRHGMG-SCSKSZFBSA-N 0.000 claims description 4
- 241000208822 Lactuca Species 0.000 claims description 4
- 241000723343 Cichorium Species 0.000 claims description 3
- 229930000766 bergamotene Natural products 0.000 claims description 3
- DGZBGCMPRYFWFF-ZYOSVBKOSA-N (1s,5s)-6-methyl-4-methylidene-6-(4-methylpent-3-enyl)bicyclo[3.1.1]heptane Chemical compound C1[C@@H]2C(CCC=C(C)C)(C)[C@H]1CCC2=C DGZBGCMPRYFWFF-ZYOSVBKOSA-N 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- BLUAFEHZUWYNDE-XRNKLDBLSA-N chembl77 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4C31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-XRNKLDBLSA-N 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- 239000000758 substrate Substances 0.000 abstract description 67
- 229930004725 sesquiterpene Natural products 0.000 abstract description 64
- 150000004354 sesquiterpene derivatives Chemical class 0.000 abstract description 44
- 229940088598 enzyme Drugs 0.000 description 128
- 244000298479 Cichorium intybus Species 0.000 description 97
- HRYLQFBHBWLLLL-AHNJNIBGSA-N costunolide Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 HRYLQFBHBWLLLL-AHNJNIBGSA-N 0.000 description 85
- 238000006243 chemical reaction Methods 0.000 description 74
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 70
- 239000000047 product Substances 0.000 description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
- 238000011534 incubation Methods 0.000 description 55
- 230000000694 effects Effects 0.000 description 53
- BJPSSVHNEGMBDQ-NUZBWSBOSA-N Desacetoxymatricarin Chemical compound C1CC(C)=C2C(=O)C=C(C)[C@@H]2[C@H]2OC(=O)[C@@H](C)[C@@H]21 BJPSSVHNEGMBDQ-NUZBWSBOSA-N 0.000 description 52
- XMRKUJJDDKYUHV-OAHLLOKOSA-N (+)-germacrene A Chemical compound CC(=C)[C@@H]1CCC(C)=CCCC(C)=CC1 XMRKUJJDDKYUHV-OAHLLOKOSA-N 0.000 description 48
- 229930009674 sesquiterpene lactone Natural products 0.000 description 47
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 47
- 238000005805 hydroxylation reaction Methods 0.000 description 45
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 44
- XMRKUJJDDKYUHV-DEKOOOMZSA-N (+)-Germacrene A Natural products CC(=C)[C@@H]1CC\C(C)=C/CC\C(C)=C/C1 XMRKUJJDDKYUHV-DEKOOOMZSA-N 0.000 description 43
- BJPSSVHNEGMBDQ-UHFFFAOYSA-N desacetoxymatricarin Natural products C1CC(C)=C2C(=O)C=C(C)C2C2OC(=O)C(C)C21 BJPSSVHNEGMBDQ-UHFFFAOYSA-N 0.000 description 43
- 230000033444 hydroxylation Effects 0.000 description 42
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 40
- IBJVPIJUFFVDBS-JBMXZMKISA-N germacra-1(10),4,11(13)-trien-12-oic acid Chemical compound C\C1=C/C[C@H](C(=C)C(O)=O)CC\C(C)=C\CC1 IBJVPIJUFFVDBS-JBMXZMKISA-N 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 37
- 150000001875 compounds Chemical class 0.000 description 34
- -1 terpenoid compounds Chemical class 0.000 description 34
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 31
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 29
- YOVSPTNQHMDJAG-QLFBSQMISA-N β-eudesmene Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)C)CC[C@]21C YOVSPTNQHMDJAG-QLFBSQMISA-N 0.000 description 27
- DUYRYUZIBGFLDD-AAVRWANBSA-N (1r,3ar,4r,7r)-1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene Chemical compound C[C@@H]1CC[C@@H](C(C)=C)C=C2[C@H](C)CC[C@@H]21 DUYRYUZIBGFLDD-AAVRWANBSA-N 0.000 description 26
- 239000000203 mixture Substances 0.000 description 26
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 24
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 24
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 24
- DUYRYUZIBGFLDD-UHFFFAOYSA-N gamma-gurjunene Natural products CC1CCC(C(C)=C)C=C2C(C)CCC21 DUYRYUZIBGFLDD-UHFFFAOYSA-N 0.000 description 24
- 239000006228 supernatant Substances 0.000 description 24
- LMNJALUUIMXUQQ-UHFFFAOYSA-N saussurea lactone Chemical compound C1CC(C)(C=C)C(C(C)=C)C2OC(=O)C(C)C21 LMNJALUUIMXUQQ-UHFFFAOYSA-N 0.000 description 23
- 238000003556 assay Methods 0.000 description 22
- IBJVPIJUFFVDBS-UHFFFAOYSA-N germacrene A Natural products CC1=CCC(C(=C)C(O)=O)CCC(C)=CCC1 IBJVPIJUFFVDBS-UHFFFAOYSA-N 0.000 description 22
- ZNTHTBBAGNVESR-SFDCQRBFSA-N (3as,6s,7s,7as)-6-ethenyl-6-methyl-3-methylidene-7-prop-1-en-2-yl-4,5,7,7a-tetrahydro-3ah-1-benzofuran-2-one Chemical compound C1C[C@](C=C)(C)[C@H](C(=C)C)[C@H]2OC(=O)C(=C)[C@@H]21 ZNTHTBBAGNVESR-SFDCQRBFSA-N 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000008188 pellet Substances 0.000 description 21
- DPQYOKVMVCQHMY-TUVASFSCSA-N (1s,4ar,7r,8ar)-1,4a-dimethyl-7-prop-1-en-2-yl-2,3,4,5,6,7,8,8a-octahydronaphthalen-1-ol Chemical compound C1CC[C@](C)(O)[C@@H]2C[C@H](C(=C)C)CC[C@]21C DPQYOKVMVCQHMY-TUVASFSCSA-N 0.000 description 19
- 239000002299 complementary DNA Substances 0.000 description 19
- 230000003228 microsomal effect Effects 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 18
- 238000001819 mass spectrum Methods 0.000 description 17
- 238000005952 Cope rearrangement reaction Methods 0.000 description 16
- 150000003505 terpenes Chemical class 0.000 description 16
- WGTRJVCFDUCKCM-FMKGYKFTSA-N viridiflorene Chemical compound C1C[C@H]2C(C)(C)[C@H]2[C@@H]2[C@H](C)CCC2=C1C WGTRJVCFDUCKCM-FMKGYKFTSA-N 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 150000001299 aldehydes Chemical class 0.000 description 15
- 244000005700 microbiome Species 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 description 14
- FQTLCLSUCSAZDY-KAMYIIQDSA-N (6Z)-nerolidol Chemical compound CC(C)=CCC\C(C)=C/CCC(C)(O)C=C FQTLCLSUCSAZDY-KAMYIIQDSA-N 0.000 description 14
- FQTLCLSUCSAZDY-ATGUSINASA-N (Z)-Nerolidol Natural products CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- YOVSPTNQHMDJAG-UHFFFAOYSA-N beta-helmiscapene Natural products C1CCC(=C)C2CC(C(=C)C)CCC21C YOVSPTNQHMDJAG-UHFFFAOYSA-N 0.000 description 14
- IEICDHBPEPUHOB-UHFFFAOYSA-N ent-beta-selinene Natural products C1CCC(=C)C2CC(C(C)C)CCC21C IEICDHBPEPUHOB-UHFFFAOYSA-N 0.000 description 14
- WGTRJVCFDUCKCM-UHFFFAOYSA-N ent-ledene Natural products C1CC2C(C)(C)C2C2C(C)CCC2=C1C WGTRJVCFDUCKCM-UHFFFAOYSA-N 0.000 description 14
- 239000003205 fragrance Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- CZSSHKCZSDDOAH-UNQGMJICSA-N (+)-artemisinic alcohol Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(=C)CO)[C@H]21 CZSSHKCZSDDOAH-UNQGMJICSA-N 0.000 description 13
- XMRKUJJDDKYUHV-HNNXBMFYSA-N (1E,4E,7betaH)-germacra-1(10),4,11(12)-triene Chemical compound CC(=C)[C@H]1CCC(C)=CCCC(C)=CC1 XMRKUJJDDKYUHV-HNNXBMFYSA-N 0.000 description 13
- 108020005199 Dehydrogenases Proteins 0.000 description 13
- ZNTHTBBAGNVESR-UHFFFAOYSA-N dehydrosaussurea lactone Natural products C1CC(C=C)(C)C(C(=C)C)C2OC(=O)C(=C)C21 ZNTHTBBAGNVESR-UHFFFAOYSA-N 0.000 description 13
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 13
- 238000007254 oxidation reaction Methods 0.000 description 13
- GXEGJTGWYVZSNR-UHFFFAOYSA-N (1E,4Z)-germacrene B Chemical compound CC(C)=C1CCC(C)=CCCC(C)=CC1 GXEGJTGWYVZSNR-UHFFFAOYSA-N 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 240000000560 Citrus x paradisi Species 0.000 description 12
- 101710088194 Dehydrogenase Proteins 0.000 description 12
- XMRKUJJDDKYUHV-UHFFFAOYSA-N Helminthogermacrene Natural products CC(=C)C1CCC(C)=CCCC(C)=CC1 XMRKUJJDDKYUHV-UHFFFAOYSA-N 0.000 description 12
- OZQAPQSEYFAMCY-UHFFFAOYSA-N alpha-selinene Natural products C1CC=C(C)C2CC(C(=C)C)CCC21C OZQAPQSEYFAMCY-UHFFFAOYSA-N 0.000 description 12
- 229930001612 germacrene Natural products 0.000 description 12
- GXEGJTGWYVZSNR-OMQMMEOVSA-N germacrene-B Natural products CC(C)=C1CC\C(C)=C/CC\C(C)=C/C1 GXEGJTGWYVZSNR-OMQMMEOVSA-N 0.000 description 12
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 12
- 230000003647 oxidation Effects 0.000 description 12
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 11
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 11
- LMNJALUUIMXUQQ-RLPMIEJPSA-N Saussurea lactone Natural products O=C1[C@@H](C)[C@H]2[C@H]([C@@H](C(=C)C)[C@@](C=C)(C)CC2)O1 LMNJALUUIMXUQQ-RLPMIEJPSA-N 0.000 description 11
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 10
- 229960004191 artemisinin Drugs 0.000 description 10
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 10
- 150000004273 guaianolide derivatives Chemical class 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- KTEXNACQROZXEV-PVLRGYAZSA-N parthenolide Chemical compound C1CC(/C)=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 KTEXNACQROZXEV-PVLRGYAZSA-N 0.000 description 10
- 241000894007 species Species 0.000 description 10
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 9
- XMRKUJJDDKYUHV-DFSVIBJJSA-N (+)-germacrene A Chemical compound CC(=C)[C@@H]1CC\C(C)=C\CC\C(C)=C\C1 XMRKUJJDDKYUHV-DFSVIBJJSA-N 0.000 description 9
- CUGKULNFZMNVQI-UHFFFAOYSA-N Costunolid I Natural products CC1=CCC=C(/C)CCC2C(C1)OC(=O)C2=C CUGKULNFZMNVQI-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 150000001298 alcohols Chemical class 0.000 description 9
- MMTZAJNKISZWFG-UHFFFAOYSA-N costunolide Natural products CC1CCC2C(CC(=C/C=C1)C)OC(=O)C2=C MMTZAJNKISZWFG-UHFFFAOYSA-N 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 150000002576 ketones Chemical class 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- YHRUHBBTQZKMEX-YFVJMOTDSA-N (2-trans,6-trans)-farnesal Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\C=O YHRUHBBTQZKMEX-YFVJMOTDSA-N 0.000 description 8
- YHRUHBBTQZKMEX-UHFFFAOYSA-N (2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-al Natural products CC(C)=CCCC(C)=CCCC(C)=CC=O YHRUHBBTQZKMEX-UHFFFAOYSA-N 0.000 description 8
- 102000018832 Cytochromes Human genes 0.000 description 8
- 108010052832 Cytochromes Proteins 0.000 description 8
- YHRUHBBTQZKMEX-FBXUGWQNSA-N E,E-Farnesal Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/C=O YHRUHBBTQZKMEX-FBXUGWQNSA-N 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 8
- 101150053185 P450 gene Proteins 0.000 description 8
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha-cubebene Chemical compound CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 description 8
- 239000012084 conversion product Substances 0.000 description 8
- 230000001419 dependent effect Effects 0.000 description 8
- 238000002955 isolation Methods 0.000 description 8
- 150000002596 lactones Chemical class 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- CRDAMVZIKSXKFV-YFVJMOTDSA-N (2-trans,6-trans)-farnesol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO CRDAMVZIKSXKFV-YFVJMOTDSA-N 0.000 description 7
- KNLJFYVIVVSUNJ-QLFBSQMISA-N 2-[(1r,3s,4s)-4-ethenyl-4-methyl-3-prop-1-en-2-ylcyclohexyl]prop-2-en-1-ol Chemical compound CC(=C)[C@@H]1C[C@H](C(=C)CO)CC[C@@]1(C)C=C KNLJFYVIVVSUNJ-QLFBSQMISA-N 0.000 description 7
- MTBNHGFRLZSOTC-UHFFFAOYSA-N Alloisolongifolene Natural products CC12CCCC3(C(=C)C)C2CCC1(C)C3 MTBNHGFRLZSOTC-UHFFFAOYSA-N 0.000 description 7
- SGZOYHLQNUSAIL-UHFFFAOYSA-N Ioscostussaeure Natural products C1C(C(=C)C(O)=O)CCC2(C)CCCC(C)=C21 SGZOYHLQNUSAIL-UHFFFAOYSA-N 0.000 description 7
- 240000008415 Lactuca sativa Species 0.000 description 7
- 235000003228 Lactuca sativa Nutrition 0.000 description 7
- WGTRJVCFDUCKCM-ASEORRQLSA-N Ledene Natural products C[C@@H]1[C@H]2[C@H]3C(C)(C)[C@@H]3CCC(C)=C2CC1 WGTRJVCFDUCKCM-ASEORRQLSA-N 0.000 description 7
- CKZXONNJVHXSQM-UHFFFAOYSA-N Ledol Natural products CC(C)C1CCC(C)(O)C2C3CC(C)CC123 CKZXONNJVHXSQM-UHFFFAOYSA-N 0.000 description 7
- BUQLXKSONWUQAC-UHFFFAOYSA-N Parthenolide Natural products CC1C2OC(=O)C(=C)C2CCC(=C/CCC1(C)O)C BUQLXKSONWUQAC-UHFFFAOYSA-N 0.000 description 7
- 244000272264 Saussurea lappa Species 0.000 description 7
- 235000006784 Saussurea lappa Nutrition 0.000 description 7
- FQJRQKXSGHUMRO-SHWKFHJASA-N alloisolongifolene alcohol Chemical compound C1CC[C@@]2(C(=C)CO)C[C@@]3(C)C1(C)C2CC3 FQJRQKXSGHUMRO-SHWKFHJASA-N 0.000 description 7
- 125000000746 allylic group Chemical group 0.000 description 7
- UTXMCYDEIZPGME-UHFFFAOYSA-N beta-Isocostic acid Natural products C1CC(C(=C)C(O)=O)CC2C(C)=CCCC21C UTXMCYDEIZPGME-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 238000001952 enzyme assay Methods 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 229930002882 germacranolide Natural products 0.000 description 7
- 150000003073 germacranolide derivatives Chemical class 0.000 description 7
- 238000010348 incorporation Methods 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 229940069510 parthenolide Drugs 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 235000007586 terpenes Nutrition 0.000 description 7
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 7
- WGTRJVCFDUCKCM-SCUASFONSA-N viridiflorene Natural products C1C[C@@H]2C(C)(C)[C@H]2[C@@H]2[C@@H](C)CCC2=C1C WGTRJVCFDUCKCM-SCUASFONSA-N 0.000 description 7
- MTBNHGFRLZSOTC-AJNGGQMLSA-N (1S,2S,6R,8S)-2,8-dimethyl-6-prop-1-en-2-yltricyclo[4.4.0.02,8]decane Chemical compound C([C@]12C)CC[C@]3(C(=C)C)[C@H]2CC[C@@]1(C)C3 MTBNHGFRLZSOTC-AJNGGQMLSA-N 0.000 description 6
- 240000006740 Cichorium endivia Species 0.000 description 6
- 208000003311 Cytochrome P-450 Enzyme Inhibitors Diseases 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 6
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 6
- 108091034057 RNA (poly(A)) Proteins 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 230000001851 biosynthetic effect Effects 0.000 description 6
- 235000003733 chicria Nutrition 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- AXUADEXBLHHYAJ-OAHLLOKOSA-N germacra-1(10),4,11(13)-trien-12-al Chemical compound CC1=CC[C@H](C(=C)C=O)CCC(C)=CCC1 AXUADEXBLHHYAJ-OAHLLOKOSA-N 0.000 description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- QVGXLLKOCUKJST-NJFSPNSNSA-N oxygen-18 atom Chemical compound [18O] QVGXLLKOCUKJST-NJFSPNSNSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 239000002676 xenobiotic agent Substances 0.000 description 6
- WJHFZYAELPOJIV-IJFRVEDASA-N (2E,6E)-farnesoic acid Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\C(O)=O WJHFZYAELPOJIV-IJFRVEDASA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- NDZJCEAHBZKIDU-OAHLLOKOSA-N 2-[(1R,3E,7E)-4,8-dimethylcyclodeca-3,7-dien-1-yl]prop-2-en-1-ol Chemical compound CC1=CC[C@H](C(=C)CO)CCC(C)=CCC1 NDZJCEAHBZKIDU-OAHLLOKOSA-N 0.000 description 5
- FKWGZOFNSIESOX-QLFBSQMISA-N 2-[(2r,4ar,8as)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-en-1-ol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)CO)CC[C@]21C FKWGZOFNSIESOX-QLFBSQMISA-N 0.000 description 5
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 5
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 5
- WKSUCCVMYJRMFR-UHFFFAOYSA-N Dehydrocostus lactone Natural products C12OC(=O)C(=C)C2CCC(=C)C2(C)C1(C)C(=C)CC2 WKSUCCVMYJRMFR-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- CRDAMVZIKSXKFV-FBXUGWQNSA-N E,E-Farnesol Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 5
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 5
- 241000208818 Helianthus Species 0.000 description 5
- 241000196323 Marchantiophyta Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- YMBFCQPIMVLNIU-SOUVJXGZSA-N alpha-trans-Bergamotene Natural products C1[C@@H]2[C@@](CCC=C(C)C)(C)[C@H]1CC=C2C YMBFCQPIMVLNIU-SOUVJXGZSA-N 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000012131 assay buffer Substances 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229930000731 eudesmanolide Natural products 0.000 description 5
- 150000000551 eudesmanolide derivatives Chemical class 0.000 description 5
- 239000011536 extraction buffer Substances 0.000 description 5
- NDZJCEAHBZKIDU-UHFFFAOYSA-N germacra-1(10),4,11(13)-trien-12-ol Natural products CC1=CCC(C(=C)CO)CCC(C)=CCC1 NDZJCEAHBZKIDU-UHFFFAOYSA-N 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 5
- 229930003658 monoterpene Natural products 0.000 description 5
- 150000002773 monoterpene derivatives Chemical class 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 108010087432 terpene synthase Proteins 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 4
- NMQLKXNABMBXMS-UHFFFAOYSA-N (-)-beta-elemene Natural products CC(=C)C1CCC(C)(C=C)C(C=C)C1 NMQLKXNABMBXMS-UHFFFAOYSA-N 0.000 description 4
- XMGQYMWWDOXHJM-SNVBAGLBSA-N (-)-α-limonene Chemical compound CC(=C)[C@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-SNVBAGLBSA-N 0.000 description 4
- CAULGCQHVOVVRN-UHFFFAOYSA-N (3Z,9E)-Germacra-3,7(11),9-trien-6-on Natural products CC(C)=C1CC=C(C)CCC=C(C)CC1=O CAULGCQHVOVVRN-UHFFFAOYSA-N 0.000 description 4
- CAULGCQHVOVVRN-SWZPTJTJSA-N (E,E)-germacrone Chemical compound CC(C)=C1C\C=C(C)\CC\C=C(C)\CC1=O CAULGCQHVOVVRN-SWZPTJTJSA-N 0.000 description 4
- UJQGVDNQDFTTLZ-VNHYZAJKSA-N 2-[(2r,4ar,8as)-4a-methyl-8-methylidene-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl]prop-2-enoic acid Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(=C)C(O)=O)CC[C@]21C UJQGVDNQDFTTLZ-VNHYZAJKSA-N 0.000 description 4
- ZDWPBMJZDNXTPG-UHFFFAOYSA-N 2h-benzotriazol-4-amine Chemical compound NC1=CC=CC2=C1NN=N2 ZDWPBMJZDNXTPG-UHFFFAOYSA-N 0.000 description 4
- 235000016626 Agrimonia eupatoria Nutrition 0.000 description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 4
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 235000019106 Cynara scolymus Nutrition 0.000 description 4
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- ZVSZHMFUICOVPY-UHFFFAOYSA-N Germacrone Natural products CC(=C)C1CC=C(/C)CCC=C(/C)CC1=O ZVSZHMFUICOVPY-UHFFFAOYSA-N 0.000 description 4
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 4
- 235000003222 Helianthus annuus Nutrition 0.000 description 4
- 240000008892 Helianthus tuberosus Species 0.000 description 4
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 4
- 108010020056 Hydrogenase Proteins 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- GFNWRKNVTHDNPV-GBOPCIDUSA-N alpha-nootkatol Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)C[C@@H](O)C=C21 GFNWRKNVTHDNPV-GBOPCIDUSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229930010846 beta-costol Natural products 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- NETSQGRTUNRXEO-XUXIUFHCSA-N dehydrocostus lactone Chemical compound C([C@H]1C(=C)C(=O)O[C@@H]11)CC(=C)[C@H]2[C@@H]1C(=C)CC2 NETSQGRTUNRXEO-XUXIUFHCSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000012259 ether extract Substances 0.000 description 4
- DLLJVQNYBYOKGS-UHFFFAOYSA-N ethoxyethane;pentane Chemical compound CCCCC.CCOCC DLLJVQNYBYOKGS-UHFFFAOYSA-N 0.000 description 4
- AXUADEXBLHHYAJ-UHFFFAOYSA-N germacra-1(10),4,11(13)-trien-12-al Natural products CC1=CCC(C(=C)C=O)CCC(C)=CCC1 AXUADEXBLHHYAJ-UHFFFAOYSA-N 0.000 description 4
- 239000011491 glass wool Substances 0.000 description 4
- 150000003278 haem Chemical class 0.000 description 4
- 239000002932 luster Substances 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 150000003222 pyridines Chemical class 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- FKWGZOFNSIESOX-UHFFFAOYSA-N β-costol Chemical compound C1CCC(=C)C2CC(C(=C)CO)CCC21C FKWGZOFNSIESOX-UHFFFAOYSA-N 0.000 description 4
- OVDMFKGCVWVONO-CTXCDQGASA-N (+)-Dihydrocostunolide Natural products O=C1[C@@H](C)[C@H]2[C@@H](O1)/C=C(/C)\CC/C=C(/C)\CC2 OVDMFKGCVWVONO-CTXCDQGASA-N 0.000 description 3
- SPCXZDDGSGTVAW-XIDUGBJDSA-N (-)-alpha-gurjunene Chemical compound C[C@@H]1CC[C@H]2C(C)(C)[C@H]2C2=C(C)CC[C@H]12 SPCXZDDGSGTVAW-XIDUGBJDSA-N 0.000 description 3
- WJHFZYAELPOJIV-UHFFFAOYSA-N (2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienoic acid Natural products CC(C)=CCCC(C)=CCCC(C)=CC(O)=O WJHFZYAELPOJIV-UHFFFAOYSA-N 0.000 description 3
- JEPRHCQQNHNKJV-LGBFMXSASA-N (2z)-2-[(3e,7z)-4,8-dimethylcyclodeca-3,7-dien-1-ylidene]propan-1-ol Chemical compound OCC(/C)=C1/CC\C(C)=C/CC\C(C)=C\C1 JEPRHCQQNHNKJV-LGBFMXSASA-N 0.000 description 3
- OVDMFKGCVWVONO-YZBSBUPCSA-N (3s,3as,10e,11as)-3,6,10-trimethyl-3a,4,5,8,9,11a-hexahydro-3h-cyclodeca[b]furan-2-one Chemical compound C1CC(C)=CCC\C(C)=C\[C@H]2OC(=O)[C@@H](C)[C@@H]21 OVDMFKGCVWVONO-YZBSBUPCSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 240000000011 Artemisia annua Species 0.000 description 3
- 235000001405 Artemisia annua Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 108030000724 Costunolide synthases Proteins 0.000 description 3
- 244000019459 Cynara cardunculus Species 0.000 description 3
- OVDMFKGCVWVONO-UHFFFAOYSA-N Dihydrocostunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(C)C21 OVDMFKGCVWVONO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 3
- UMVSOHBRAQTGQI-UPZYVNNASA-N Lactucopicrin Natural products O=C(O[C@@H]1[C@H]2C(=C)C(=O)O[C@@H]2[C@@H]2C(CO)=CC(=O)C2=C(C)C1)Cc1ccc(O)cc1 UMVSOHBRAQTGQI-UPZYVNNASA-N 0.000 description 3
- 229910010084 LiAlH4 Inorganic materials 0.000 description 3
- 229910020284 Na2SO4.10H2O Inorganic materials 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- FJNHFUOCVLERHW-UHFFFAOYSA-N alpha-gurjunene Natural products CC1CCC2C(C3=CCCC13)C2(C)C FJNHFUOCVLERHW-UHFFFAOYSA-N 0.000 description 3
- 239000003430 antimalarial agent Substances 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000011942 biocatalyst Substances 0.000 description 3
- 239000003139 biocide Substances 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 3
- 229960004022 clotrimazole Drugs 0.000 description 3
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 3
- 229930016889 costol Natural products 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 229960004132 diethyl ether Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000006735 epoxidation reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- ITRHZWKEZJYJQO-UHFFFAOYSA-N gamma-costol Natural products C1C(C(=C)CO)CCC2(C)CCCC(C)=C21 ITRHZWKEZJYJQO-UHFFFAOYSA-N 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 108010024445 germacrene A hydroxylase Proteins 0.000 description 3
- 150000001297 germacrene derivatives Chemical class 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 3
- VJQAFLAZRVKAKM-QQUHWDOBSA-N lactucin Chemical compound O[C@@H]1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 VJQAFLAZRVKAKM-QQUHWDOBSA-N 0.000 description 3
- VJQAFLAZRVKAKM-UHFFFAOYSA-N lactucine Natural products OC1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 VJQAFLAZRVKAKM-UHFFFAOYSA-N 0.000 description 3
- QCDLLIUTDGNCPO-UHFFFAOYSA-N lactupicrin Natural products C12OC(=O)C(=C)C2C(O)CC(C)=C(C(C=2)=O)C1C=2COC(=O)CC1=CC=C(O)C=C1 QCDLLIUTDGNCPO-UHFFFAOYSA-N 0.000 description 3
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- FJLBFSROUSIWMA-UHFFFAOYSA-N metyrapone Chemical compound C=1C=CN=CC=1C(C)(C)C(=O)C1=CC=CN=C1 FJLBFSROUSIWMA-UHFFFAOYSA-N 0.000 description 3
- 229960004465 metyrapone Drugs 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000002577 monoterpenes Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000003598 selinene derivatives Chemical class 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- 229940099369 (+)- limonene Drugs 0.000 description 2
- 229930000700 (+)-beta-selinene Natural products 0.000 description 2
- 229960003595 (-)- limonene Drugs 0.000 description 2
- YHRUHBBTQZKMEX-PVMFERMNSA-N (2-cis,6-trans)-farnesal Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C/C=O YHRUHBBTQZKMEX-PVMFERMNSA-N 0.000 description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 2
- 239000001706 (4R)-4-methyloctanoic acid Substances 0.000 description 2
- RUJPNZNXGCHGID-UHFFFAOYSA-N (Z)-beta-Terpineol Natural products CC(=C)C1CCC(C)(O)CC1 RUJPNZNXGCHGID-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- QXRKIZKJLNNMNC-UHFFFAOYSA-N 11,13-Dihydrocostic acid Natural products CC(C1CCC2(C)CCCC(=C)C2C1)C(=O)O QXRKIZKJLNNMNC-UHFFFAOYSA-N 0.000 description 2
- SNIFBMIPCYBVSS-LMVZTGKYSA-N 11beta,13-dihydro-8-deoxylactucin Chemical compound C1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)[C@@H](C)[C@@H]21 SNIFBMIPCYBVSS-LMVZTGKYSA-N 0.000 description 2
- TVTRVIJHJANPCN-UHFFFAOYSA-N 2-(3,8-dimethyl-1,2,3,5,6,7,8,8a-octahydroazulen-5-yl)prop-2-en-1-ol Chemical compound CC1CCC(C(=C)CO)C=C2C(C)CCC21 TVTRVIJHJANPCN-UHFFFAOYSA-N 0.000 description 2
- DJZHNAGRSWMVPA-QLFBSQMISA-N 2-[(1r,3s,4s)-4-ethenyl-4-methyl-3-prop-1-en-2-ylcyclohexyl]prop-2-enal Chemical compound CC(=C)[C@@H]1C[C@H](C(=C)C=O)CC[C@@]1(C)C=C DJZHNAGRSWMVPA-QLFBSQMISA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 2
- XQVSREKNQZKAKU-UHFFFAOYSA-N 4'-demethuylpodophyllotoxin-7-Deoxy Natural products C1CC(C)=CCC(O)C(C)=CC2OC(=O)C(=C)C21 XQVSREKNQZKAKU-UHFFFAOYSA-N 0.000 description 2
- LEGGANXCVQPIAI-UHFFFAOYSA-N 4-methyl-octanoic acid Chemical compound CCCCC(C)CCC(O)=O LEGGANXCVQPIAI-UHFFFAOYSA-N 0.000 description 2
- NIYXMGSLECQTQT-UHFFFAOYSA-N 8-deoxylactucin Natural products C1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 NIYXMGSLECQTQT-UHFFFAOYSA-N 0.000 description 2
- WLJQSNNKIQSGBT-UHFFFAOYSA-N 8-hydroxy-5a,9-dimethyl-3-methylidene-4,5,6,7,8,9b-hexahydro-3aH-benzo[g][1]benzofuran-2-one Chemical compound C1CC2(C)CCC(O)C(C)=C2C2OC(=O)C(=C)C21 WLJQSNNKIQSGBT-UHFFFAOYSA-N 0.000 description 2
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
- GXEGJTGWYVZSNR-SJRHNVSNSA-N CC(C)=C1C/C=C(\C)CC/C=C(\C)CC1 Chemical compound CC(C)=C1C/C=C(\C)CC/C=C(\C)CC1 GXEGJTGWYVZSNR-SJRHNVSNSA-N 0.000 description 2
- 241001674345 Callitropsis nootkatensis Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 240000001879 Digitalis lutea Species 0.000 description 2
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MCNAURNYDFSEML-UHFFFAOYSA-N Guaiane Natural products CC1CCC(C(C)=C)C(O)C2=C(C)C(=O)CC12 MCNAURNYDFSEML-UHFFFAOYSA-N 0.000 description 2
- 235000009417 Helenium Nutrition 0.000 description 2
- 241000521915 Helenium Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- VMOFNEIWZSLTBX-UHFFFAOYSA-N Laurenobiolide Natural products COC(=O)C1C=C(/C)CCC=C(/C)CC2OC(=O)C(=C)C12 VMOFNEIWZSLTBX-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 101710198130 NADPH-cytochrome P450 reductase Proteins 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- AVFIYMSJDDGDBQ-UHFFFAOYSA-N Parthenium Chemical compound C1C=C(CCC(C)=O)C(C)CC2OC(=O)C(=C)C21 AVFIYMSJDDGDBQ-UHFFFAOYSA-N 0.000 description 2
- 241001495454 Parthenium Species 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 244000292071 Scorzonera hispanica Species 0.000 description 2
- 235000018704 Scorzonera hispanica Nutrition 0.000 description 2
- 229910018162 SeO2 Inorganic materials 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 235000012363 Tragopogon porrifolius Nutrition 0.000 description 2
- 244000300530 Tragopogon porrifolius Species 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- TVTRVIJHJANPCN-HBJVGIJOSA-N [H][C@]12CC[C@@H](C)C1=C[C@H](C(=C)CO)CC[C@H]2C Chemical compound [H][C@]12CC[C@@H](C)C1=C[C@H](C(=C)CO)CC[C@H]2C TVTRVIJHJANPCN-HBJVGIJOSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000000078 anti-malarial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 235000016520 artichoke thistle Nutrition 0.000 description 2
- UJQGVDNQDFTTLZ-UHFFFAOYSA-N beta-costic acid Natural products C1CCC(=C)C2CC(C(=C)C(O)=O)CCC21C UJQGVDNQDFTTLZ-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000008238 biochemical pathway Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000012681 biocontrol agent Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 108010064866 biozym Proteins 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- QABCGOSYZHCPGN-UHFFFAOYSA-N chloro(dimethyl)silicon Chemical compound C[Si](C)Cl QABCGOSYZHCPGN-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000006957 competitive inhibition Effects 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- SKNVIAFTENCNGB-UHFFFAOYSA-N dehydroleucodine Natural products C1CC2C(=C)C(=O)OC2C2C(C)=CC(=O)C2=C1C SKNVIAFTENCNGB-UHFFFAOYSA-N 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 2
- 229960000648 digitoxin Drugs 0.000 description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
- 229960005156 digoxin Drugs 0.000 description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 125000000567 diterpene group Chemical group 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 229930002886 farnesol Natural products 0.000 description 2
- 229940043259 farnesol Drugs 0.000 description 2
- 238000003818 flash chromatography Methods 0.000 description 2
- RMZHSBMIZBMVMN-UHFFFAOYSA-N gamma-Selinene Chemical compound C1CCC(=C)C2CC(=C(C)C)CCC21C RMZHSBMIZBMVMN-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- QAQCPAHQVOKALN-RMEBNNNOSA-N guaiane Chemical compound C1[C@H](C(C)C)CC[C@H](C)[C@@H]2CC[C@H](C)[C@@H]21 QAQCPAHQVOKALN-RMEBNNNOSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical class [H]O* 0.000 description 2
- 230000000640 hydroxylating effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
- 229960002695 phenobarbital Drugs 0.000 description 2
- 150000003097 polyterpenes Chemical class 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000024053 secondary metabolic process Effects 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 150000004506 (+)-germacrene A derivatives Chemical class 0.000 description 1
- MOTCYZHGMCNNRH-UHFFFAOYSA-N (+)-selina-4,11-diene Natural products C1CCC(C)=C2CC(C(=C)C)CCC21C MOTCYZHGMCNNRH-UHFFFAOYSA-N 0.000 description 1
- 229930014548 (-)-alpha-gurjunene Natural products 0.000 description 1
- MZJCFRKLOXHQIL-CCAGOZQPSA-N (1Z,3Z)-cyclodeca-1,3-diene Chemical group C1CCC\C=C/C=C\CC1 MZJCFRKLOXHQIL-CCAGOZQPSA-N 0.000 description 1
- WJHFZYAELPOJIV-UBWQMIQVSA-N (2z,6e)-3,7,11-trimethyldodeca-2,6,10-trienoic acid Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C/C(O)=O WJHFZYAELPOJIV-UBWQMIQVSA-N 0.000 description 1
- OCZYALGLUPTEFV-JHZZJYKESA-N (3r,3as,5ar,9as,9bs)-3-(methoxymethyl)-5a-methyl-9-methylidene-3a,4,5,6,7,8,9a,9b-octahydro-3h-benzo[g][1]benzofuran-2-one Chemical compound C([C@]1(C)CC2)CCC(=C)[C@@H]1[C@@H]1[C@@H]2[C@H](COC)C(=O)O1 OCZYALGLUPTEFV-JHZZJYKESA-N 0.000 description 1
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- ZHZZKRDEPZMPLJ-WLVQVHLUSA-N 11beta,13-dihydrolactucin Chemical compound [C@@H]1([C@H](CC(C)=C2C(=O)C=C(CO)[C@@H]22)O)[C@@H]2OC(=O)[C@H]1C ZHZZKRDEPZMPLJ-WLVQVHLUSA-N 0.000 description 1
- QYIMSPSDBYKPPY-BANQPHDMSA-N 2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC1OC1(C)C QYIMSPSDBYKPPY-BANQPHDMSA-N 0.000 description 1
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 1
- UTXMCYDEIZPGME-VNHYZAJKSA-N 2-[(2r,4ar,8ar)-4a,8-dimethyl-2,3,4,5,6,8a-hexahydro-1h-naphthalen-2-yl]prop-2-enoic acid Chemical compound C1C[C@@H](C(=C)C(O)=O)C[C@H]2C(C)=CCC[C@@]21C UTXMCYDEIZPGME-VNHYZAJKSA-N 0.000 description 1
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 1
- FTCASOKOHIRYPL-UHFFFAOYSA-N 3,5a,9-trimethyl-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,3a,4,5,6,7,8,9b-octahydrobenzo[g][1]benzofuran-2-one Chemical compound CC1=C2C3OC(=O)C(C)C3CCC2(C)CCC1OC1OC(CO)C(O)C(O)C1O FTCASOKOHIRYPL-UHFFFAOYSA-N 0.000 description 1
- WNRBYZQFEBIUGD-UHFFFAOYSA-N 3,7(11)-Eudesmadiene Natural products C1CC=C(C)C2CC(=C(C)C)CCC21C WNRBYZQFEBIUGD-UHFFFAOYSA-N 0.000 description 1
- MUROMQNYCWNWFJ-UHFFFAOYSA-N 3-Ketone-9beta-Hydroxy-4beta, 11alpha, 13, 15-tetrahydrozaluzanin C Natural products C1C(O)C(=C)C2CC(=O)C(C)C2C2OC(=O)C(C)C21 MUROMQNYCWNWFJ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MWWKESKJRHQWEF-UHFFFAOYSA-N 4-Methyloctan-1-ol Chemical compound CCCCC(C)CCCO MWWKESKJRHQWEF-UHFFFAOYSA-N 0.000 description 1
- GRRNPXSTCFOUCZ-UHFFFAOYSA-N 4-methyloctanal Chemical compound CCCCC(C)CCC=O GRRNPXSTCFOUCZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- AWCOKEKYXUVULZ-UHFFFAOYSA-N Achillin Natural products CC1C2CCC(=C3C(=O)C=C(C)C3(C)C2OC1=O)C AWCOKEKYXUVULZ-UHFFFAOYSA-N 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 108010022380 Amorpha-4,11-diene synthase Proteins 0.000 description 1
- 241001472919 Anthemideae Species 0.000 description 1
- NNDHDYDFEDRMGH-CAEIVAEBSA-N Anthranoyllycoctonine Chemical compound C([C@]12CN(C3[C@@]4(O)[C@]5(O)[C@H]6[C@@H](OC)[C@@H]([C@H](C5)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]4OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N NNDHDYDFEDRMGH-CAEIVAEBSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241001473000 Astereae Species 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- MTBNHGFRLZSOTC-SHWKFHJASA-N C=C(C)[C@@]12CCCC3(C)C1CC[C@@]3(C)C2 Chemical compound C=C(C)[C@@]12CCCC3(C)C1CC[C@@]3(C)C2 MTBNHGFRLZSOTC-SHWKFHJASA-N 0.000 description 1
- WXTBDQGCMRRCDE-SFDCQRBFSA-N C=C(CC1)[C@H]([C@H]([C@@H](CCC2=C)C3=C)OC3=O)[C@@]12O Chemical compound C=C(CC1)[C@H]([C@H]([C@@H](CCC2=C)C3=C)OC3=O)[C@@]12O WXTBDQGCMRRCDE-SFDCQRBFSA-N 0.000 description 1
- YXKFKSFIOIGJMR-NFAWXSAZSA-N C=C(CO)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1 Chemical compound C=C(CO)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1 YXKFKSFIOIGJMR-NFAWXSAZSA-N 0.000 description 1
- NDZJCEAHBZKIDU-KGSGWQTPSA-N C=C(CO)[C@H]1C/C=C(\C)CC/C=C(\C)CC1 Chemical compound C=C(CO)[C@H]1C/C=C(\C)CC/C=C(\C)CC1 NDZJCEAHBZKIDU-KGSGWQTPSA-N 0.000 description 1
- 239000008001 CAPS buffer Substances 0.000 description 1
- JGINTSAQGRHGMG-MCKJQBSKSA-N CC1=CC[C@H]2C[C@@H]1[C@]2(C)CC/C=C(\C)CO Chemical compound CC1=CC[C@H]2C[C@@H]1[C@]2(C)CC/C=C(\C)CO JGINTSAQGRHGMG-MCKJQBSKSA-N 0.000 description 1
- ODQJAVKGDMHFSX-UHFFFAOYSA-N CC1CCC2C(C)CCC(C=C12)C(C)=C.CC1CCC2C(C)CCC(C=C12)C(C)=C Chemical compound CC1CCC2C(C)CCC(C=C12)C(C)=C.CC1CCC2C(C)CCC(C=C12)C(C)=C ODQJAVKGDMHFSX-UHFFFAOYSA-N 0.000 description 1
- HPIKFWIDHCWTLO-DVKSKCSOSA-N C[C@H](CC[C@@H]1[C@H](C)CC2)C1=C[C@@H]2C(C)(CO)O Chemical compound C[C@H](CC[C@@H]1[C@H](C)CC2)C1=C[C@@H]2C(C)(CO)O HPIKFWIDHCWTLO-DVKSKCSOSA-N 0.000 description 1
- DIRLETUBBJIYMQ-GBTROYITSA-N C[C@H](CC[C@@H]1[C@](C)(CC2)O)C1=C[C@@H]2C(C)(CO)O Chemical compound C[C@H](CC[C@@H]1[C@](C)(CC2)O)C1=C[C@@H]2C(C)(CO)O DIRLETUBBJIYMQ-GBTROYITSA-N 0.000 description 1
- 241000132570 Centaurea Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241001643144 Cichorieae Species 0.000 description 1
- JSOWYWSOJSNXRV-GPEWDUERSA-N Cichorioside C Chemical compound C[C@H]1[C@@H]2[C@H](C/C(=C/C[C@@H](/C(=C/[C@@H]2OC1=O)/C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)/C)O JSOWYWSOJSNXRV-GPEWDUERSA-N 0.000 description 1
- JSOWYWSOJSNXRV-UHFFFAOYSA-N Cichorioside C Natural products CC1C2C(O)CC(=CCC(OC3OC(CO)C(O)C(O)C3O)C(=CC2OC1=O)C)C JSOWYWSOJSNXRV-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 244000155563 Cnicus benedictus Species 0.000 description 1
- 235000007856 Cnicus benedictus Nutrition 0.000 description 1
- 235000007460 Coffea arabica Nutrition 0.000 description 1
- 241001133184 Colletotrichum agaves Species 0.000 description 1
- 240000001689 Cyanthillium cinereum Species 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 235000012040 Dahlia pinnata Nutrition 0.000 description 1
- 244000033273 Dahlia variabilis Species 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 241000409203 Doronicum Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- BWRZDLYJNURUHS-UHFFFAOYSA-N Eremanthine Natural products CC1=CCC2C(=C)C(=O)OC2C2C(=C)CCC12 BWRZDLYJNURUHS-UHFFFAOYSA-N 0.000 description 1
- 241000055886 Eremanthus Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000735527 Eupatorium Species 0.000 description 1
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 1
- MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical compound [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 241000371710 Frullania Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241001138373 Geranium macrorrhizum Species 0.000 description 1
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 1
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 1
- 241000735332 Gerbera Species 0.000 description 1
- 108030004951 Germacrene-A synthases Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241001472926 Heliantheae Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000610693 Hymenoxys Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 241001473010 Inuleae Species 0.000 description 1
- UXOXDDUEWZOAIW-UHFFFAOYSA-N Inuline Natural products CCN1CC2(CC(=O)Oc3ccccc3N)CCC(OC)C45C6CC7C(CC(O)(C6C7OC)C(O)(C(OC)C24)C15)OC UXOXDDUEWZOAIW-UHFFFAOYSA-N 0.000 description 1
- 241000085532 Iva axillaris Species 0.000 description 1
- BVQAARKEKMVAKI-UHFFFAOYSA-N Khusimol Natural products CC1(C)C2CCC(=C)C3CCC(CO)C13C2 BVQAARKEKMVAKI-UHFFFAOYSA-N 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 241001293495 Lactuca virosa Species 0.000 description 1
- 235000007279 Lewisia rediviva Nutrition 0.000 description 1
- 244000228367 Lewisia rediviva Species 0.000 description 1
- 108010054320 Lignin peroxidase Proteins 0.000 description 1
- 241001635500 Linzia glabra Species 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- XUYAKPXYKQEFPD-UHFFFAOYSA-N Morifolin B Natural products C1CC2(C)CCCC(=C)C2C2C1C(=C)C(=O)O2 XUYAKPXYKQEFPD-UHFFFAOYSA-N 0.000 description 1
- 241001472928 Mutisieae Species 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- CBSRFDQDBGGSEA-UHFFFAOYSA-N Selinene Natural products CC(=C1CCC2(C)CCCC(=C)C2(C)C1)C CBSRFDQDBGGSEA-UHFFFAOYSA-N 0.000 description 1
- 241001472923 Senecioneae Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- OWPORVMZZJAHEF-IMWNGCBJSA-N Sonchuside A Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1/C(/C)=C\[C@H]2OC(=O)[C@@H](C)[C@@H]2CC/C(/C)=C/C1 OWPORVMZZJAHEF-IMWNGCBJSA-N 0.000 description 1
- GOVDYISAWRKFQB-YHTJFKHUSA-N Sonchuside C Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)C1=C2[C@](C)(CC[C@@H]3[C@H](C)C(=O)O[C@H]23)CCC1 GOVDYISAWRKFQB-YHTJFKHUSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241001643138 Tageteae Species 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 235000012308 Tagetes Nutrition 0.000 description 1
- 241000404542 Tanacetum Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000006754 Taraxacum officinale Nutrition 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 241000202349 Taxus brevifolia Species 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 235000004478 Tragopogon dubius Nutrition 0.000 description 1
- OOYRHNIVDZZGQV-UHFFFAOYSA-N Tricyclovetivenol Natural products C=C1C(C)(C)C(C2)CCC32C(CO)CCC31 OOYRHNIVDZZGQV-UHFFFAOYSA-N 0.000 description 1
- 241001472918 Vernonieae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- RMARCXQAHOJNRB-TUVASFSCSA-N [H][C@@]12C[C@H](C(=C)CO)CC[C@@]1(C)CCC[C@]2(C)O Chemical compound [H][C@@]12C[C@H](C(=C)CO)CC[C@@]1(C)CCC[C@]2(C)O RMARCXQAHOJNRB-TUVASFSCSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- BJPSSVHNEGMBDQ-OAACRXHESA-N achillin Chemical compound C1CC(C)=C2C(=O)C=C(C)[C@@H]2[C@H]2OC(=O)[C@H](C)[C@@H]21 BJPSSVHNEGMBDQ-OAACRXHESA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- UHODXTMZSDNATP-SFDCQRBFSA-N alpha-Cyclocostunolide Chemical compound C1C[C@H]2C(=C)C(=O)O[C@@H]2[C@H]2C(C)=CCC[C@@]21C UHODXTMZSDNATP-SFDCQRBFSA-N 0.000 description 1
- TUFPZQHDPZYIEX-UHFFFAOYSA-N alpha-Santonin Natural products C1CC2(C)C=CC(=O)C=C2C2C1C(C)C(=O)O2 TUFPZQHDPZYIEX-UHFFFAOYSA-N 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- IGODOXYLBBXFDW-NSHDSACASA-N alpha-Terpinyl acetate Natural products CC(=O)OC(C)(C)[C@@H]1CCC(C)=CC1 IGODOXYLBBXFDW-NSHDSACASA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- GSLDEZOOOSBFGP-UHFFFAOYSA-N alpha-methylene-gamma-butyrolactone Natural products C=C1CCOC1=O GSLDEZOOOSBFGP-UHFFFAOYSA-N 0.000 description 1
- XJHDMGJURBVLLE-BOCCBSBMSA-N alpha-santonin Chemical compound C([C@]1(C)CC2)=CC(=O)C(C)=C1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 XJHDMGJURBVLLE-BOCCBSBMSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- VNRZCPPHNPEBFC-UHFFFAOYSA-N anthranoyllycoctonine Natural products CCN1CC2(COC(=O)c3ccccc3N)CCC(OC)C45C2C(OC)C(O)(C14)C6(O)CC(OC)C7CC5(O)C6C7OC VNRZCPPHNPEBFC-UHFFFAOYSA-N 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OINFTKHXNVCYLH-UHFFFAOYSA-N beta-cyclocostunolide Natural products CC12CCCC(=C)C1C3CC(=O)C(=C)C3CC2 OINFTKHXNVCYLH-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 230000031902 chemoattractant activity Effects 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- USPLDBATMHXKKD-UHFFFAOYSA-N dichloromethane;pentane Chemical compound ClCCl.CCCCC USPLDBATMHXKKD-UHFFFAOYSA-N 0.000 description 1
- 108010057730 digitoxin 12-beta-hydroxylase Proteins 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000002375 environmental carcinogen Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- QPMJENKZJUFOON-PLNGDYQASA-N ethyl (z)-3-chloro-2-cyano-4,4,4-trifluorobut-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/Cl)C(F)(F)F QPMJENKZJUFOON-PLNGDYQASA-N 0.000 description 1
- DYEQPYSFRWUNNV-XQLPTFJDSA-N eudesmane group Chemical group [C@H]12C[C@H](CC[C@]1(C)CCC[C@@H]2C)C(C)C DYEQPYSFRWUNNV-XQLPTFJDSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- PJPHIAMRKUNVSU-UHFFFAOYSA-N gamma-cyclocostunolide Natural products C1CC2(C)CCCC(C)=C2C2OC(=O)C(=C)C21 PJPHIAMRKUNVSU-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 1
- OINNEUNVOZHBOX-KGODAQDXSA-N geranylgeranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C\CC\C(C)=C\CO[P@@](O)(=O)OP(O)(O)=O OINNEUNVOZHBOX-KGODAQDXSA-N 0.000 description 1
- 229930001431 germacrane Natural products 0.000 description 1
- 150000003655 germacrane derivatives Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 229930015714 guaianolide Natural products 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- OOYRHNIVDZZGQV-BHPKHCPMSA-N khusimol Chemical compound C=C1C(C)(C)[C@@H](C2)CC[C@]32[C@@H](CO)CC[C@@H]31 OOYRHNIVDZZGQV-BHPKHCPMSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- UHODXTMZSDNATP-UHFFFAOYSA-N morifolin A Natural products C1CC2C(=C)C(=O)OC2C2C(C)=CCCC21C UHODXTMZSDNATP-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- GGHMUJBZYLPWFD-CUZKYEQNSA-N patchouli alcohol Chemical compound C1C[C@]2(C)[C@@]3(O)CC[C@H](C)[C@@H]2C[C@@H]1C3(C)C GGHMUJBZYLPWFD-CUZKYEQNSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- GGHMUJBZYLPWFD-UHFFFAOYSA-N rac-patchouli alcohol Natural products C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000006965 reversible inhibition Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910001927 ruthenium tetroxide Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940074353 santonin Drugs 0.000 description 1
- 239000001290 saussurea lappa clarke root oil Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- VPQBJIRQUUEAFC-UHFFFAOYSA-N selinene Natural products C1CC=C(C)C2CC(C(C)C)CCC21C VPQBJIRQUUEAFC-UHFFFAOYSA-N 0.000 description 1
- RXHIKAIVEMAPRU-JRIGQVHBSA-N sequiterpene Natural products C1=C(C)[C@@H](OC(C)=O)[C@H](O)[C@@]2(O)[C@H](C)CC[C@@H](C(C)=C)[C@H]21 RXHIKAIVEMAPRU-JRIGQVHBSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- RCINICONZNJXQF-XAZOAEDWSA-N taxol® Chemical compound O([C@@H]1[C@@]2(CC(C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3(C21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-XAZOAEDWSA-N 0.000 description 1
- 150000003535 tetraterpenes Chemical class 0.000 description 1
- 235000009657 tetraterpenes Nutrition 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
- 150000001378 valencene derivatives Chemical class 0.000 description 1
- QEBNYNLSCGVZOH-UHFFFAOYSA-N valencene group Chemical group CC1CCC=C2CCC(CC12C)C(C)=C QEBNYNLSCGVZOH-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 150000007934 α,β-unsaturated carboxylic acids Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Definitions
- the invention relates to the field of bioconversion, using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates. More specifically it relates to a process for production of terpenoid compounds by the use of plant enzymes.
- biocatalysts enzyme, cells
- the most important features of biocatalysts are (Faber, 2000): 1. they are very efficient; 2. they are environmentally acceptable; 3. they operate under mild conditions; 4. they are selective.
- Plants make compounds with the most fantastic chemical structures: the antitumor drug TAXOL® (paclitaxel) (from Taxus brevifolia ), the insect feeding deterrent azadirachtin (from the Indian neem tree Azadirachta indica ) and the analgesic morphine (from Papaver somniferum ). It is mainly because of the tremendous importance of compounds like these that science has been, and still is, interested in the application of plant cells and enzymes, irrespective of the disadvantages they sometimes have (Walton and Brown, 1999).
- TAXOL® paclitaxel
- azadirachtin from the Indian neem tree Azadirachta indica
- analgesic morphine from Papaver somniferum
- the terpenoids belong to the isoprenoids.
- isoprenoids are made up of so-called isoprene (C5) units. This can be recognized in the number of C-atoms present in the isoprenoids which usually can be divided by five (C5, C10, C15, C20, C25, C30 and C40), although also irregular isoprenoids (e.g. C13, C16) and polyterpenes (Cn) have been reported.
- the terpenoids consist of a. o. monoterpenes, sesquiterpenes, diterpenes, triterpenes, tetraterpenes and polyterpenes (rubbers), etc.
- Mono- and sesquiterpenes the C10 and C15 branch of the isoprenoid family, are economically interesting as flavor and fragrance compounds in foods and cosmetics, and can have anti-carcinogenic effects and antimicrobial properties.
- Mono- and sesquiterpenes have also been shown to be of ecological significance, for instance in the interaction and signaling between plants, plants and insects/spider mites and plants and microorganisms.
- sesquiterpene lactones are an important subgroup of the sesquiterpenes, and over 4000 different structures have been identified. A wealth of information is available about the structural aspects and biological activities of these type of compounds (e.g. Picman, 1986; Harborne et al., 1999; Seigler, 1995).
- Sesquiterpene lactones may constitute up to 5% of the dry weight of the plant and occur mainly in members of the Asteraceae (in about 450 species), the largest of all plant families, but also occur in other higher plant families such as the Apiaceae (12 species) and lower plants such as liverworts, for example the genus Frullania (Harborne et al., 1999). Sesquiterpene lactones may occur throughout a plant, but are most commonly associated with leaves, flower parts and taproots.
- the Asteraceae contain 1317 genera and 21000 species. They are mainly herbaceous plants, sometimes shrubs or trees, usually with a taproot, sometimes with tubers. Many of the Asteraceae contain (essential) oil bearing organs, such as ducts or trichomes, some of them contain latex.
- the Asteraceae contain many economic and ornamental plants, such as Sunflower ( Helianthus annuus ; for the production of seeds and sunflower oil), Jerusalem Artichoke ( Helianthus tuberosus ; of which the tubers are eaten and that is also used for the fructan production), and Artemisia annua (for the production of the effective anti-malarial artemisinin).
- Salsify Tragopogon porrifolius
- Scorzonera Scorzonera hispanica
- the young flower-heads of Globe Artichoke Cynara scolymus
- Lettuce Lactuca sativa
- Endive Cichorium endiva
- Radicchio and Brussels Endive Cichorium intybus
- sesquiterpene lactones in the tribes of the Asteraceae is of taxonomic interest. They are common in the Heliantheae, occur frequently in the Anthemideae, Cichorieae, Cynareae, Senecioneae, Inuleae and Vernonieae, only infrequently in the Eupatoriaea and not in the Astereae, Mutisieae, Tageteae and Arcoteae-Calenduleae (Seigler, 1995).
- Crop species that have been shown to contain sesquiterpene lactones are for example: Artichoke, Lettuce, Endive, Radicchio, Brussels Endive, Sunflower, Jerusalem Artichoke, Artemisia annua, Matricaria recutita .
- Some wild (or ornamental) Asteracea species containing sesquiterpene lactones are: Lactuca virosa, Achillea spp., Ambrosia spp.
- Cnicus benedictus Artemisia spp., Xanthium spp., Iva axillaris, Parthenium spp., Helenium spp., Hymenoxys odorata, Vernonia spp., Vanillosmopsis spp., Eremanthus spp., Moquinea spp., Parthenium spp., Arnica spp., Atractylodis macrocephala, Eupatorium cannabium, Achillea millefolium, Tanacetum ( Chrysanthemum ) vulgare, Inula helenium and Taraxacum officinale (Seigler, 1995; Van Genderen et al., 1996).
- Asteraceous species that contains large amounts of sesquiterpene lactones is Chicory.
- the roots of chicory are extremely bitter, due to these sesquiterpene lactones.
- Chicory is a blue-flowered composite plant that has spread all over the world from the Mediterranean and east Asia. Since the seventeenth century it has been cultivated (var. sativum ) for its bitter roots that were roasted and used in hot ‘coffee-like’ beverages. While the use of its roots was displaced by genuine coffee from Coffea arabica , sprouts of chicory (var. foliosum ) that are grown in the dark became popular as a vegetable (Belgian endive) halfway through the nineteenth century. Today it is a common crop in Belgium, northern France and The Netherlands (Weeda et al., 1991; Vogel et al., 1996).
- the plant During the first year of growth, the plant develops a deep taproot and produces a rosette of leaves on a short stem. Following a period of cold exposure, the plant develops a floral meristem.
- Commercial production involves harvesting the plant following the attainment of a proper stage of maturity of the root, followed by floral bud induction (cold storage) and then an accelerated but controlled development of the floral axis and surrounding basal leaves in the dark (forcing).
- the end product of forcing is a chicon, a small white head of leaves ringed with regions of yellow-green.
- This Belgian endive is known for its slightly bitter taste originating from sesquiterpene lactones (Pyrek, 1985; Seto et al., 1988; van Beek et al., 1990; Price et al., 1990).
- the major sesquiterpene lactones of chicory are guaianolides, but smaller amounts of eudesmanolides and germacranolides are also present.
- the bitter taste of chicory is in particular associated with the presence of the guaianolides lactucin, 8-deoxylactucin, and lactucopicrin.
- sesquiterpene lactones Although a lot of information is available about the structural aspects and biological activities of the sesquiterpene lactones, little is known about their biosynthesis. By far the largest group of naturally occurring sesquiterpene lactones is the group of germacranolides, and the majority of sesquiterpene lactones are thought to evolve from this group. The simplest member of the germacranolides, (+)-costunolide, is generally accepted as the common intermediate of all germacranolide-derived lactones (Geissman, 1973; Herz, 1977; Fischer et al., 1979; Seaman, 1982; Song et al., 1995).
- (+)-Costunolide was first isolated from costus roots ( Saussurea lappa Clarke) by Paul et al. (1960) and Somasekar Rao et al. (1960), and has since been found with other sesquiterpene lactones in various plants (Fischer et al., 1979). Amongst them is lettuce ( Lactuca sativa ), a species that is closely related to chicory and also contains the bitter tasting compounds lactucin and lactucopicrin (Takasugi et al, 1985; Price et al., 1990).
- the sesquiterpenoid backbone of the sesquiterpene lactones in chicory is formed by a (+)-germacrene A synthase which cyclizes FPP to (+)-germacrene A (de Kraker et al., 1998; Bouwmeester et al., 1999b).
- This (+)-germacrene A is not further transformed into a guaiane or a eudesmane skeleton, indicating that functionalization of the molecule precedes its cyclization.
- (+)-germacrene A is hydroxylated to germacra-1(10),4,11(13)-trien-12-ol that is further oxidized via germacra-1(10),4,11(13)-trien-12-al to germacra-1(10),4,11(13)-trien-12-oic acid.
- the germacrene acid is thought to be hydroxylated at the C 6 -position and subsequent loss of water leads to the formation of a lactone ring such as present in (+)-costunolide.
- germacrenes are notoriously unstable compounds, susceptible to proton-induced cyclizations and heat induced (e.g. steam distillation, GC-analysis) Cope rearrangement (Takeda, 1974; Bohlman et al., 1983; Reichardt et al., 1988; Teisseire, 1994; de Kraker et al, 1998). None of the intermediates between (+)-germacrene A and (+)-costunolide has ever been isolated, apart from germacra-1(10),4,11(13)-trien-12-al that was isolated with greatest difficulty from Vernonia glabra and could not be separated from its cyclization product costal (Bohlman et al, 1983).
- (+)-costunolide has merely been based on the isolation from costus roots of the Cope-rearrangement products ( ⁇ )-elema-1,3,11(13)-trien-12-ol and ( ⁇ )-elema-1,3,11(13)-trien-12-al, and the proton-induced cyclization products costol, costal and costic acid (Bawdekar and Kelkar, 1965; Bawdekar et al., 1967; Maurer and Grieder, 1977).
- Most vertebrate genomes contain more than 30 different structural genes for cytochromes P450 (Mathews and van Holde, 1996), making this a large and diverse protein family. These proteins resemble mitochondrial cytochrome oxidase in being able to bind both O 2 and CO. Cytochromes P450, however, strongly absorb light at 450 nm when they are in the reduced state and complexed with CO.
- Plant cytochrome P450 monooxygenase systems are associated with the endoplasmic reticulum or a prevacuole, and consequently are located in the light membrane (microsomal) fraction of the cell.
- Cytochrome P450 enzymes are involved in the hydroxylation of a large variety of compounds.
- cytochrome P450 activities There are two classes of cytochrome P450 activities known: those involved in biosynthetic routes and those involved in detoxification of xenobiotics (Donaldson and Luster, 1991; Mihaliak et al., 1993; Schuler, 1996). These reactions include the hydroxylations of steroid hormone biosynthesis, and the synthesis of hydroxylated fatty acids and fatty acid epoxides.
- cytochromes P450 act upon thousands of xenobiotics, including drugs such as phenobarbital and environmental carcinogens such as benzopyrene, a constituent of tobacco smoke. Hydroxylation of foreign substances usually increases their solubility and is a step in their detoxification, or metabolism and excretion.
- Cytochrome P450 systems participate in a wide variety of additional reactions, including epoxidation, peroxygenation, desulfinuration, dealkylation, deamination, and dehalogenation. These reactions are particularly active in the liver, where a number of cytochromes P450 are xenobiotic-inducible; that is, their synthesis is stimulated by substrates that are metabolized by these enzymes (Mathews and van Holde, 1996). Inducers include drugs such as phenobarbital and other barbiturates.
- the amino acid residues that constitute the active site of the enzyme determine the specificity of a given P450. They can vary widely between different cytochromes P450; however, the principal component of the active site of all these enzymes is a heme moiety.
- the iron ion of the heme moiety is the site of the catalytic reaction, and is also responsible for the strong 450 nm absorption peak in combination with CO.
- the substrate specificity of cytochrome P450 enzymes depends on their function in the organism: the biosynthesis of metabolites or the breakdown of xenobiotics in animals. The enzymes that take care of the breakdown of xenobiotics have a low specificity, so that a few enzymes can protect the organism against a large diversity of xenobiotics.
- the enzymes catalyse, among others, stereo- and regioselective hydroxylations, (ep)oxidations, reductions, glycosylations, esterifications and cyclisations.
- the enzymes that are involved in hydroxylations and oxidations have great potential in chemistry, since the corresponding chemical transformations involve the use of toxic reagents and halogenated solvents, which is undesirable because of safety and environmental reasons (March, 2001).
- allylic hydroxylations are usually performed using selenium dioxide in methylene chloride (Jerussi, 1970).
- Digitoxin is a cardiac glycoside from Digitalis sp. Its ⁇ -hydroxylation on the 11-position yields the more potent digoxin. This has been achieved by purified, reconstituted and immobilized digitoxin 12 ⁇ -hydroxylase (a cytochrome P450 enzyme complex) from Digitalis lanata in a bioreactor (Petersen and Seitz, 1988; Petersen et al., 1987).
- Sesquiterpene alcohols and ketones are an interesting group of compounds for a number of reasons. Sesquiterpene alcohols, for example have been shown to be involved in resistance against micro-organisms: the Solanaceae for example produce sesquiterpene alcohol phytoalexins upon infection with pathogenic fungi and in vitro assays have shown that these sequiterpene alcohols have a strong antifungal activity. Also a number of sesquiterpene alcohols are important in the flavor and fragrance industry, for example santalol, typical for the very expensive sandalwood essential oil, and khusimol, patchoulol, etc. Also the sesquiterpene ketone, nootkatone is a commercially important compound.
- nootkatone is a widely used ingredient in perfumery and the flavor industry. Nootkatone was also shown to inhibit gastric lesion which explains that it is a constituent of some stomach medications (Yamahara et al., 1990). Although nootkatone can be obtained from valencene or other substrates using chemical synthesis (Hunter and Brogden, 1965; Wilson and Shaw, 1978; Canadian patent n o 901601; M. Pesaro et al., 1968; Birch, 1974; U.S. Pat. No. 5,847,226) there is a large demand for natural nootkatone.
- the invention relates to the field of bioconversion, using oxidising enzymes, in particular cytochrome P450 related enzymes, with high regio- and enantioselectivity, for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates. More specifically it relates to a process for production of bioactive terpenoid compounds by the use of plant enzymes.
- the invention provides the use of enzymes derived from an organism, in particularly from a plant, that contains sesquiterpene lactones, in biocatalysis. The regio- and stereoselective oxidation of organic compounds is still a largely unresolved challenge to organic chemistry (Faber, 2000).
- oxidising enzymes of a sesquiterpene containing organism such as an Asteraceae species
- a sesquiterpene containing organism such as an Asteraceae species
- Asteraceae, but also plant species from other families, that contain sesquiterpene lactones also contain the enzymes required for their biosyntheis, and thus can be used as a preferred source for these enzymes.
- the invention provides an enzyme that is useful for nootkatone synthesis. Nootkatone is a compound mainly founds in grapefruits and other citrus fruits.
- nootkatone synthesis can also occur with an enzyme that is not derived from a citrus fruit, but from another sesquiterpene containing species instead.
- non-citrus derived enzymes for example from the large amounts of chicory taproots that remain after the growing of the chicory vegetable or inuline chicory, or from other Asteraceae species, such as lettuces, sunflower, artichoke, radicchio, etc, etc, that can easily and abundantly be grown, we have provided here useful enzymes for example the flavor, aroma, pharmaceutical or biocide industry.
- liverworts are another good example of a cheap and widely available source for these oxidising enzymes and several families of the liverworts have been reported to contain sesquiterpene lactones. Sesquiterpene lactones isolated from higher plants contain, essentially without exception, ⁇ -methylene- ⁇ -lactone groups in which H-7 is ⁇ -oriented. The liverworts produce sesquiterpene lactones of the enantiomeric series. Nevertheless, the oxidising enzymes from these organisms can carry out similar reactions as the enzymes from higher plants and are a valuable addition to the higher-plant enzymes.
- the invention provides a method for converting a substrate and generating a stereo- and regioselective conversion product comprising subjecting said substrate to enzymes derived from a plant species producing sesquiterpene lactones, especially wherein said conversion product comprises an alcohol, aldehyde/ketone or carboxylic acid.
- the conversion products can be further modified using commercial enzymes such as alcohol dehydrogenases or microbial bioconversion systems. Considering that useful Asteraceae and liverwort species can easily be grown, the invention provides an inexpensive resource of enzymes or other biocatalysts (cells, explants, tissue, hairy roots or cell cultures) for bioconversion.
- Particularly useful crops comprise Cichorium spp, lettuces such as Lactuca spp., Helianthus spp. etc. but are not limited to these.
- the method as provided herein allows the conversion of a terpene in a useful stereo- and regioselective conversion product, for example linear or branched terpene alcohols, aldehydes/ketones or carboxylic acids, especially where said substrate comprises a sesquiterpene.
- a method wherein said enzyme comprises a cytochrome P450 monooxygenase, such as (+)-germacrene A hydroxylase or a sesquiterpenolide C2 hydroxylase
- cytochrome P450 monooxygenase such as (+)-germacrene A hydroxylase or a sesquiterpenolide C2 hydroxylase
- These enzymes catalyse the hydroxylation of (+)-germacrene A and a sesquiterpene lactone intermediate in chicory sesquiterpene lactone biosynthesis.
- the enzymes belong to a biochemical pathway, they do not have a high substrate specificity. Hydroxylation of a sesquiterpene occurs when the compound contains, like germacrene A, an isopropenyl substituent or, like germacrene B, an isopropylidene substituent or like valencene an allylic C2-position.
- substrates that were hydroxylated include germacrene A, as one might expect, the substrate with the highest rate of conversion and ⁇ -selinene.
- Alternative substrates that are converted to their corresponding alcohols are: alloisolongifolene (at 1.49% compared to ⁇ -selinene).
- Amorphadiene is converted to two products, at 74.0 and 18.7%; the first is amorpha-4,11-dien-12-ol the precursor of artemisinin and the identity of the latter is unknown.
- the relative rate of conversions of the other substrates were found to be the following: ( ⁇ )- ⁇ -trans-bergamotene (13.5%), ( ⁇ )- ⁇ -elemene (56.2%), germacrene A (110%, probably even higher), germacrene B (3.13% and 8.60%, cis-trans isomers), (+)- ⁇ -gurjunene (54.9%), (+)-ledene (7.20%), and neointermedeol (6.92%). It is particularly useful when said enzymes are derived from an extract of said Asteraceae species, extracts being easily made according to a method known in the art. It is also contemplated herein to use free latex from an Asteraceae as enzyme preparation.
- the invention provides a method to make enzyme extracts that contain the P450 enzymes. These can be prepared by homogenising chicory roots in an extraction buffer according to Example 1 containing PVPP. The resulting slurry is then filtered and centrifuged.
- the suitable substrates can be any sesquiterpene hydrocarbon that could yield an interesting product after hydroxylation at positions equivalent to the positions described in the examples, for example valencene, amorphadiene, ( ⁇ )- ⁇ -trans-bergamotene, ⁇ -gurjunene, ledene, germacrene A, germacrene B, but not limited to those.
- the corresponding alcohols formed enzymatically from these substrates could be further oxidised to the corresponding aldehydes/ketones or acids—if these are of more value—using a chicory alcohol and aldehyde dehydrogenase or commercially available dehydrogenases.
- a tissue- or cell culture derived from said Asteraceae species for example a hairy root culture.
- Hairy root and cell cultures of chicory can be obtained using standard protocols (hairy root cultures: Song et al., 1995; cell cultures: Dubois et al., 1988).
- the cultures are supplied with sesquiterpenes such as valencene, amorphadiene, ( ⁇ )- ⁇ -trans-bergamotene, ⁇ -gurjunene, ledene, germacrene A, germacrene B, but not limited to those, preferably at 200-1000 mg/l.
- cytochrome P450 cDNAs can be obtained using random sequencing of a cDNA library of chicory taproots, the organ where the activity of these enzymes is highest. Also a PCR approach is feasible where the sequence homology of cytochrome P450 enzymes is used to design degenerate primers that can be used to generate PCR fragments.
- These fragments are used to screen a cDNA library to obtain full-length cDNAs.
- These cDNAs can be expressed in E. coli , yeast or any other micro-organism adapted to large-scale industrial fermentation and suitable for the expression of P450s.
- the transgenic micro-organisms will be fed the desired sesquiterpene hydrocarbon substrates for example valencene, amorphadiene, ( ⁇ )- ⁇ -trans-bergamotene, ⁇ -gurjunene, ledene, germacrene A, germacrene B, but not limited to those.
- the produced alcohol products can be extracted continuously or in batch.
- micro-organisms could also be equipped with the synthase of the desired sesquiterpene hydrocarbon substrate, such as for example the valencene synthase, which would further reduce the costs of production, and an alcohol and/or aldehyde dehydrogenase in order to produce ketones/aldehydes, such as in the case of nootkatone production, or acids—when required.
- synthase of the desired sesquiterpene hydrocarbon substrate such as for example the valencene synthase, which would further reduce the costs of production
- an alcohol and/or aldehyde dehydrogenase in order to produce ketones/aldehydes, such as in the case of nootkatone production, or acids—when required.
- the invention also provides a conversion product obtainable by a method according to the invention.
- interesting products are (E)-trans-bergamota-2,12-diene-14-ol, the direct precursor of the corresponding aldehyde with sandalwood-like fragrance properties, and a number of novel conversion products such as alloisolongifolene alcohol, amorpha-4,11-diene-12-ol, germacrene B alcohol, 5,11(13)-guaiadiene-12-ol and a ledene alcohol, all alcohols that have not been reported before.
- larger amounts of these alcohols can be produced to confirm their identity and to investigate their properties as flavor and fragrance compounds, pharmaceuticals or biocides, or of their corresponding aldehydes/ketones and carboxylic acids.
- the invention provides an isolated or recombinant enzyme or enzyme extract derived from an Asteraceae species capable of converting a substrate and generating a conversion product after subjecting said substrate to said enzyme(s) and use of such enzyme(s) or extract according to the invention in biocatalysis, for example for the generation of a flavor or fragrance compound, pharmaceutical or biocide.
- the invention thus provides for example the use of micro-organisms, expressing genes encoding said oxidising enzymes that were isolated from sesquiterpene lactone producing plant species for bioconversion.
- micro-organisms expressing genes encoding said oxidising enzymes that were isolated from sesquiterpene lactone producing plant species in combination with genes that introduce the formation of said substrates in the micro-organism and hence the formation of said oxidised bioconversion products is provided herein.
- transgenic sesquiterpene lactone producing plant species such as chicory
- genes that introduce the formation of said substrates in planta such as terpene synthase genes that introduce the formation of said terpenes in planta and hence the formation of said oxidised bioconversion products or expressing a valencene synthase that introduces the formation of valencene in planta and hence the formation of nootkatone, or expressing amorpha-4,11-diene synthase that introduces the formation of amorpha-4,11-diene in planta and hence the formation of artemisinin or its precursors, or expressing ⁇ -trans-bergamotene synthase that introduces the formation of ⁇ -trans-bergamotene in planta and hence the formation of (E)-trans-bergamota-2,12-dien-14-ol.
- FIG. 1 Bitter principles of chicory.
- the guaianolides lactucin, 8-deoxylactucin and lactucopicrin are major compounds.
- Minor sesquiterpene lactones of chicory are the guaianolides 11 (S), 13-dihydrolactucin ( ⁇ ), 11 (S), 13-dihydro-8-deoxylactucin (b), 11 (S), 13-dihydrolactucopicrin, (c); the eudesmanolides sonchuside C (d) and cichoriolide A (e), and the germacranolides sonchuside A (f) and cichorioside C (g).
- FIG. 2 Proposed biosynthetic route from (+)-germacrene A (1) to (+)-costunolide (5) via germacra-1(10),4,11(13)-trien-12-ol (2), germacra-1 (10),4,11(13)-trien-12-al (3), and germacra-1(10),4,11(13)-trien-12-oic acid (4).
- FIG. 3 Schematic drawing of the cytochrome P450 complex (taken from Meijer, 1993). Instead of O 2 , cytochrome P450 is also able to bind CO which inhibits its catalytic action.
- FIG. 4 Chemical structure of ⁇ - and ⁇ -terpineol and their acetate esters.
- FIG. 5 Chemical structure of digitoxin and digoxin.
- FIG. 6 Substrates that were not converted, i.e. ( ⁇ )-( ⁇ )-cubebene, ( ⁇ )-( ⁇ )-gurjunene, and germacrone; or hardly converted, ie. limonen, by the (+)-germacrene A hydroxylase containing microsomal pellet from chicory roots.
- FIG. 7 Biotransformation of (+)- ⁇ -gurjunene with a plant pathogenic fungus yields (1S,4S,7R, 10R)-5-guaien-11,13-diol and (1S,4S,7R,10S)-5-guaien-10,11,13-triol; incubation of ⁇ -gurjunene with a microsomal pellet of chicory gave (1S,4S,7R, 10R)-5,11(13)-guaiadiene-12-ol.
- FIG. 8 Postulated cytochrome P450 catalysed conversion of germacra-1(10),4,11(13)-trien-12-oic acid (4) into (+)-costunolide (5) via hydroxylation and subsequent lactonisation.
- FIG. 9 Various substrates that were also incubated with the chicory supernatant and NADPH: a mixture of ⁇ - and ⁇ -costic acid (15), elema-1,3,11(13)-trien-12-oic acid (16), parthenolide (17) and dehydrocostus lactone (18).
- FIG. 10 A, GC-MS analyses of the products formed in the incubation of a 20,000 g supernatant from chicory roots with NADPH and germacra-1(10),4,11(13)-trien-12-oic acid (4) displays peaks of dehydrosaussurea lactone (dHSausL [7]), saussurea lactone (SausL [9]), and leukodin (Leuk [10]).
- dHSausL [7] dehydrosaussurea lactone
- SausL [9] saussurea lactone
- Leukodin Leuk [10]
- Gernacrene-1(10),4,11(13)-trien-12-oic acid (1) is observed as elema-1,3,11(13)-trien-12-oic acid (EAc) plus its diastereomer (EAc*); the internal standard (i.s.) is 1 nmol cis-nerolidol.
- the huge fronting peaks ( ) are fatty acids (palmatic- and linoleic acid).
- C A standard of 0.5 mM costunolide (2) in ethanol yields a tailing peak of dehydrosaussurea lactone (dHSausL [7]).
- FIG. 11 Products formed from germacra-1(10),4,1,1(13)-trien-12-oic acid (4) in the presence of NADPH and oxygen by a chicory 20,000 g supernatant.
- Leukodin (22) is detected as a genuine GC-peak
- costunolide (5) and 11,13-dihydrocostunolide (20) are detected as their Cope-rearrangement products dehydrosaussurrea lactone (19) and saussurea lactone (21), respectively.
- FIG. 12 Demonstration of blue light reversible CO-inhibition of the costunolide synthase.
- Enzyme activity in the presence of 90% N 2 +10 O 2 (N2) is set at 100% and this activity corresponds to a peak of dehydrosaussurea lactone (costunolide), saussurea lactone (dihydrocostunolide) and leucodin of respectively 0.58, 0.27, and 0.15 ⁇ internal standard (1 ⁇ M).
- the inhibition in the presence of 90% CO+10% O 2 was slightly reversed by irradiation with blue light (450 nm). All incubations were done in the absence of FAD and FMN.
- FIG. 13 Mass spectra of dehydrosaussurea lactone (19) originating from (+)-costunolide (5) that has been produced from germacrene acid (4) under standard assay conditions (A), in the presence of 18 O 2 (B), or that originates from a standard of (+)-costunolide (C).
- FIG. 14 Mass spectra of leucodin (22) produced from germacrene acid (4) in an enzyme assay under standard conditions (A) or in the presence of 18 O 2 (B). Panel C shows the mass spectrum of the leucodin standard (C).
- FIG. 15 Mechanism for the enzyme catalysed formation of (+)-costunolide (5) from germacrene acid (4) that results in the incorporation of one atom of 18 O.
- FIG. 16 (+)-Costunolide (5) is in the presence of NADP and O further enzymatically converted into 11(S), 13-dihydrocostunolide (20) and leucodin (22). Incubation of germacrene acid in the presence of 18 O 2 gives incorporation at positions marked with an asterisk. It is unclear whether leucodin (22) is formed via 20.
- Both (+)-costunolide and 1 (S),13-dihydrocostunolide (20) are likely precursors of other sesquiterpene lactones present in chicory; whereas leucodin (22) is only one hydroxylation away from 11(S),13-dihydro-8-deoxylactucin, a minor sesquiterpene lactone of chicory.
- FIG. 17 GC-MS analysis of the products formed by a microsomal preparation of chicory roots incubated with (+)-valencene (Val) in the presence (A) or absence (B) of NADPH. Incubation in the presence of NADPH yields nootkatone (Nkatone), ⁇ -nootkatol (Nkatol), and valencene-12-ol (ValOH). Peaks marked with A are GC-induced dehydration products of ⁇ -nootkatol ([M] + 202). Peaks labelled with an asterisk are sesquiterpene alcohols that presumably origin from enzymatic conversion of sesquiterpene impurities (marked with in panel B) present in the commercial sample of (+)-valencene used as substrate.
- FIG. 18 Conversion of (+)-valencene into nootkatone proceeds via ⁇ -nootkatol and not via ⁇ -nootkatol.
- FIG. 19 Conversion of trans, trans-farnesol into farnesal and farnesoic acid by a 150,000 g supernatant of chicory roots in the presence of NADP + .
- FIG. 20 Similarity between the formation of leucodin in chicory sesquiterpene lactone biosysthesis and the conversion of (+)-valencene to nootkatone by a chicory enzyme preparation.
- the Kovats' indices of these germacrene are determined at an injection port temperature of 150° C.; quantitative measurements are done on the basis of their Cope-rearrangements products measured at an injection port temperature of 250° C.
- This conversion rate is a summation of the peaks of elematrien-12-ol, costol, elematrien-12-al, and elematrien-12-oic acid.
- Kovats' indices were determined at an injection port temperature of 250° C. and probably belong to the Cope-rearrangement products. ⁇ Hydroxylation probably occurs at one of these allylic positions.
- b 100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.63 and 0.34 ⁇ internal standard (1 nmol cis-nerolidol in all assays).
- c 100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.34 and 0.42 ⁇ internal standard (1 nmol cis-nerolidol in all assays).
- d 100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.43 and 0.18 ⁇ internal standard (1 nmol cis-nerolidol).
- (+)-Germacrene A was isolated from costus roots (De Kraker et al, 2001b). Alloisolongifolene, ( ⁇ )- ⁇ -gurjunene, (+)- ⁇ -gurjunene, and (+)-ledene were purchased from Fluka. ICN Biomedicals furnished ( ⁇ )- ⁇ -cubebene. The compounds ( ⁇ )-limonene and (+)-limonene were purchased from Merck and Janssen, respectively. Amorpha-4,11-diene was synthesised by Dr. B. J. M. Jansen (Bouwmeester et al., 1999a). Germacrone was isolated from the natural oil of Geranium macrorrhizum and germacrene B was synthesised by Dr.
- Alloisolongifolene alcohol was prepared from alloisolongifolene via its corresponding aldehyde by SeO 2 , according to the protocol of Umbreit and Sharpless (1977).
- SeO 2 SeO 2
- 68 mg salicylic acid 100 mg alloisolongifolene was added. Stirring at room temperature turned the reaction mixture yellow and a red solid precipitated in the first few hours.
- the reaction was monitored by GC-MS along with TLC and was stopped by the addition of 60 mL demineralised water after 2.5 days. The reaction mixture was extracted with 45 mL ether, and the organic phase was subsequently washed with 30 mL brine.
- the grey suspension was stirred for 17.5 hours at room temperature and for an additional half our after the careful addition of one spatula Na 2 SO 4 .10H 2 O.
- One and a half millilitre of demineralised water was added to the mixture that was subsequently 3 times extracted with 1 mL of ether.
- the ether was passed through glasswool-plugged Pasteur pipette filled with silica and a spatula tip of MgSO 4 .
- the solvent was evaporated yielding 17 mg of alloisolongifolene alcohol.
- Amorpha-4,11-diene-12-ol was prepared from 100 mg artemisinic acid.
- the acid was dissolved in 6 mL of dry ether and esterified by adding diazomethane and mixing for 1 hour.
- GC-MS analyses of the reaction mixture showed the methyl ester and another compound (3:1), probably the methyl ester that was not connected to a cyclopropyl group.
- 8.6 mg of the mixture was dissolved in 20 mL of ether-THF (1:1) and cooled at ⁇ 60° C. under a flow of dry nitrogen for 2 hours. The mixture was subsequently stirred for 1 hour at ⁇ 30° C.
- the filtrate was divided over 8 ml centrifuge tubes and subsequently centrifuged (Centrikon T-2070, Kontron Instruments) for 90 minutes at 150,000 g and 4° C.
- the resulting microsomal pellets (about 6) were stored under argon at ⁇ 80° C.
- assay buffer consisting of 25 mM Tris (pH 7.5), 2 mM DTT, 1 mM ascorbic acid, 5 ⁇ M FAD, 5 ⁇ M FMN and 10% (v/v) glycerol.
- the enzyme suspension was divided in 1 mL aliquots and incubated with 5 ⁇ L substrate solution in the presence of a 1 mM NADPH-regenerating system that consisted of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase (all from Sigma).
- the initial concentration of substrate in each assay was 45 ⁇ M and all were done in duplicate.
- cytochrome P450 enzymes including the (+)-germacrene A hydroxylase
- the enzyme assays were extracted 2 times with 1 mL 20% (v/v) ether in pentane, after the addition of 5 ⁇ M cis-nerolidol (Fluka).
- the organic phase was filtered through a glasswool-plugged (dimethyl chlorosilane-treated, Chrompack) Pasteur pipette that contained 0.4 gram of silica and a little anhydrous MgSO 4 .
- the pipette was rinsed with 1.5 mL ether and the extract was concentrated to approximately 50 ⁇ L under a stream of nitrogen.
- the concentrated extracts were analysed by GC-MS as described by De Kraker et al. (2001a).
- the sesquiterpenes are depicted that were converted into sesquiterpene alcohols in the presence of NADPH and the microsomal pellet that contains the (+)-germacrene A hydroxylase.
- the conversion rates of the various reactions are expressed relatively to the hydroxylation of ⁇ -selinene that is set at 100% and corresponds to a ⁇ -costol peak-size of 6.3 ⁇ the internal standard (2.5 nmol cis-nerolidol in each assay).
- Approximately 30% of the added 50 nmol ⁇ -selinene was hydroxylated. Not all formed hydroxylation products could be identified, since reference samples or mass spectra of the expected sesquiterpene alcohols were not available.
- (+)-Germacrene A was, according to previous results, converted into germacra-1(10), 4,11-trien-12-ol, but somewhat unexpected the subsequent oxidations (approx. 15% of the produced germacrene alcohol) into germacra-1(10),4,11-trien-12-al and germacra-1(10),4,1-trien-12-oic were also clearly detected. This indicated that the microsomal pellet is not completely free of active dehydrogenases. Apparently the amount of produced germacrene alcohol is sufficient to enable these subsequent reactions. Moreover the dehydrogenases are active despite the used pH of 7.5 and the presence of the NADPH-regenerating system that reduces any NADP + present.
- both methyl groups in the isopropenyl side chain of germacrene B are hydroxylated yielding almost identical products. Hydroxylation at any other position is unlikely, because they would probably also have been observed for (+)-germacrene A.
- the products are measured as their Cope-rearrangement products and lowering the injection port temperature from 250° C. to 150° C. yielded faint broadened peaks due to on-column Cope-rearrangement.
- Neointermedeol is presumably hydroxylated in the isopropenyl side chain like ⁇ -selinene, yielding 4 ⁇ -H-eudesm-11(13)-ene, 4,12-diol.
- microsomal pellets that were used in the experiments do not exclusively contain the (+)-germacrene A hydroxylase, but also other membrane bound enzymes that are present in chicory roots. Hence, some of the conversion described in Table I might as well be catalysed by other oxidising enzymes than the (+)-germacrene A hydroxylase.
- incubations of the different substrates were done in the presence of 50, ⁇ M (+)-germacrene A. Incubations were also carried out with 50 ⁇ M ( ⁇ )- ⁇ -cubebene instead, a sesquiterpene that is not hydroxylated ( FIG. 6 ), to test the effect of the addition of any arbitrary sesquiterpene olefin on enzyme activity (see Table II).
- Hydroxylation of the sesquiterpenes is not dramatically influenced by the addition of ( ⁇ )- ⁇ -cubebene, except for the formation of alloisolongifolene alcohol, a product that already under normal assay conditions is only formed in small quantities.
- a microsomal enzyme preparation from chicory roots can hydroxylate sesquiterpene olefins that are not present in chicory in the presence of NADPH (Table I). Most of these hydroxylations occur at the isopropenyl or isopropylidene side chain, yielding in some cases sesquiterpene alcohols that have not previously been described, e.g. amorpha-4,11-dien-12-ol and alloisolongifolene alcohol.
- the novelty of the formed sesquiterpene alcohols in some cases hampered their identification, and the structure assignment of the hydroxylation products of germacrene B, (+)- ⁇ -gurjunene and neointermedeol is tentative or, like for (+)-ledene, not possible at all.
- these compounds were not yet produced in sufficient amount to isolate them for structure elucidation by 1 H NMR.
- the substrates for hydroxylation preferably do not contain any polar group, according the observation that neointermedeol is 15-fold less efficiently hydroxylated than ⁇ -selinene and the observation that germacrone is not hydroxylated whereas germacrene B is.
- the size of the substrate is also of importance as hydroxylation of limonene, a smaller monoterpene, did hardly occur. In the case of amorpha-4,11-diene two distinct sesquiterpene alcohol products were formed.
- (+)- ⁇ -gurjunene incubation with the plant pathogenic fungus Glomerella cingulata yields (1S,4S,7R, 10R)-5-guaien-11,13-diol and (1S,4S,7R, 10S)-5-guaien-10,11,13-triol (Miyazawa et al., 1998), whereas incubation with the microsomal pellet of chicory yielded (1S,4S,7R,10R)-5,11(13)-guaiadien-12-ol ( FIG. 7 ).
- (+)-Costunolide is the most rudimentary structure of a germacranolide and considered to be the parent-compound of all germacrene-derived sesquiterpene lactones, among them the guaianolides, eudesmanolides and germacranolides of chicory. It is very likely that this compound is formed from FPP through (+)-germacrene A, germacra-1(10),4,11(13)-trien-12-ol, and germacra-1(10),4,11(13)-trien-12-oic acid (4) ( FIG. 2 ) (De Kraker et al., 1998, 2001 a).
- This germacrane acid 4 is thought to be hydroxylated at the C 6 -position by a cytochrome P450 enzyme after which lactonisation yields (+)-costunolide (5) ( FIG. 8 )
- Germacrene acid was isolated from fresh costus roots (De Kraker et al., 2001b), which makes it possible to investigate this last step in formation of the lactone ring of sesquiterpene lactones (Geissman, 1973; Fischer et al., 1979; Fischer, 1990).
- (+)-Costunolide is considered to be a branching point in the biosynthesis of sesquiterpene lactones from where pathways for the formation of guaianolides, eudesmanolides and germacranohdes divide. It has been postulated by various authors that cyclisation of (+)-costunolide to either guaianolides or eudesmanolides is mediated by respectively C 4 -C 5 epoxidation or C 1 -C 10 epoxidation, respectively (Brown et al., 1975; Fischer 1990; Teisseire, 1994; Piet et al., 1995). Alternatively, the necessity of a C 3 -hydroxylation of the germacrenolide for formation of a guaianolide has been proposed (Piet et al., 1996).
- a GC-standard of 11(S),13-dihydro-costunolide (20) was prepared from 2 mg of (+)-costunolide (5) that was dissolved in 1.5 mL ethyl acetate and stirred with 1.5 mg of NaBH 4 at 0° C., a procedure described for the reduction of the C 11 -C 13 exocyclic double bond of various sesquiterpene lactones (Asakawa et al., 1980; Asakawa, 1982; Seto et al., 1988). After 45 minutes the reaction was stopped by the addition of 1% HAc and 2 ml extra ethyl acetate.
- the organic phase was filtered through a glass-wool plugged Pasteur pipette that contained 0.45 g of silica and a little anhydrous MgSO 4 .
- GC-MS analysis of the filtrate showed that half of the (+)-costunolide was converted into 11(S),13-dihydro-costunolide, whereas no trace of its C 11 -epimer was detected.
- a cell free extract of chicory roots was prepared from the frozen material in the same way as described for isolation of the germacrene A hydroxylase (Example 1), but MgCl 2 was not added to the extraction buffer since the accompanying (+)-germacrene A synthase activity was not essential for the detection of (+)-costunolide synthase activity.
- the prepared 20,000 g supernatant was desalted with an Econo-Pac 10 DG column (Biorad) to an assay buffer consisting of 25 mM Tris (pH 7.5), 1 mM ascorbic acid, 5 ⁇ M FAD, 5 ⁇ M FMN and 10% (v/v) glycerol.
- DTT was omitted from the assay buffer, because SH-groups present in DTT might undergo an “Michael-type addition” to the C 11 -C 13 exocyclic double bond of (+)-costunolide (Kupchan et al., 1970).
- a 1-ml aliquot of the desalted supernatant was incubated with 3 ⁇ L of a 15 mM solution of germacrene acid (4) in tert-butylmethylether and a 1 mM NADPH-regenerating system, which consists of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase (all from Sigma).
- (+)-costunolide (5) from germacrene acid (4) was catalysed by a cytochrome P450-enzyme
- the effect of various established cytochrome P450-inhibitors cytochrome C, metyrapone, clotrimazole, micozanole, and amino-benzotriazole
- the cofactor dependence was also investigated, i.e. NAD(P) + or NADH was added instead of NADPH.
- the two other products were identified as 11(S), 13-dihydrocostunolide (20) that is Cope-rearranged into saussurea lactone (21), and leucodin (22) ( FIG. 11 ).
- Both 11(S),13-dihydrocostunolide and leucodin are enzymatically formed from (+)-costunolide and accordingly they also appeared in incubations of (+)-costunolide with the 20,000 g supernatant and NADPH. It cannot be excluded that even more products are formed during the incubation of germacrene acid, because higher oxygenated sesquiterpene lactones are likely not volatile enough for detection by gas chromatography. Furthermore, the presence of fatty acids in chicory extracts (Sannai et al., 1982) complicates the GC-analysis, because they yield big peaks ( ) under which smaller product peaks might “disappear”.
- (+)-costunolide For characterisation of the (+)-costunolide synthase the response of the GC-MS to different concentrations of (+)-costunolide should preferably be linear. Yet, at the used injection port temperature of 320° C., the GC-trace of costunolide ( FIG. 10C ) does not show a sharp peak of dehydrosaussurea lactone (19)—but a tailing peak that contains minor peaks of costunolide-related products like ⁇ - and ⁇ -cyclocostunolide. Apparently (+)-costunolide is more resistant to Cope-rearrangement than for instance germacrene acid (4).
- the response factor relative to cis-nerolidol is 0.15, and concentrations below 5 ⁇ M are not measurable which means that (+)-costunolide concentrations below 0.25 ⁇ M in the incubation mixture, i.e. 0.25 nmol, are not detected.
- Table IV shows that the costunolide synthase is dependent on oxygen and NADPH, whereas NADH was much less effective as a reductant. This suggests the involvement of a cytochrome P450 enzyme, which was confirmed by the effect of various established cytochrome P450 inhibitors (West, 1980; Mihaliak et al., 1993). In the presence of cytochrome C (100 ⁇ M), no enzymatic products of germacrene acid (4) were measured; miconazole (100 ⁇ M) reduced the amount of measurable products with 71%, aminobenzotriazole (100 ⁇ M) with 44%, metyrapone (1 mM) with 78%, and clotrimazole (100, ⁇ M) with 97%.
- parthenolide (17) did not give leucodin (22), but conversion of parthenolide into other not-measurable sesquiterpene lactones cannot be excluded. Parthenolide itself disintegrates upon GC-analyses in a number of peaks and hence no quantitative determination was done on the amount of parthenolide present in after incubation.
- Table VI shows that formation of leucodin from (+)-costunolide is dependent upon oxygen, whereas the formation of 11,13-dihydrocostunolide is not. Formation of leucodin is strongly inhibited by CO which suggests the involvement of a cytochrome P450 enzyme. Accordingly it is also inhibited by all of the tested cytochrome P450 inhibitors except amino-benzotriazole.
- chicory contains an enzyme that converts germacra-1(10), 4,11(13)-trien-12-oic acid (4) into (+)-costunolide (5), yielding the lactone ring present in sesquiterpene lactones.
- This step is the final proof for the postulated pathway from FPP through (+)-germacrene A, germacra-1(10),4,11(13)-trien-12-ol, and germacra-1(10),4,11(13)-trien-12-oic acid (4) to the germacrene-derived sesquiterpene lactones (Geissman, 1973; Fischer et al., 1979; Fischer, 1990).
- the (+)-costunolide synthase is a cytochrome P450 enzyme that is dependent upon NADPH and O 2 and is accordingly inhibited by various established cytochrome P450 inhibitors (West, 1980; Mihaliak et al., 1993). Blue light reversible CO-inhibition of enzyme activity could be demonstrated as well, although the results were somewhat disturbed by subsequent enzymatic conversions of (+)-costunolide. Incubation in the presence of oxygen-18 showed the incorporation of one atom of 18 O into (+)-costunolide, another typical feature of cytochrome P-450 enzymes (West, 1980; Mihaliak et al., 1993).
- the (+)-costunolide synthase is not capable of converting the substrate analogues ⁇ -costic acid ( FIGS. 2, 14 ), or elema-1,3,11(13)-trien-12-oic acid (9) which is not unexpected, because the C 6 -position is not allylic.
- ⁇ -costic acid (13), in which the C 6 -position is allylic, was not converted either, so apparently the geometry of the cyclodecadiene ring system is necessary for reaction.
- (+)-Costunolide (5) is in incubations with NADPH and the 20,000 g supernatant of chicory roots subsequently converted into 11(S),13-dihydrocostunolide (20) and leucodin (22) ( FIG. 16 ). Formation of 11(S),13-dihydrocostunolide is not dependent upon oxygen, but is strongly enhanced in the presence of NADPH whereas a small enzyme activity of 15% is retained in its absence.
- the reduction of the C 11 -C 13 exocyclic double bond is similar to the type of reactions catalysed by enoate reductases, a group of iron-sulphur flavoproteins that has been isolated from Clostridium and catalyses the reduction of the olefinic bond of ⁇ , ⁇ -unsaturated carboxylic acids under anaerobic conditions in the presence of reducing agents (Holland, 1992).
- the reduction of the C 11 -C 13 exocyclic double bond in costunolide occurs stereoselectively and yields only the 11(8),13-stereoisomer is formed.
- the stereochemistry at C11 is identical to that of the 11(S),13-dihydro sesquiterpene lactones present in chicory (Seto et al., 1988; van Beek et al., 1990).
- some other plant species contain C 11 -epimers like achillin which is the 11(R)-epimer of leucodin (Martinez et al., 1988; Ho et al., 1998), indicating that an enantioselective enzyme that synthesises these C 11 -epimers should exist in these other species.
- the enzyme exhibits at least some substrate specificity because the C 11 -C 13 exocyclic double bond of dehydrocostuslacton (18) was not reduced.
- leucodin (22) proves that guaianolides originate from (+)-costunolide. Their formation likely involves more than one enzyme. It was not investigated whether leucodin originates from 11(S),13-dihydrocostunolide (20). Parthenolide (17) is not involved in leucodin biosynthesis, but it cannot be excluded that 11(S), 13-dihydroparthenohde is. Various authors have suggested that either 4,5-epoxide or C 3 -hydroxylation is necessary to direct cyclisation of (+)-costunolide towards a guaiane framework (Brown et al., 1975; Fischer 1990; Teisseire, 1994; Piet et al., 1995, Piet et al., 1996).
- Leucodin can be regarded as a precursor of 11(S),13-dihydro-8-deoxylactucin, a minor sesquiterpene lactone of chicory (van Beek et al, 1990). Possibly this sesquiterpene lactone is also formed during the executed incubations, but it is not detected in GC-MS measurement due to its polarity/lesser volatility. (+)-Costunolide and possibly 11 (S),13-dihydrocostunolide (20) are likely to be involved in the biosynthesis of the other bitter tasting sesquiterpene lactones of chicory. To detect and analyse these compounds in enzymatic reaction mixtures will involve derivatisation and/or the use of other chromatographic techniques like HPLC.
- ⁇ -Nootkatol was prepared by reduction of 190 mg nootkatone (Fluka) with 20 mg of LiAlH 4 in 5 mL dry ether (diethyl-ether) (Shoji et al., 1984). After stirring the grey suspension for one night, the reaction was stopped by careful addition of Na 2 SO 4 .10H 2 O. The mixture was stirred for an additional 30 minutes, and dried by the addition of MgSO 4 . The solids were filtered off and the ether was washed with distilled water.
- trans, trans-farnesal and cis, trans-farnesal were prepared by dissolving trans, trans-farnesol (Sigma) in pentane and stirring with MnO 2 .
- Farnesal was oxidised to a mixture of cis, trans- and trans, trans-farnesoic acid with silver oxide (Caliezi and Schinz, 1947).
- Microsomal pellets that contain (+)-germacrene A hydroxylase activity and an enzyme suspension were prepared from deep frozen chicory cubes as described in Example 1.
- the enzyme suspension was divided in 1 mL aliquots and incubated with 50 ⁇ M (+)-valencene in the presence of a 1 mM NADPH-regenerating system that consisted of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase.
- the initial concentration of substrate in each assay was 45 ⁇ M and all experiments were done in duplicate.
- the major product was nootkatone (Table VII), whereas in most experiments the corresponding ⁇ -nootkatol was detected in amounts smaller than the valencene-12-ol (the chromatogram depicted in FIG. 17 is an exception!).
- trans-farnesol was converted up to 60% into a mixture of trans, trans-farnesal and cis,trans-farnesal, and small amounts of farnesoic acid were observed as well.
- a chicory enzyme extract efficiently catalysed the conversion of (+)-valencene via nootkatol into nootkatone ( FIGS. 17 and 18 ). Possibly these reactions are catalysed by the same enzymes that are involved in the biosynthesis of leucodin from (+)-costunolide ( FIG. 20 ; Example 2). On basis of its structural resemblance with leucodin, the same might have occurred to (+)-ledene (see Example 2, Table I), but this compound was only hydroxylated and not converted into a ketone.
- nootkatone catalysed by enzymes of chicory proceeds via ⁇ -nootkatol that is subsequently oxidised to nootkatone by NAD(P) + -dependent dehydrogenase(s).
- These dehydrogenases are operationally soluble enzymes, but apparently partially end up in the microsomal pellet, just as the germacrene alcohol dehydrogenase(s).
- the dehydrogenase(s) involved in formation of nootkatone have a strong preference for ⁇ -nootkatol over ⁇ -nootkatol and this may indicate the involvement of a specific enzyme that perhaps in planta is responsible for the oxidation of the alcohol precursor of leucodin.
- the dehydrogenase(s) present in a 150,000 g supernatant of chicory do not seem to act with a high substrate specificity.
- NAD(P) + -dependent oxidation of farnesol to farnesal, including the observed isomerisation of farnesal has also been reported for other crude plant extracts, (Chayet et al., 1973; Overton and Roberts, 1974).
- the isolated dehydrogenase activities are exclusively involved in sesquiterpene lactone biosynthesis or have (also) a different function is uncertain.
- Nootkatone is a much sought-after aromatic substance with a distinctive flavor of grapefruit that is widely used in the flavor and fragrance and food industry.
- Nootkatone was also shown to be an important constituent of anti-ulcer medication (Yamahara et al., 1990). For this reason the possibilities for conversion of the less valuable (+)-valencene has intensively been studied, but the yields obtained by either chemical methods or microbiological methods were not satisfying or too laborious (Dhavlikar and Albroscheit, 1973; Kunststoff et al. 1975; Lamare and Furstoss, 1990). Remarkably, there is not yet any direct proof that in grapefruit, the source of valencene and nootkatone, a biochemical pathway exists for the conversion of (+)-valencene via ⁇ -nootkatol into nootkatone (del Rio et al., 1992).
- Carboxylic acids are important flavours and fragrances. For instance, fatty acids of various chain lengths are very characteristic for the flavour of cheese (West, 1996), whereas higher fatty acids contribute to the taste and smell of peanuts (Hashim et al., 1993). Branched chain fatty acids are important flavour notes in mutton and sheep cheese (Heinsman, 2000; Heinsman et al., submitted).
- the chicory dehydrogenases responsible for the conversion of germacrene alcohol to germacrene acid have a rather low substrate specificity. Therefore we have investigated whether these dehydrogenases are capable of oxidising other kinds of terpene alcohols and aldehydes as well as linear and branched aliphatic alcohols and aldehydes.
- a chicory enzyme preparation or extract containing the dehydrogenases is made according to De Kraker et al. (2001a). Incubation with an alcohol or aldehyde, for instance amorpha-4,11-diene-12-ol or the corresponding aldehyde, in the presence of NADP + at pH 10 leads to the formation of the corresponding carboxylic acid in high yield. In case of amorpha-4,11-diene-12-ol, a mixture of artemisinic and dihydroartemisinic acid are produced.
- the dehydrogenases are not only capable of oxidising amorphadiene to artemisinic acid but also the reductase responsible for the reduction of the double bond in the isopropenyl group in the pathway after costunolide (Example 2) is capable of reducing artemisinic acid to dihydroartemisinic acid.
- chicory may be a suitable production organism for artemisinin, or a source of genes that can be used to produce artemisinin in other organisms.
- octanol or octanal and 4-methyloctanol or 4-methyloctanal are oxidised to the corresponding octanoic acid and 4-methyloctanoic acid, respectively. Since 4-methyloctanoic acid is chiral, we checked the stereochemical composition of the product, which appears to contain the R-enantiomer in preference.
- Fresh roots of cultivated chicory are processed as described in Example 1, and the 150,000 g pellets are used for the following experiment.
- Two grams of pellets are suspended in 50 ml of demineralised water containing 25 mM Tris pH 7.5, 10% glycerol, 1 mM ascorbic acid and 2 mM DTT.
- an NADPH-regenerating enzyme like glucose 6-phosphate dehydrogenase, hydrogenase, or, preferably, formate dehydrogenase (Seelbach et al., 1996) and 100 g of a solid support like DEAE-Sepharose, polyacrylamide or, preferably, Accurel beads.
- the mixture is stirred overnight at 4° C.
- the immobilised enzymes are filtered, washed with demineralised water containing 25 mM Tris pH 7.5, 10% glycerol and 1 mM ascorbic acid, and stored at 4° C. until usage.
- demineralised water containing 25 mM Tris pH 7.5, 10% glycerol and 1 mM ascorbic acid, and stored at 4° C. until usage.
- the mixture of chicory enzymes and cofactor-recycling enzyme is brought into contact with a hydrophobic membrane (flat membrane or hollow fibre unit) for one night at 4° C., after which the membrane is washed and the membrane (containing the immobilised enzymes) is stored at 4° C. until usage.
- the immobilised enzyme is placed in a bioreactor and suspended in 500 ml of demineralised water containing 25 mM Tris pH 7.5, 10% glycerol, and 1 mM ascorbic acid, at room temperature.
- NADPH is added up to 0.3 mM, together with a suitable amount of cosubstrate, for cofactor recycling.
- 1.5 mM of glucose 6-phosphate is added as a cosubstrate when using glucose 6-phosphate dehydrogenase for the recycling of NADPH, whereas 100 mM of formic acid/sodium formate pH 7.5 is added when formate dehydrogenase is the enzyme of choice.
- the sesquiterpene substrate (100 mM in ethanol) is pumped into the bioreactor at a speed of 0.1 ml/min, under continuous gentle stirring.
- oxygen is pumped into the bioreactor using a thin-walled silicon tube which allows bubble-free aeration (Rissom et al., 1997). This system is chosen since it is known that gas-liquid interfaces (like air bubbles) frequently cause inactivation of monooxygenases. Pumping is stopped when 50 ml of substrate solution (5 mmol, about 1 g of sesquiterpene) has been added, and the reaction mixture is stirred at room temperature until the concentration of product does no longer increase (as monitored by off-line GC).
- the immobilised enzyme is filtered off and the product is obtained by extraction of the aqueous medium with pentane, followed by chromatography over silica (using petroleum ether/ethyl acetate mixtures as the solvents).
- aqueous medium with pentane
- chromatography using petroleum ether/ethyl acetate mixtures as the solvents.
- nootkatone can be obtained in this way in yields around 50% or higher, using valencene as the substrate.
- the immobilised enzymes are washed with buffer and can be reused many times. Enzymatic reactions at temperatures higher than ambient are possible but lead to a decreased lifetime of the enzyme preparation.
- enzymes that are co-immobilised on solid beads can be used in a fed-batch bioreactor where the outlet is equipped with a hydrophobic membrane such that the product is able to pass whereas the cofactors and the enzymes remain inside the reactor.
- a membrane reactor in which both enzyme preparations are immobilised on the membrane is most advantageous.
- the enzymes can be used continuously since they are stable for a prolonged period, allowing the facile preparation of several hundred grams of hydroxylated sesquiterpenes or nootkaton.
- reaction products are extracted from the culture medium and the hairy roots/cells using pentane/ether.
- the reaction products are characterised using GC-MS.
- Incubations with valencene yield an efficient conversion to nootkatone.
- Incubations with ⁇ -gurjunene, amorphadiene and ⁇ -trans-bergamotene yield an efficient conversion to the corresponding alcohols with a high regioselectivity: hydroxylation occurs only in the isopropenyl group.
- sesquiterpenoid backbone of the sesquiterpene lactones in chicory is formed by a (+)-germacrene A synthase which cyclizes FPP to (+)-germacrene A (de Kraker et al., 1998; Bouwmeester et al., 1999b).
- terpene synthases catalyse the first committed step in all terpenoid biosynthetic pathways.
- the terpene synthases are a large group of enzymes that all convert the ubiquitous substrates geranyl diphosphate (to the monoterpenes), farnesyl diphosphate (to the sesquiterpenes), geranylgeranyl diphosphate (to the diterpenes) or squalene epoxide (to the triterpenes) (Bohlmann et al, 1998).
- the sesquiterpenes exhibit an exceptional large structural diversity, and over 7000 different compounds have been described.
- sesquiterpene synthases Like the other terpene synthases (leading to mono-, di- and triterpenes), sesquiterpene synthases exhibit a fair degree of sequence similarity, which allows them—in most cases—to be recognized as a sesquiterpene synthase, and enables the design of degenerate primers to be used in PCR to generate fragments that can be used to screen libraries or can be extended using RACE-PCR to obtain the full-length cDNAs (Bohlmann et al, 1998). Particularly in specialised tissues or enriched libraries also random sequencing may be used to obtain these (sesqui)terpene synthases (Bohlmann et al., 1998).
- the valencene synthase gene is isolated from grapefruit, orange, pomelo and Claamaecyparis nootkatensis using PCR with degenerate primers based on the sequence homology existing between sesquiterpene synthases (see for example Bouwmeester et al., 1999b) or using the sequence information of the putative sesquiterpene synthase isolated from grapefruit, as published in Genbank (AF411120).
- RNA isolation kit Biozym
- DNase I Deoxyribonuclease I, RNase free
- the DNase I is removed with a phenol/chloroform extraction after which the RNA is precipitated (ethanol precipitation with NaAc).
- Poly (A)+ RNA is extracted from 20 ⁇ g of total RNA using 2 ⁇ g poly-d(T)25V oligonucleotides coupled to 1 mg paramagnetic beads (Dynal A. S.). The poly(A)+ RNA is resuspended in 20 ⁇ l H 2 O.
- the reverse transcription reaction is carried out in a 50 ⁇ l reaction containing 10 ⁇ l poly (A)+ mixture, 0.3 ⁇ g oligo (dT) 25 V, 1 mM each dATP, dTTP, dCTP and dGTP, 50 mM Tris-HCl pH 8.3, 80 mM KCl, 10 mM MgCl 2 and catalyzed with 12 U AMV reverse transcriptase (Pharmacia). After an incubation for 2 h at 42° C. the reaction is stopped and the cDNA purified with the Wizard PCR Preps DNA purification system (Promega). The cDNA is resuspended in 50 ⁇ l H 2 O.
- PCR is performed in a total volume of 50 ⁇ l containing 0.5 ⁇ M of each of the two primers, 0.2 mM dNTP, 1 U Super Taq polymerase/1 ⁇ PCR buffer (HT Biotechnology LTD, Cambridge, England) and 10 ⁇ l cDNA.
- the reaction mixture is incubated in a thermocycler (Robocycler, Stratagene) with 1 min denaturation at 94° C., 1.5 min annealing at 42° C. and 1 min elongation at 72° C. during 40 cycles.
- Agarose gel electrophoresis revealed a single specific PCR product of 550 bp that BLAST comparison shows to have homology with sesquiterpene synthases.
- the PCR product is purified using the Wizard PCR Preps DNA purification system (Promega) and subcloned using the pGEMT system. E. coli JM101 is transformed with this construct. The full length cDNA is obtained using RACE-PCR.
- the cDNA clone is subcloned in frame into the expression vector pET 11d (Stratagene).
- the construct and pET 11d without an insert are transformed to E. coli BL 21 (DE3) (Stratagene), and grown overnight on LB agar plates supplemented with ampicillin at 37° C.
- the cells are harvested by centrifugation during 8 minutes at 2000 g and resuspended in 1.2 ml buffer containing 15 mM Mopso (pH 7.0), 10% (v/v) glycerol, 10 mM MgC12, 1 mM sodium ascorbate and 2 mM DTT (buffer A).
- the resuspended cells are sonicated on ice during 4 min (5 sec on, 30 sec off), centrifuged for 5 minutes at 4° C. (14.000 rpm) and the supernatant used for assays.
- the extract is analysed using radio-GLC and GC-MS (Bouwmeester et al., 1999a, b).
- Radio-GLC analysis shows that the cDNA formed a functionally active protein catalysing the formation of one radiolabelled sesquiterpene from [ 3 H]-FDP.
- the negative control (vector without insert) produced no radioactivity.
- the samples are also analysed by GC-MS using a HP 5890 series II gas chromatograph equipped with an HP5-MS column (30 m ⁇ 0.25 mm i.d., 0.25 ⁇ m df) and HP 5972A Mass Selective Detector (Hewlett-Packard). The oven is programmed at an initial temperature of 70° C.
- the injection port (splitless mode), interface and MS source temperatures are 150, 290 and 180° C., respectively, and the He inlet pressure is controlled by electronic pressure control to achieve a constant column flow of 1.0 mL min ⁇ 1 .
- Ionization potential is set at 70 eV, and scanning is performed from 30-250 amu.
- the negative control produced no sesquiterpenes, whereas in assays with the expression products valencene is the major product. The identity of the latter is confirmed by analysis of an authentic standard and comparison of the mass spectra with the authentic standard.
- Two strategies are used to isolate the sesquiterpene hydroxylases and dehydrogenase from chicory.
- One is based on the presence of sequence homology between P450 genes on the one hand and dehydrogenases on the other.
- the other method uses random sequencing of a C. intybus root cDNA library which has been shown to be a powerful tool for the isolation of biosynthetic genes (Aharoni, et al., 2000).
- RNA isolation kit Biozym
- DNase I Deoxyribonuclease I, RNase free
- the DNase I is removed with a phenol/chloroform extraction after which the RNA is precipitated (ethanol precipitation with NaAc).
- Poly (A)+ RNA is extracted from 20 ⁇ g of total RNA using 2 ⁇ g poly-d(T)25V oligonucleotides coupled to 1 mg paramagnetic beads (Dynal A. S.). The poly(A)+ RNA is resuspended in 20 ⁇ l H 2 O.
- the reverse transcription reaction is carried out in a 50 ⁇ l reaction containing 10 ⁇ l poly (A)+ mixture, 0.3 ⁇ g oligo (dT) 25 V, 1 mM each dATP, dTTP, dCTP and dGTP, 50 mM Tris-HCl pH 8.3, 80 mM KCl, 10 mM MgCl 2 and catalyzed with 12 U AMV reverse transcriptase (Pharmacia). After an incubation for 2 h at 42° C. the reaction is stopped and the cDNA purified with the Wizard PCR Preps DNA purification system (Promega). The cDNA is resuspended in 50 ⁇ l H 2 O
- PCR-based probe generation Based on comparison of sequences of cytochrome P450 and dehydrogenase enzymes, degenerate primers are designed for conserved regions such as the ER targeting signal, the heme-binding domain, the central region of helix I and the PERF-motif. PCR is performed in a total volume of 50 ⁇ l containing 0.5 ⁇ M of each of the two primers, 0.2 mM dNTP, 1 U Super Taq polymerase/1 ⁇ PCR buffer (HT Biotechnology LTD, Cambridge, England) and 10 ⁇ l cDNA.
- the reaction mixture is incubated in a thermocycler (Robocycler, Stratagene) with 1 min denaturation at 94° C., 1.5 min annealing at 42° C. and 1 min elongation at 72° C. during 40 cycles. Agarose gel electrophoresis revealed a single specific PCR product.
- a thermocycler Robot, Stratagene
- a cDNA library is constructed using the UniZap XR custom cDNA library service (Stratagene). For library screening 200 ng of the PCR amplified probes are gel-purified, randomly labelled with [ ⁇ - 32 P]dCTP, according to manufacturer's recommendation (Ready-To-Go DNA labelling beads ( ⁇ dCTP), Pharmacia) and used to screen replica filters of 10 4 plaques of the cDNA library plated on E. coli XL1-Blue MRF (Stratagene). The plaque lifting and hybridization are carried out according to standard protocols. Positive clones are isolated using a second and third round of hybridization. In vivo excision of the pBluescript phagemid from the Uni-Zap vector is performed according to manufacturer's instructions (Stratagene).
- 1500 clones from the cDNA library are randomly sequenced and compared to sequences in the databases using BLAST. Promising P450 and dehydrogenase-like sequences were found and are further characterised by heterologous expression.
- the cDNA clones are subcloned into suitable expression vectors and transformed to a suitable expression host. Induced cells are harvested by centrifugation during 8 minutes at 2000 g and resuspended in 1 ml assay buffer. The resuspended cells are either sonicated on ice during 4 min (5 sec on, 30 sec off), centrifuged for 5 minutes at 4° C. (14.000 rpm) and the supernatant used for assays or used as intact cells. In both systems germacrene A, valencene and nootkatol are used as substrates. Ether extracts of the assays are analysed using GC-MS (see Example 7).
- the negative control produced no germacrene A alcohol, nootkatol, or nootkatone, whereas in assays with the expression products of both genes conversion of germacrene A to germacrene A alcohol, valencene to nootkatol and of nootkatol to nootkatone, respectively, occurred.
- Chicory transformation Chicory is transformed as described in PCT/EP00/02130 (Bouwmeester et al., 1999b) with a construct harboring the valencene or amorphadiene synthase. After regeneration, transgenic plants are screened for the activity of the introduced gene by examining sesquiterpene synthase activity in enzyme extracts.
- 100 mg of tissue, ground in liq N 2 is extracted in a 2-ml Eppendorf vial, using a plastic probe to further homogenize the tissue, in 1.0 ml of extraction buffer containing 50 mM Mopso (pH 6.8), 20% (v/v) glycerol, 50 mM sodium ascorbate, 50 mM NaHSO 3 , 1% PV ⁇ -40, 10 mM MgCl 2 and 5 mM DTT. After extraction, the samples are centrifuged for 20 min at 20,000 g at 4° C.
- Example 7 0.5 mL of the supernatant are diluted 2-fold with buffer A (Example 7) also containing 6 mM sodium orthovanadate (an inhibitor of phosphohydrolase activity). After addition of 20 ⁇ M 3 H-FPP and a 1 mL redistilled pentane overlay, the tubes are carefully mixed and incubated for 1 h at 30° C. The assays are extracted and analysed using radio-GC and GC-MS as described for Example 7.
- the wildtype and GUS-construct controls all exhibit a similar sesquiterpene synthase activity, which is due to the presence of endogenous germacrene A synthase activity.
- the transformants exhibit an altered sesquiterpene profile, with varying amounts of valencene and amorphadiene, respectively in addition to germacrene A.
- 90% of the in vitro produced sesquiterpene is valencene.
- Extracts of the transgenic plants that were analysed using GC-MS showed the presence of valencene, nootkatol and nootkatone on the one hand and artemisinic acid, dihydroartemisinic acid and artemisinin on the other hand, respectively.
- Saccharomyces cerevisiae and Pichia pastoris are transformed using the S. cerevisae EasyCompTM transformation kit (Invitrogen) according to manufacturer's instructions with constructs harboring:
- Transgenic cells are grown in a reactor, and products of the cells are analysed after extraction.
- Transgenic yeast cells harboring constructs 2 and 3 produce nootkatone, showing that the yeast dehydrogenases oxidise the nootkatol produced (in 2).
- Yeast cells harboring construct 1 produce nootkatone upon feeding of valencene.
- Saccharomyces cerevisiae and Pichia pastoris are transformed using the S. cerevisae EasyCompTM transformation kit (Invitrogen) according to manufacturer's instructions with a construct harboring a sesquiterpene synthase, such as, but not limited to, amorphadiene synthase, ( ⁇ )- ⁇ -trans-bergamotene synthase, alloisolongifolene synthase, ⁇ -gurjunene synthase and a sesquiterpene hydroxylase cDNA (obtained as described in Example 8).
- a sesquiterpene synthase such as, but not limited to, amorphadiene synthase, ( ⁇ )- ⁇ -trans-bergamotene synthase, alloisolongifolene synthase, ⁇ -gurjunene synthase and a sesquiterpene hydroxylase cDNA (obtained as described in Example 8).
- Transgenic cells are grown in a reactor, and products of the cells are analysed after extraction.
- Transgenic yeast cells are harboring the constructs produce amorphadien-12-ol, (E)-trans-bergamota-2,12-dien-14-ol; alloisologifolene alcohol; and 5,11(13)-guaiadiene-12-ol, respectively.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
- This application is a divisional application of pending U.S. application Ser. No. 10/489,762 filed on Sep. 7, 2004, which is the U.S. National Phase of International Application Number PCT/NL02/00591 filed on 17 Sep. 2002, which are incorporated herein by reference.
- The invention relates to the field of bioconversion, using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates. More specifically it relates to a process for production of terpenoid compounds by the use of plant enzymes.
- Modern chemistry strongly depends on the use of catalysts in order to have efficient and clean reactions with a minimum of waste. Especially the use of biocatalysts (enzymes, cells) is strongly increasing, also in industry. The most important features of biocatalysts are (Faber, 2000): 1. they are very efficient; 2. they are environmentally acceptable; 3. they operate under mild conditions; 4. they are selective.
- Up to now, the large majority of enzymes used in bioconversion employing biocatalysis for industrial and laboratory applications is obtained from microbial sources. A minor fraction of enzymes is obtained from plant sources (Faber, 2000). Nevertheless, the plant kingdom is an important source for the chemist and the biotechnologist because plants produce a unique variety of chemicals (Franssen and Walton, 1999). The rationale for this is simple: there is no way plants can escape from their predators, so they have to defend themselves by chemical ways. Plants make compounds with the most fantastic chemical structures: the antitumor drug TAXOL® (paclitaxel) (from Taxus brevifolia), the insect feeding deterrent azadirachtin (from the Indian neem tree Azadirachta indica) and the analgesic morphine (from Papaver somniferum). It is mainly because of the tremendous importance of compounds like these that science has been, and still is, interested in the application of plant cells and enzymes, irrespective of the disadvantages they sometimes have (Walton and Brown, 1999). By far the most important group of secondary metabolites, containing a vast number of components that act as flavor, fragrance, pharmaceutical or bioactive (insecticidal, anti-microbial, repellent, attractant, etc, etc) compounds, are the terpenoids. The terpenoids belong to the isoprenoids. By definition isoprenoids are made up of so-called isoprene (C5) units. This can be recognized in the number of C-atoms present in the isoprenoids which usually can be divided by five (C5, C10, C15, C20, C25, C30 and C40), although also irregular isoprenoids (e.g. C13, C16) and polyterpenes (Cn) have been reported.
- The terpenoids consist of a. o. monoterpenes, sesquiterpenes, diterpenes, triterpenes, tetraterpenes and polyterpenes (rubbers), etc. Mono- and sesquiterpenes, the C10 and C15 branch of the isoprenoid family, are economically interesting as flavor and fragrance compounds in foods and cosmetics, and can have anti-carcinogenic effects and antimicrobial properties. Mono- and sesquiterpenes have also been shown to be of ecological significance, for instance in the interaction and signaling between plants, plants and insects/spider mites and plants and microorganisms.
- The sesquiterpene lactones are an important subgroup of the sesquiterpenes, and over 4000 different structures have been identified. A wealth of information is available about the structural aspects and biological activities of these type of compounds (e.g. Picman, 1986; Harborne et al., 1999; Seigler, 1995).
- Sesquiterpene lactones may constitute up to 5% of the dry weight of the plant and occur mainly in members of the Asteraceae (in about 450 species), the largest of all plant families, but also occur in other higher plant families such as the Apiaceae (12 species) and lower plants such as liverworts, for example the genus Frullania (Harborne et al., 1999). Sesquiterpene lactones may occur throughout a plant, but are most commonly associated with leaves, flower parts and taproots.
- The Asteraceae contain 1317 genera and 21000 species. They are mainly herbaceous plants, sometimes shrubs or trees, usually with a taproot, sometimes with tubers. Many of the Asteraceae contain (essential) oil bearing organs, such as ducts or trichomes, some of them contain latex. The Asteraceae contain many economic and ornamental plants, such as Sunflower (Helianthus annuus; for the production of seeds and sunflower oil), Jerusalem Artichoke (Helianthus tuberosus; of which the tubers are eaten and that is also used for the fructan production), and Artemisia annua (for the production of the effective anti-malarial artemisinin). Also used as food are the roots of Salsify (Tragopogon porrifolius) and Scorzonera (Scorzonera hispanica), the young flower-heads of Globe Artichoke (Cynara scolymus), and the leaves of Lettuce (Lactuca sativa), Endive (Cichorium endiva) and Radicchio and Brussels Endive (Cichorium intybus). In addition, there are many ornamental Asteraceae, for example in the genera Dahlia, Doronicum, Helenium, Tagetes, Helianthus, Aster, Centaurea, Gerbera, etc.
- The occurrence of sesquiterpene lactones in the tribes of the Asteraceae is of taxonomic interest. They are common in the Heliantheae, occur frequently in the Anthemideae, Cichorieae, Cynareae, Senecioneae, Inuleae and Vernonieae, only infrequently in the Eupatoriaea and not in the Astereae, Mutisieae, Tageteae and Arcoteae-Calenduleae (Seigler, 1995). Crop species that have been shown to contain sesquiterpene lactones are for example: Artichoke, Lettuce, Endive, Radicchio, Brussels Endive, Sunflower, Jerusalem Artichoke, Artemisia annua, Matricaria recutita. Some wild (or ornamental) Asteracea species containing sesquiterpene lactones are: Lactuca virosa, Achillea spp., Ambrosia spp. Cnicus benedictus, Artemisia spp., Xanthium spp., Iva axillaris, Parthenium spp., Helenium spp., Hymenoxys odorata, Vernonia spp., Vanillosmopsis spp., Eremanthus spp., Moquinea spp., Parthenium spp., Arnica spp., Atractylodis macrocephala, Eupatorium cannabium, Achillea millefolium, Tanacetum (Chrysanthemum) vulgare, Inula helenium and Taraxacum officinale (Seigler, 1995; Van Genderen et al., 1996).
- One example of an Asteraceous species that contains large amounts of sesquiterpene lactones is Chicory. The roots of chicory are extremely bitter, due to these sesquiterpene lactones.
- Chicory is a blue-flowered composite plant that has spread all over the world from the Mediterranean and east Asia. Since the seventeenth century it has been cultivated (var. sativum) for its bitter roots that were roasted and used in hot ‘coffee-like’ beverages. While the use of its roots was displaced by genuine coffee from Coffea arabica, sprouts of chicory (var. foliosum) that are grown in the dark became popular as a vegetable (Belgian endive) halfway through the nineteenth century. Nowadays it is a common crop in Belgium, northern France and The Netherlands (Weeda et al., 1991; Vogel et al., 1996). During the first year of growth, the plant develops a deep taproot and produces a rosette of leaves on a short stem. Following a period of cold exposure, the plant develops a floral meristem. Commercial production involves harvesting the plant following the attainment of a proper stage of maturity of the root, followed by floral bud induction (cold storage) and then an accelerated but controlled development of the floral axis and surrounding basal leaves in the dark (forcing). The end product of forcing is a chicon, a small white head of leaves ringed with regions of yellow-green. This Belgian endive is known for its slightly bitter taste originating from sesquiterpene lactones (Pyrek, 1985; Seto et al., 1988; van Beek et al., 1990; Price et al., 1990). The major sesquiterpene lactones of chicory are guaianolides, but smaller amounts of eudesmanolides and germacranolides are also present. The bitter taste of chicory is in particular associated with the presence of the guaianolides lactucin, 8-deoxylactucin, and lactucopicrin.
- Although a lot of information is available about the structural aspects and biological activities of the sesquiterpene lactones, little is known about their biosynthesis. By far the largest group of naturally occurring sesquiterpene lactones is the group of germacranolides, and the majority of sesquiterpene lactones are thought to evolve from this group. The simplest member of the germacranolides, (+)-costunolide, is generally accepted as the common intermediate of all germacranolide-derived lactones (Geissman, 1973; Herz, 1977; Fischer et al., 1979; Seaman, 1982; Song et al., 1995).
- (+)-Costunolide was first isolated from costus roots (Saussurea lappa Clarke) by Paul et al. (1960) and Somasekar Rao et al. (1960), and has since been found with other sesquiterpene lactones in various plants (Fischer et al., 1979). Amongst them is lettuce (Lactuca sativa), a species that is closely related to chicory and also contains the bitter tasting compounds lactucin and lactucopicrin (Takasugi et al, 1985; Price et al., 1990).
- Recently we have demonstrated that the sesquiterpenoid backbone of the sesquiterpene lactones in chicory is formed by a (+)-germacrene A synthase which cyclizes FPP to (+)-germacrene A (de Kraker et al., 1998; Bouwmeester et al., 1999b). This (+)-germacrene A is not further transformed into a guaiane or a eudesmane skeleton, indicating that functionalization of the molecule precedes its cyclization. Studies on the biosynthesis of santonin (Barton et al., 1968) suggested that lactone formation precedes any other oxidation of the sesquiterpenoid ring system (Cordell, 1976), and various authors have proposed a biosynthetic route from (+)-germacrene A (8) toward (+)-costunolide (Geissman, 1973; Herz, 1977; Seaman, 1982; Fischer, 1990; Song et al., 1995). In this hypothetical route (+)-germacrene A is hydroxylated to germacra-1(10),4,11(13)-trien-12-ol that is further oxidized via germacra-1(10),4,11(13)-trien-12-al to germacra-1(10),4,11(13)-trien-12-oic acid. The germacrene acid is thought to be hydroxylated at the C6-position and subsequent loss of water leads to the formation of a lactone ring such as present in (+)-costunolide.
- Unfortunately, germacrenes are notoriously unstable compounds, susceptible to proton-induced cyclizations and heat induced (e.g. steam distillation, GC-analysis) Cope rearrangement (Takeda, 1974; Bohlman et al., 1983; Reichardt et al., 1988; Teisseire, 1994; de Kraker et al, 1998). None of the intermediates between (+)-germacrene A and (+)-costunolide has ever been isolated, apart from germacra-1(10),4,11(13)-trien-12-al that was isolated with greatest difficulty from Vernonia glabra and could not be separated from its cyclization product costal (Bohlman et al, 1983). Probably as a result of this instability, the hypothetical biosynthetic route for (+)-costunolide has merely been based on the isolation from costus roots of the Cope-rearrangement products (−)-elema-1,3,11(13)-trien-12-ol and (−)-elema-1,3,11(13)-trien-12-al, and the proton-induced cyclization products costol, costal and costic acid (Bawdekar and Kelkar, 1965; Bawdekar et al., 1967; Maurer and Grieder, 1977).
- The next step in the biosynthesis of sesquiterpene lactones is catalysed by a cytochrome P450 enzyme (De Kraker et al., 2001). Cytochrome P450 enzymes (Mr=±50,000) mostly catalyzes oxidation reactions, but also reductions. Most vertebrate genomes contain more than 30 different structural genes for cytochromes P450 (Mathews and van Holde, 1996), making this a large and diverse protein family. These proteins resemble mitochondrial cytochrome oxidase in being able to bind both O2 and CO. Cytochromes P450, however, strongly absorb light at 450 nm when they are in the reduced state and complexed with CO. Light of 450 nm displaces CO from the heme, hence CO binding is photoreversible. For this reason, cytochrome P450 enzymes exhibit photoreversible inhibition by CO (Donaldson and Luster, 1991). Plant cytochrome P450 monooxygenase systems are associated with the endoplasmic reticulum or a prevacuole, and consequently are located in the light membrane (microsomal) fraction of the cell.
- Cytochrome P450 enzymes are involved in the hydroxylation of a large variety of compounds. There are two classes of cytochrome P450 activities known: those involved in biosynthetic routes and those involved in detoxification of xenobiotics (Donaldson and Luster, 1991; Mihaliak et al., 1993; Schuler, 1996). These reactions include the hydroxylations of steroid hormone biosynthesis, and the synthesis of hydroxylated fatty acids and fatty acid epoxides. In addition, cytochromes P450 act upon thousands of xenobiotics, including drugs such as phenobarbital and environmental carcinogens such as benzopyrene, a constituent of tobacco smoke. Hydroxylation of foreign substances usually increases their solubility and is a step in their detoxification, or metabolism and excretion.
- Cytochrome P450 systems participate in a wide variety of additional reactions, including epoxidation, peroxygenation, desulfinuration, dealkylation, deamination, and dehalogenation. These reactions are particularly active in the liver, where a number of cytochromes P450 are xenobiotic-inducible; that is, their synthesis is stimulated by substrates that are metabolized by these enzymes (Mathews and van Holde, 1996). Inducers include drugs such as phenobarbital and other barbiturates.
- The amino acid residues that constitute the active site of the enzyme determine the specificity of a given P450. They can vary widely between different cytochromes P450; however, the principal component of the active site of all these enzymes is a heme moiety. The iron ion of the heme moiety is the site of the catalytic reaction, and is also responsible for the strong 450 nm absorption peak in combination with CO. The substrate specificity of cytochrome P450 enzymes depends on their function in the organism: the biosynthesis of metabolites or the breakdown of xenobiotics in animals. The enzymes that take care of the breakdown of xenobiotics have a low specificity, so that a few enzymes can protect the organism against a large diversity of xenobiotics. How the detoxification of xenobiotics in plants is accomplished is not clear yet. Enzymes that are involved in biosynthetic routes of metabolites in plants or animals in general have a very high substrate specificity (Donaldson and Luster, 1991; Mihaliak et al., 1993; Schuler, 1996).
- Many different enzymes are involved in the biosynthetic pathways of complex plant metabolites. The enzymes catalyse, among others, stereo- and regioselective hydroxylations, (ep)oxidations, reductions, glycosylations, esterifications and cyclisations. Especially the enzymes that are involved in hydroxylations and oxidations have great potential in chemistry, since the corresponding chemical transformations involve the use of toxic reagents and halogenated solvents, which is undesirable because of safety and environmental reasons (March, 2001). For example, allylic hydroxylations are usually performed using selenium dioxide in methylene chloride (Jerussi, 1970). The direct introduction of a carbonyl function next to a carbon-carbon double bond requires the use of toxic chromium trioxide (March, 2001) or the expensive and highly toxic ruthenium tetroxide (e.g., Petit and Furstoss, 1995). Furthermore, hydroxylating and oxidizing enzymes usually have far greater regio- and stereoselectivity than the chemical reagents. A few examples are given below.
- Partly on account of their importance in fragrance and flavour industries, the hydroxylation and further biotransformation of terpenoids has been particularly well studied, using cell cultures of essential oil producing species and of other plants, such as Nicotiana tabacum (Suga and Hirata, 1990). Stereospecificity was shown, for example, by the formation of only trans isomers from hydroxylation occurring at C4 of β-terpineol and its acetate and by the predominant formation of a trans-diol as a result of hydroxylation of the endocyclic double bond of α-terpinyl acetate (
FIG. 4 ). - Digitoxin is a cardiac glycoside from Digitalis sp. Its β-hydroxylation on the 11-position yields the more potent digoxin. This has been achieved by purified, reconstituted and immobilized digitoxin 12β-hydroxylase (a cytochrome P450 enzyme complex) from Digitalis lanata in a bioreactor (Petersen and Seitz, 1988; Petersen et al., 1987).
- Sesquiterpene alcohols and ketones are an interesting group of compounds for a number of reasons. Sesquiterpene alcohols, for example have been shown to be involved in resistance against micro-organisms: the Solanaceae for example produce sesquiterpene alcohol phytoalexins upon infection with pathogenic fungi and in vitro assays have shown that these sequiterpene alcohols have a strong antifungal activity. Also a number of sesquiterpene alcohols are important in the flavor and fragrance industry, for example santalol, typical for the very expensive sandalwood essential oil, and khusimol, patchoulol, etc. Also the sesquiterpene ketone, nootkatone is a commercially important compound. Because of its excellent organoleptic qualities and in particular its typical grapefruit taste, nootkatone is a widely used ingredient in perfumery and the flavor industry. Nootkatone was also shown to inhibit gastric lesion which explains that it is a constituent of some stomach medications (Yamahara et al., 1990). Although nootkatone can be obtained from valencene or other substrates using chemical synthesis (Hunter and Brogden, 1965; Wilson and Shaw, 1978; Canadian patent no 901601; M. Pesaro et al., 1968; Birch, 1974; U.S. Pat. No. 5,847,226) there is a large demand for natural nootkatone. At present, such a quality can only be obtained by extraction of natural products containing nootkatone, in particular grapefruit, a method which is hardly economic. With the enzymes lignin peroxidase (from Phanerochaete chrysosporium) and lactoperoxidase it is possible to convert (+)-valencene into nootkatone under certain conditions. In this way, the conversion is very low and is most probably due to singlet oxygen that is formed by these two enzymes (Willershausen and Graf, 1991). Several microorganisms, bacteria and fungi, were also screened for their capability to transform (+)-valencene into nootkatone all without much success. (Balfoort, 1994). Two bacteria of the genus Enterobacter from a Dutch soil and an infected local beer were isolated by enrichment cultures on (+)-valencene. These bacteria transformed (+)-valencene into nootkatone (12% yield) and many other valencene derivatives (Dhavlikar and Albroscheit, 1973). Also other methods for the bioconversion of valencene to nootkatone using micro-organisms have been studied, but none of these methods have proven commercially viable (Dhavlikar et al., 1973; Drawert et al., 1984).
- The invention relates to the field of bioconversion, using oxidising enzymes, in particular cytochrome P450 related enzymes, with high regio- and enantioselectivity, for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates. More specifically it relates to a process for production of bioactive terpenoid compounds by the use of plant enzymes. The invention provides the use of enzymes derived from an organism, in particularly from a plant, that contains sesquiterpene lactones, in biocatalysis. The regio- and stereoselective oxidation of organic compounds is still a largely unresolved challenge to organic chemistry (Faber, 2000). We investigated whether the oxidising enzymes of a sesquiterpene containing organism such as an Asteraceae species, are capable of converting for example sesquiterpene olefins to commercially interesting products. We found useful enzymes with a surprisingly broad application. Asteraceae, but also plant species from other families, that contain sesquiterpene lactones also contain the enzymes required for their biosyntheis, and thus can be used as a preferred source for these enzymes. In a preferred embodiment, the invention provides an enzyme that is useful for nootkatone synthesis. Nootkatone is a compound mainly founds in grapefruits and other citrus fruits. Surprisingly, however, we provide here evidence that nootkatone synthesis can also occur with an enzyme that is not derived from a citrus fruit, but from another sesquiterpene containing species instead. Considering the large availability of non-citrus derived enzymes, for example from the large amounts of chicory taproots that remain after the growing of the chicory vegetable or inuline chicory, or from other Asteraceae species, such as lettuces, sunflower, artichoke, radicchio, etc, etc, that can easily and abundantly be grown, we have provided here useful enzymes for example the flavor, aroma, pharmaceutical or biocide industry. In addition to the Asteraceae, the liverworts (Hepaticae) are another good example of a cheap and widely available source for these oxidising enzymes and several families of the liverworts have been reported to contain sesquiterpene lactones. Sesquiterpene lactones isolated from higher plants contain, essentially without exception, α-methylene-γ-lactone groups in which H-7 is α-oriented. The liverworts produce sesquiterpene lactones of the enantiomeric series. Nevertheless, the oxidising enzymes from these organisms can carry out similar reactions as the enzymes from higher plants and are a valuable addition to the higher-plant enzymes. In particular, the invention provides a method for converting a substrate and generating a stereo- and regioselective conversion product comprising subjecting said substrate to enzymes derived from a plant species producing sesquiterpene lactones, especially wherein said conversion product comprises an alcohol, aldehyde/ketone or carboxylic acid. Also, the conversion products can be further modified using commercial enzymes such as alcohol dehydrogenases or microbial bioconversion systems. Considering that useful Asteraceae and liverwort species can easily be grown, the invention provides an inexpensive resource of enzymes or other biocatalysts (cells, explants, tissue, hairy roots or cell cultures) for bioconversion. Particularly useful crops comprise Cichorium spp, lettuces such as Lactuca spp., Helianthus spp. etc. but are not limited to these. The method as provided herein allows the conversion of a terpene in a useful stereo- and regioselective conversion product, for example linear or branched terpene alcohols, aldehydes/ketones or carboxylic acids, especially where said substrate comprises a sesquiterpene. In particular, a method is provided wherein said enzyme comprises a cytochrome P450 monooxygenase, such as (+)-germacrene A hydroxylase or a sesquiterpenolide C2 hydroxylase These enzymes catalyse the hydroxylation of (+)-germacrene A and a sesquiterpene lactone intermediate in chicory sesquiterpene lactone biosynthesis. Although the enzymes belong to a biochemical pathway, they do not have a high substrate specificity. Hydroxylation of a sesquiterpene occurs when the compound contains, like germacrene A, an isopropenyl substituent or, like germacrene B, an isopropylidene substituent or like valencene an allylic C2-position. The conversion carried out by these hydroxylases occurs with high regio- and stereoselectivity which is a big advantage compared with microbial hydroxylations which usually occur with very low specificity. In the detailed description, examples are given for the conversion of valencene to the commercially important flavor/fragrance compound nootkaton. The substrate, (+)-valencene, is converted to several products; two of them are valencene alcohol (2.61%) and nootkatone (24.4%). Nootkatone is used as a constituent of soft drinks and perfumes. Also, a method is provided wherein the substrate amorpha-4,11-dien-12-ol, is converted to the antimalarial artemisinin or a precursor thereof. Other substrates that were hydroxylated include germacrene A, as one might expect, the substrate with the highest rate of conversion and β-selinene. Alternative substrates that are converted to their corresponding alcohols are: alloisolongifolene (at 1.49% compared to β-selinene). Amorphadiene is converted to two products, at 74.0 and 18.7%; the first is amorpha-4,11-dien-12-ol the precursor of artemisinin and the identity of the latter is unknown. The relative rate of conversions of the other substrates were found to be the following: (−)-α-trans-bergamotene (13.5%), (−)-β-elemene (56.2%), germacrene A (110%, probably even higher), germacrene B (3.13% and 8.60%, cis-trans isomers), (+)-γ-gurjunene (54.9%), (+)-ledene (7.20%), and neointermedeol (6.92%). It is particularly useful when said enzymes are derived from an extract of said Asteraceae species, extracts being easily made according to a method known in the art. It is also contemplated herein to use free latex from an Asteraceae as enzyme preparation. In the detailed description, examples are given with enzymes derived from chicory roots. Because the roots of chicory are extremely bitter, they are regarded as a waste product of chicory cultivation. About 100,000 tons of chicory roots are produced annually in The Netherlands, but because of their bitter taste, it is not even possible to use them as cattle feed. Therefore they provide a vast and cheap source for the enzymes described in the invention. For an industrial process, the invention provides a method to make enzyme extracts that contain the P450 enzymes. These can be prepared by homogenising chicory roots in an extraction buffer according to Example 1 containing PVPP. The resulting slurry is then filtered and centrifuged. Low-(20,000× g) followed by high-speed (150,000× g) centrifugation will result in highly-enriched microsomal pellets, but also supernatants obtained after very low speed (for example 2,000× g) centrifugation are active, making it easier to adapt the procedure for industrial processes. The pellets or supernatants can be resuspended in a suitable assay buffer to which the appropriate substrates, and NADPH or an NADPH-regenerating system can be added or the enzymes may be immobilised according to Example 5 to increase their efficiency and lifetime. Cofactor recycling will further increase the economic feasability. After incubation at a suitable temperature, the alcohol products can be easily extracted and separated from the substrate using preparative-scale column chromatography. The suitable substrates can be any sesquiterpene hydrocarbon that could yield an interesting product after hydroxylation at positions equivalent to the positions described in the examples, for example valencene, amorphadiene, (−)-α-trans-bergamotene, γ-gurjunene, ledene, germacrene A, germacrene B, but not limited to those. The corresponding alcohols formed enzymatically from these substrates could be further oxidised to the corresponding aldehydes/ketones or acids—if these are of more value—using a chicory alcohol and aldehyde dehydrogenase or commercially available dehydrogenases. However, another possible method is provided wherein said enzymes are present in a tissue- or cell culture derived from said Asteraceae species, for example a hairy root culture. Hairy root and cell cultures of chicory can be obtained using standard protocols (hairy root cultures: Song et al., 1995; cell cultures: Dubois et al., 1988). The cultures are supplied with sesquiterpenes such as valencene, amorphadiene, (−)-α-trans-bergamotene, γ-gurjunene, ledene, germacrene A, germacrene B, but not limited to those, preferably at 200-1000 mg/l. After one week of growth in the presence of the sesquiterpenes, the reaction products are extracted from the culture medium and the hairy roots/cells. It is also possible to make use of a recombinant enzyme, for example derived from a transgenic plant or micro-organism provided with a nucleic acid encoding an enzyme according to the invention. According to the invention, cytochrome P450 cDNAs can be obtained using random sequencing of a cDNA library of chicory taproots, the organ where the activity of these enzymes is highest. Also a PCR approach is feasible where the sequence homology of cytochrome P450 enzymes is used to design degenerate primers that can be used to generate PCR fragments. These fragments are used to screen a cDNA library to obtain full-length cDNAs. These cDNAs can be expressed in E. coli, yeast or any other micro-organism adapted to large-scale industrial fermentation and suitable for the expression of P450s. In such a fermentation procedure, the transgenic micro-organisms will be fed the desired sesquiterpene hydrocarbon substrates for example valencene, amorphadiene, (−)-α-trans-bergamotene, γ-gurjunene, ledene, germacrene A, germacrene B, but not limited to those. The produced alcohol products can be extracted continuously or in batch. These micro-organisms could also be equipped with the synthase of the desired sesquiterpene hydrocarbon substrate, such as for example the valencene synthase, which would further reduce the costs of production, and an alcohol and/or aldehyde dehydrogenase in order to produce ketones/aldehydes, such as in the case of nootkatone production, or acids—when required.
- The invention also provides a conversion product obtainable by a method according to the invention. In particular interesting products are (E)-trans-bergamota-2,12-diene-14-ol, the direct precursor of the corresponding aldehyde with sandalwood-like fragrance properties, and a number of novel conversion products such as alloisolongifolene alcohol, amorpha-4,11-diene-12-ol, germacrene B alcohol, 5,11(13)-guaiadiene-12-ol and a ledene alcohol, all alcohols that have not been reported before. With the invention larger amounts of these alcohols can be produced to confirm their identity and to investigate their properties as flavor and fragrance compounds, pharmaceuticals or biocides, or of their corresponding aldehydes/ketones and carboxylic acids.
- Also, the invention provides an isolated or recombinant enzyme or enzyme extract derived from an Asteraceae species capable of converting a substrate and generating a conversion product after subjecting said substrate to said enzyme(s) and use of such enzyme(s) or extract according to the invention in biocatalysis, for example for the generation of a flavor or fragrance compound, pharmaceutical or biocide. The invention thus provides for example the use of micro-organisms, expressing genes encoding said oxidising enzymes that were isolated from sesquiterpene lactone producing plant species for bioconversion. Also the use of micro-organisms, expressing genes encoding said oxidising enzymes that were isolated from sesquiterpene lactone producing plant species in combination with genes that introduce the formation of said substrates in the micro-organism and hence the formation of said oxidised bioconversion products is provided herein. Also the invention provides the use of transgenic sesquiterpene lactone producing plant species, such as chicory, expressing genes that introduce the formation of said substrates in planta, such as terpene synthase genes that introduce the formation of said terpenes in planta and hence the formation of said oxidised bioconversion products or expressing a valencene synthase that introduces the formation of valencene in planta and hence the formation of nootkatone, or expressing amorpha-4,11-diene synthase that introduces the formation of amorpha-4,11-diene in planta and hence the formation of artemisinin or its precursors, or expressing α-trans-bergamotene synthase that introduces the formation of α-trans-bergamotene in planta and hence the formation of (E)-trans-bergamota-2,12-dien-14-ol.
-
FIG. 1 . Bitter principles of chicory. The guaianolides lactucin, 8-deoxylactucin and lactucopicrin are major compounds. Minor sesquiterpene lactones of chicory are the guaianolides 11 (S), 13-dihydrolactucin (α), 11 (S), 13-dihydro-8-deoxylactucin (b), 11 (S), 13-dihydrolactucopicrin, (c); the eudesmanolides sonchuside C (d) and cichoriolide A (e), and the germacranolides sonchuside A (f) and cichorioside C (g). -
FIG. 2 . Proposed biosynthetic route from (+)-germacrene A (1) to (+)-costunolide (5) via germacra-1(10),4,11(13)-trien-12-ol (2), germacra-1 (10),4,11(13)-trien-12-al (3), and germacra-1(10),4,11(13)-trien-12-oic acid (4). At the right side of the dotted line, compounds are shown that can be formed from these unstable germacrenes: the heat induced Cope rearrangement products (−)-β-elemene (6), (−)-elema-1,3,11(13)-trien-12-ol (7), (−)-elema-1,3,11(13)-trien-12-al (8), elema-1,3,11(13)-trien-12-oic acid (9), and dehydro-saussurea lactone (10); and the acid induced cyclisation products selinene (11) (γ-selinene is usually named selina-4,11-diene), costol (12), costal (13), and costic acid (14). Compounds with underlined numbers have all been identified in costus roots; (+)-germacrene A (1) and germacra-1(10),4,11(13)-trien-12-al (3) were isolated from other plant species. Note that after hydroxylation the numbering ofcarbon atoms -
FIG. 3 . Schematic drawing of the cytochrome P450 complex (taken from Meijer, 1993). Instead of O2, cytochrome P450 is also able to bind CO which inhibits its catalytic action. -
FIG. 4 . Chemical structure of α- and β-terpineol and their acetate esters. -
FIG. 5 . Chemical structure of digitoxin and digoxin. -
FIG. 6 . Substrates that were not converted, i.e. (−)-(α)-cubebene, (−)-(α)-gurjunene, and germacrone; or hardly converted, ie. limonen, by the (+)-germacrene A hydroxylase containing microsomal pellet from chicory roots. -
FIG. 7 . Biotransformation of (+)-γ-gurjunene with a plant pathogenic fungus yields (1S,4S,7R, 10R)-5-guaien-11,13-diol and (1S,4S,7R,10S)-5-guaien-10,11,13-triol; incubation of γ-gurjunene with a microsomal pellet of chicory gave (1S,4S,7R, 10R)-5,11(13)-guaiadiene-12-ol. -
FIG. 8 . Postulated cytochrome P450 catalysed conversion of germacra-1(10),4,11(13)-trien-12-oic acid (4) into (+)-costunolide (5) via hydroxylation and subsequent lactonisation. -
FIG. 9 . Various substrates that were also incubated with the chicory supernatant and NADPH: a mixture of α- and γ-costic acid (15), elema-1,3,11(13)-trien-12-oic acid (16), parthenolide (17) and dehydrocostus lactone (18). -
FIG. 10 . A, GC-MS analyses of the products formed in the incubation of a 20,000 g supernatant from chicory roots with NADPH and germacra-1(10),4,11(13)-trien-12-oic acid (4) displays peaks of dehydrosaussurea lactone (dHSausL [7]), saussurea lactone (SausL [9]), and leukodin (Leuk [10]). B, These products are not observed in the absence of NADPH. Gernacrene-1(10),4,11(13)-trien-12-oic acid (1) is observed as elema-1,3,11(13)-trien-12-oic acid (EAc) plus its diastereomer (EAc*); the internal standard (i.s.) is 1 nmol cis-nerolidol. The huge fronting peaks () are fatty acids (palmatic- and linoleic acid). C, A standard of 0.5 mM costunolide (2) in ethanol yields a tailing peak of dehydrosaussurea lactone (dHSausL [7]). -
FIG. 11 . Products formed from germacra-1(10),4,1,1(13)-trien-12-oic acid (4) in the presence of NADPH and oxygen by a chicory 20,000 g supernatant. Leukodin (22) is detected as a genuine GC-peak, whereas costunolide (5) and 11,13-dihydrocostunolide (20) are detected as their Cope-rearrangement products dehydrosaussurrea lactone (19) and saussurea lactone (21), respectively. -
FIG. 12 . Demonstration of blue light reversible CO-inhibition of the costunolide synthase. Enzyme activity in the presence of 90% N2+10 O2 (N2) is set at 100% and this activity corresponds to a peak of dehydrosaussurea lactone (costunolide), saussurea lactone (dihydrocostunolide) and leucodin of respectively 0.58, 0.27, and 0.15× internal standard (1 μM). The inhibition in the presence of 90% CO+10% O2 was slightly reversed by irradiation with blue light (450 nm). All incubations were done in the absence of FAD and FMN. -
FIG. 13 . Mass spectra of dehydrosaussurea lactone (19) originating from (+)-costunolide (5) that has been produced from germacrene acid (4) under standard assay conditions (A), in the presence of 18O2 (B), or that originates from a standard of (+)-costunolide (C). -
FIG. 14 . Mass spectra of leucodin (22) produced from germacrene acid (4) in an enzyme assay under standard conditions (A) or in the presence of 18O2 (B). Panel C shows the mass spectrum of the leucodin standard (C). -
FIG. 15 . Mechanism for the enzyme catalysed formation of (+)-costunolide (5) from germacrene acid (4) that results in the incorporation of one atom of 18O. -
FIG. 16 . (+)-Costunolide (5) is in the presence of NADP and O further enzymatically converted into 11(S), 13-dihydrocostunolide (20) and leucodin (22). Incubation of germacrene acid in the presence of 18O2 gives incorporation at positions marked with an asterisk. It is unclear whether leucodin (22) is formed via 20. Both (+)-costunolide and 1 (S),13-dihydrocostunolide (20) are likely precursors of other sesquiterpene lactones present in chicory; whereas leucodin (22) is only one hydroxylation away from 11(S),13-dihydro-8-deoxylactucin, a minor sesquiterpene lactone of chicory. -
FIG. 17 . GC-MS analysis of the products formed by a microsomal preparation of chicory roots incubated with (+)-valencene (Val) in the presence (A) or absence (B) of NADPH. Incubation in the presence of NADPH yields nootkatone (Nkatone), β-nootkatol (Nkatol), and valencene-12-ol (ValOH). Peaks marked with A are GC-induced dehydration products of β-nootkatol ([M]+ 202). Peaks labelled with an asterisk are sesquiterpene alcohols that presumably origin from enzymatic conversion of sesquiterpene impurities (marked with in panel B) present in the commercial sample of (+)-valencene used as substrate. -
FIG. 18 . Conversion of (+)-valencene into nootkatone proceeds via β-nootkatol and not via α-nootkatol. -
FIG. 19 . Conversion of trans, trans-farnesol into farnesal and farnesoic acid by a 150,000 g supernatant of chicory roots in the presence of NADP+. -
FIG. 20 . Similarity between the formation of leucodin in chicory sesquiterpene lactone biosysthesis and the conversion of (+)-valencene to nootkatone by a chicory enzyme preparation. -
TABLE I Conversion of sesquiterpenes by a microsomal pellet of chicory in the presence of NADPH. Alcohols marked with an asterisk were identified using reference compounds. Substrate Product(s) Relative Structure KI Structure KI conversiona 1409 1688 1.5 ± 0.1 1482 1650 74.0 ± 2.8 1720 18.7 ± 1.2 1440 1720 13.5 ± 0.2 1397 1673 56.2 ± 2.6 1512b 1673- 1806b 110.0 ± 5.1c 1566b 1694dand 1700d 3.1 ± 0.1 8.6 ± 0.8 1479 1760 54.9 ± 1.5 1504 1787 7.2 ± 0.4 1631 1909 6.9 ± 2.4 1492 1778 100 ± 4.5
a100% conversion corresponds to the hydroxylation rate of β-selinene that yields a β-costol peak-size of 6.3 x the internal standard (2.5 nmol cis-nerolidol in each assay).
bThe Kovats' indices of these germacrene are determined at an injection port temperature of 150° C.; quantitative measurements are done on the basis of their Cope-rearrangements products measured at an injection port temperature of 250° C.
cThis conversion rate is a summation of the peaks of elematrien-12-ol, costol, elematrien-12-al, and elematrien-12-oic acid.
dKovats' indices were determined at an injection port temperature of 250° C. and probably belong to the Cope-rearrangement products.
→Hydroxylation probably occurs at one of these allylic positions.
-
TABLE II Effect of the addition of 50 μM (+)-germacrene A or 50 μM (+)-α-Cubebene upon hydroxylation. Inhibition (%) ± SD Substrate Producta Germacrene A α-Cubebene alloisolongifolene alloisolongifolene alcohol 100.0 100.0 amorpha-4,11-diene amorpha-4,11-diene-12-ol 84.9 ± 0.1 −9.2 ± 2.5 amorpha-4,11-diene alcohol (KI 1720) 84.9 ± 1.0 −2.3 ± 1.5 (−)-β-trans- (E)-trans-bergamota-2,12-dien-14-ol 89.2 ± 1.8 30.2 ± 4.5 bergamotene (−)-β-elemene (−)-elema-1,3,11(13)-trien-12-ol 90.4 ± 1.2 19.5 ± 1.8 germacrene B germacrene B alcohol (KI 1694) 100.0 32.6 ± 3.6 germacrene B alcohol (KI 1700) 100.0 27.3 ± 10 (+)-γ-gurjunene (+)-γ-gurjunene alcohol 88.0 ± 0.9 −5.6 ± 0.2 (+)-ledene ledene alcohol 100.0 35.5 ± 1.9 neointermedeol 4β-H-eudesm-11(13)-ene-4,12-diol 67.5 ± 1.9 3.4 ± 4.5 (+)-β-selinene (+)-β-costol 60.3 ± 3.4 0.4 ± 2.0
aThe amount of sesquiterpene alcohol produced in control incubations is set at 100% and is comparable with those of Table I.
-
TABLE III Effect of the used solvent for (+)-γ-gurjunene on enzyme activity Solvent Enzyme activitya ± SD hexane <0.1 pentane 0.47 ± 0.07 iso-propanol 1.76 ± 0.16 ethanol 1.87 ± 0.01 DMSO 1.80 ± 0.09
aPeak height of γ-gurjunene alcohol relative to the internal standard (5 nmol cis-nerolidol)
-
TABLE IV Requirements for (+)-costunolide synthase activity Addition Percentage Enzyme Activitya ± SD none 0 ± 0 1 mM NADPH 100 ± 8 1 mM NADH 7 ± 2 1 mM NADPH + 1 mM NADH 109 ± 23 1 mM NADP+ + NAD +1 ± 1 1 mM NADPH + argon atmosphere 0 ± 0
a100% enzyme activity corresponds to the summation of a dehydrosaussurea lactone, saussurea lactone, and leucodin peak size of respectively 0.35, 0.19, and 0.09 × internal standard (1 nmol cis-nerolidol in all assays).
-
TABLE V Pyridine nucleotide cofactors dependency of 11(S),13-dihydrocostunolide and leucodin biosynthesis. Percentage Enzyme Activity ± SD Dihydrocostunolide Leucodin Pyridine Nucleotide Cofactor (20) (22) 1 mM NADPH a100 ± 3 a100 ± 10 none 15 ± 1 0 ± 0 1 mM NADH 14 ± 2 0 ± 0 1 mM NADPH + 1 mM NADH 107 ± 4 65 ± 19 1 mM NADP+ + 1 mM NAD +18 ± 3 0 ± 0
a100% enzyme activity corresponds to an saussurea lactone and leucodin peak size of respectively 1.34 and 0.42 × internal standard (1 nmol cis-nerolidol in all assays).
-
TABLE VI Inhibition experiments concerning biosynthesis of 11,13-dihydrocostunolide and leucodin. Percentage Enzyme Activity ± SD Dihydrocostunolide Leucodin Assay Conditionsa (20) (22) Air (≈80% N2 + 20% O2) b100 ± 9 b100 ± 33 80% CO + 20 % O 2140 ± 4 8 ± 1 Argon 134 ± 6 0 ± 0 Standard c100 ± 3 c100 ± 10 Cytochrome C (100 μM) 105 ± 5 0 ± 0 DMSO (1%) d100 ± 5 d100 ± 10 Metyrapone (100 μM) 87 ± 11 70 ± 16 Clotrimazole (10 μM) 119 ± 9 0 ± 0 Miconazole (10 μM) 100 ± 5 0 ± 0 Aminobenzotriazole (10 μM) 75 ± 8 86 ± 33
aAll incubations were carried out in the presence of 1 mM NADPH-regenerating system and flavins.
b100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.63 and 0.34 × internal standard (1 nmol cis-nerolidol in all assays).
c100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.34 and 0.42 × internal standard (1 nmol cis-nerolidol in all assays).
d100% enzyme activity corresponds to a saussurea lactone and leucodin peak size of respectively 1.43 and 0.18 × internal standard (1 nmol cis-nerolidol).
-
TABLE VII Conversion of (+)-valencene by a microsomal pellet of chicory in the presence of NADPH. Substrate Product(s) Relative Structure KI Structure KI conversiona 1500 1777 2.6 ± 0.1 1820 24.4 ± 1.1
a100% conversion corresponds to the hydroxylation rate of β-selinene that yields a β-costol peak-size of 6.3 × the internal standard (2.5 nmol cis-nerolidol in each assay).
eThe mass spectrum of the detected compound was identical to the mass spectrum of valencene-12-ol provided by Firmenich SA (Switzerland).
- The ability of the germacrene A hydroxylase present in chicory roots to hydroxylate other substrates in addition to germacrene A was investigated. Fresh roots of cultivated chicory (Cichorium intybus L., cv Focus) harvested during late summer were obtained from a grower in Veenendaal, The Netherlands. The chicory roots were cut into small pieces, frozen in liquid nitrogen, and stored at −80° C.
- Materials and Methods
- (+)-Germacrene A was isolated from costus roots (De Kraker et al, 2001b). Alloisolongifolene, (−)-α-gurjunene, (+)-γ-gurjunene, and (+)-ledene were purchased from Fluka. ICN Biomedicals furnished (−)-α-cubebene. The compounds (−)-limonene and (+)-limonene were purchased from Merck and Janssen, respectively. Amorpha-4,11-diene was synthesised by Dr. B. J. M. Jansen (Bouwmeester et al., 1999a). Germacrone was isolated from the natural oil of Geranium macrorrhizum and germacrene B was synthesised by Dr. D. P. Piet (Piet et al., 1995). (−)-α-trans-Bergamotene and (−)-β-elemene were a gift from Pro£ W. A. König (Hamburg University). Neointermedeol was synthesised by Dr. R. P. W. Kesselmans (Kesselmans, 1992). (+)-β-Selinene was isolated from celery oil and was a gift from Dr. T. A. van Beek. Substrates were dissolved at 10 mM concentrations in ethanol.
- Alloisolongifolene alcohol was prepared from alloisolongifolene via its corresponding aldehyde by SeO2, according to the protocol of Umbreit and Sharpless (1977). To a solution of 77 mg SeO2 and 68 mg salicylic acid in 30 mL CH2Cl2, 100 mg alloisolongifolene was added. Stirring at room temperature turned the reaction mixture yellow and a red solid precipitated in the first few hours. The reaction was monitored by GC-MS along with TLC and was stopped by the addition of 60 mL demineralised water after 2.5 days. The reaction mixture was extracted with 45 mL ether, and the organic phase was subsequently washed with 30 mL brine. The red precipitate remained in the aqueous phase during extraction. After drying and evaporation, the organic phase yielded 214 mg of a crude solid that after flash chromatography on silica with pentane-CH2Cl2 (3:1) yielded 31 mg of alloisolongifolene aldehyde, a strong odorous compound (cedar-wood like). 1H NMR (200 MHz, C6D6) δ 0.71 (s, 3H, Me) δ 0.90 (s, 3H, Me), δ 0.93-2.04 (m, 13H), δ 5.42 (s, 1H, CH2═C), δ 5.73 (δ, 1H, CH2═C), δ 9.35 (s, 1H, CH═O). 13C NMR (50 MHz, C6D6) δ 15.0 (q), δ 19.6 (q), δ 20.5 (t), δ 22.2 (t), δ 32.3 (t), δ 36.3 (t), δ 38.7 (t), δ 45.1 (t), δ 46.1 (s), δ 47.1 (s), δ 47.7 (s), δ 50.8 (d), δ 133.5 (t), δ 157.0 (s), δ 193.9 (d). EIMS (70 eV) m/z: 218 [M]+ (41), 203 (48), 189 (32), 185 (30), 175 (42), 161 (68), 147 (53), 145 (37), 133 (35), 119 (46), 107 (42), 105 (80), 95 (33), 93 (46), 91 (100), 81 (37), 79 (65), 77 (64), 55 (43), 53 (34), 41 (74), 39 (45). Fifteen milligrams of the aldehyde was added to a solution of 1.8 mg LiAlH4 in 0.5 mL ether. The grey suspension was stirred for 17.5 hours at room temperature and for an additional half our after the careful addition of one spatula Na2SO4.10H2O. One and a half millilitre of demineralised water was added to the mixture that was subsequently 3 times extracted with 1 mL of ether. The ether was passed through glasswool-plugged Pasteur pipette filled with silica and a spatula tip of MgSO4. The solvent was evaporated yielding 17 mg of alloisolongifolene alcohol. 1H NMR (200 MHz, C6D6) δ 0.77 (s, 3H, Me), δ 0.91 (s, 3H, Me), 0.96-1.63 (m, 13H), δ 3.96 (m, 2H), δ 4.95 (d, 1H, J=1.3 Hz) δ 5.30 (dd, 1H, J=3.26 Hz, 1.55 Hz). 13C NMR (50 MHz, C6D6) δ 15.1 (q), δ 19.7 (q), δ 20.7 (t), δ 22.3 (t), δ 32.4 (t), 37.5 (t), 38.7 (t), 44.0 (t), δ 46.1 (s), δ 47.8 (s), δ 48.2 (s), δ 51.6 (d), δ 63.4 (t), δ 107.9 (t), δ 155.9 (s). EIMS (70 eV) m/z: 220 [M]+ (5), 189 (35), 187 (36), 163 (30), 161 (56), 160 (37), 159 (30), 147 (36), 145 (38), 133 (32), 131 (37), 119 (44), 107 (61), 105 (91), 95 (94), 93 (57), 91 (100), 81 (53), 79 (60), 77 (52), 67 (39), 55 (45), 41 (62).
- Amorpha-4,11-diene-12-ol was prepared from 100 mg artemisinic acid. The acid was dissolved in 6 mL of dry ether and esterified by adding diazomethane and mixing for 1 hour. GC-MS analyses of the reaction mixture showed the methyl ester and another compound (3:1), probably the methyl ester that was not connected to a cyclopropyl group. After removal of ether, 8.6 mg of the mixture was dissolved in 20 mL of ether-THF (1:1) and cooled at −60° C. under a flow of dry nitrogen for 2 hours. The mixture was subsequently stirred for 1 hour at −30° C. with an excess of LiAlH4, after which the reaction was stopped by the addition of Na2SO4.10H2O. The temperature was raised to room temperature, and the reaction mixture was stirred an additional half hour. After drying with MgSO4 overnight, the mixture was filtered through a Buchner funnel and the solvent removed. The desired alcohol was isolated and purified by preparative thin layer chromatography performed on silica gel plates, using a mixture of petroleum ether-ethyl acetate (3:1) as an eluent (Rf 0.7). Amorpha-4,11-diene-12-ol was obtained in an overall yield of 14% as a mixture with 4-amorphene-12-ol (9:1). 1H NMR (400 MHz, CDCl3): δ 0.87 (d, 3H, Me15, J=6.0 Hz), δ1.50 (br s, 3H, Me14), δ1.0-2.2 (m, 11H), δ2.47 (m, 1H, H6), δ 4.10 (s, 2H, H12), δ 4.83 (br s, 1H, H13), δ 5.04 (br s, 1H, H13), δ 5.18 (br s, 1H, H4). EIMS (70 eV) m/z: 220 [M]+ (6), 202 (35), 189 (66), 187 (34), 145 (40), 132 (52), 131 (36), 121 (100), 119 (81), 105 (51), 93 (74), 91 (70), 81 (47), 79 (77), 77 (50), 55 (41), 41 (47).
- Extraction of the (+)-Germacrene A Hydroxylase from Chicory Roots.
- To prepare a crude enzyme extract that contains the cytochrome P450 enzymes including the (+)-germacrene A hydroxylase (de Kraker et al., 2001a), 25 grams of deep frozen (−80° C.) cubes of chicory roots were mixed by means of a Sorvall mixer together with 2.5 grams PVPP and 40 ml extraction buffer. During the whole procedure the plant material was kept on ice as much as possible. After 5 times several seconds of mixing, the slurry was transferred to the cheesecloth with an additional 10 ml of extraction buffer. The cheesecloth was squeezed out and the filtrate was centrifuged (Sigma 2K15) for 20 minutes at 20,000 g and 4° C. The supernatant was poured over a funnel filled with glass wool. The filtrate was divided over 8 ml centrifuge tubes and subsequently centrifuged (Centrikon T-2070, Kontron Instruments) for 90 minutes at 150,000 g and 4° C. The resulting microsomal pellets (about 6) were stored under argon at −80° C.
- Before incubation, 10 pellets were pottered in 30 mL of assay buffer consisting of 25 mM Tris (pH 7.5), 2 mM DTT, 1 mM ascorbic acid, 5 μM FAD, 5 μM FMN and 10% (v/v) glycerol. The enzyme suspension was divided in 1 mL aliquots and incubated with 5 μL substrate solution in the presence of a 1 mM NADPH-regenerating system that consisted of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase (all from Sigma). The initial concentration of substrate in each assay was 45 μM and all were done in duplicate. To the blank assays no NADPH regenerating system was added, so that cytochrome P450 enzymes (including the (+)-germacrene A hydroxylase) were not active. After 60 minutes the incubations were stopped by storing them at −20° C. in a freezer.
- The enzyme assays were extracted 2 times with 1
mL 20% (v/v) ether in pentane, after the addition of 5 μM cis-nerolidol (Fluka). The organic phase was filtered through a glasswool-plugged (dimethyl chlorosilane-treated, Chrompack) Pasteur pipette that contained 0.4 gram of silica and a little anhydrous MgSO4. The pipette was rinsed with 1.5 mL ether and the extract was concentrated to approximately 50 μL under a stream of nitrogen. The concentrated extracts were analysed by GC-MS as described by De Kraker et al. (2001a). - To investigate whether enzymatic hydroxylations of the substrates were catalysed by the (+)-germacrene A hydroxylase, standard incubations of the various substrates (50 μM) were carried out in the presence of 50 FM (+)-germacrene A, or 50 μM (−)-(α)-cubebene to exclude any possible general negative effect of sesquiterpene olefins on enzyme activity. To the
control incubations 5 μL of ethanol was added, instead of the ethanol solution of either (+)-germacrene A or (−)-(α)-cubebene. - Results (Conversion of Tested Substrates)
- Most of the tested substrates were hydroxylated (see Table 1) and their molecular mass was correspondingly raised with 16 amu. (−)-(α)-Cubebene and (−)-(α)-gurjunene which do not contain an isopropenyl or isopropylidene side chain were not converted (
FIG. 6 ). Also germacrone was not accepted as a substrate. Some conversion of (+)-limonene and (−)-limonene occurred, but in such small amounts that it was not further investigated. - In Table I the sesquiterpenes are depicted that were converted into sesquiterpene alcohols in the presence of NADPH and the microsomal pellet that contains the (+)-germacrene A hydroxylase. The conversion rates of the various reactions are expressed relatively to the hydroxylation of β-selinene that is set at 100% and corresponds to a β-costol peak-size of 6.3× the internal standard (2.5 nmol cis-nerolidol in each assay). Approximately 30% of the added 50 nmol β-selinene was hydroxylated. Not all formed hydroxylation products could be identified, since reference samples or mass spectra of the expected sesquiterpene alcohols were not available.
- Amorpha-4,11-diene
- Incubation of amorpha-4,11-diene yielded two alcohols. The major product was identified as amorpha-4,11-diene-12-ol that results from hydroxylation of the isopropenyl side chain. The structure of the earlier eluting alcohol is unknown; though assuming an allylic hydroxylation that does not take place at a bridgehead atom, it is either amorpha-4,11-diene-2-ol or amorpha-4,11-diene-14-ol. EIMS (70 eV) m/z: 220 [M]+ (12), 189 (77), 162 (46), 147 (38), 121 (45), 119 (60), 107 (58), 105 (68), 95 (41) 93 (75), 91 (72), 81 (100), 79 (70), 77 (48), 55 (52), 43 (49), 41 (52).
- (−)-α-trans-Bergarnotene
- Incubation of (−)-α-trans-bergamotene yielded (E)-trans-bergamota-2,12-dien-14-ol, EIMS (70 eV) m/z: 220 [M]+ (<1), 145 (10), 132 (28), 131 (10), 121 (11), 120 (14), 119 (75), 107 (29), 105 (22), 95 (10), 94 (15), 93 (100), 81 (14), 79 (33), 77 (31), 68 (17), 67 (11), 55 (29), 53 (11), 43 (36), 41 (28), 39 (14). Shaking the pentane-ether extract of the incubation with MnO2 overnight yielded a compound that has the same retention time and mass spectrum as (E)-trans-bergamota-2,12-dien-14-al, present in costus root oil (Maurer and Grieder 1977).
- (+)-γ-Gurjunene
- Incubation of (+)-γ-gurjunene yielded an unknown sesquiterpene alcohol. EIMS (70 eV) m/z: 220 [M]+ (35), 189 (36), 187 (37), 161 (39), 147 (31), 146 (35), 145 (55), 133 (33), 131 (64), 121 (41), 119 (54), 117 (31), 105 (81), 95 (41), 93 (58), 91 (100), 81 (92), 79 (71), 77 (54), 67 (38), 55 (49), 41 (59). Stirring the pentane-ether extract of the enzyme assay overnight with a spatula of MnO2 gave complete conversion into an aldehyde or ketone ([M+] 218). Because this reagent is specific for α, β-unsaturated alcohols (March, 1992) and the only other available allylic position are at a tertiary carbon-atom, the biochemical hydroxylation must have occurred in the isopropenyl side chain of (+)-γ-gurjunene yielding IS,4S,7R,10R-5,11(13)-guaiadiene-12-ol.
- (+)-Germacrene A
- (+)-Germacrene A was, according to previous results, converted into germacra-1(10), 4,11-trien-12-ol, but somewhat unexpected the subsequent oxidations (approx. 15% of the produced germacrene alcohol) into germacra-1(10),4,11-trien-12-al and germacra-1(10),4,1-trien-12-oic were also clearly detected. This indicated that the microsomal pellet is not completely free of active dehydrogenases. Apparently the amount of produced germacrene alcohol is sufficient to enable these subsequent reactions. Moreover the dehydrogenases are active despite the used pH of 7.5 and the presence of the NADPH-regenerating system that reduces any NADP+ present. In the incubations with β-selinene and β-elemene only minute quantities of aldehyde and/or acid were measured. For this reason the conversion of β-selinene was set at 100% and not that of (+)-germacrene A.
- Germacrene B
- GC-MS analyses of the incubation of germacrene B yielded two products with an almost identical mass spectrum and retention time. Kovats' index 1694, EIMS (70 eV) m/z: 220 [M]+ (<1), 202 (15), 187 (24), 159 (20), 147 (20), 145 (24), 134 (22), 133 (26), 131 (22), 123 (19), 121 (75), 120 (27), 119 (100), 109 (34), 108 (15), 107 (48), 106 (22), 105 (66), 95 (38), 94 (20), 93 (65), 92 (17), 91 (73), 81 (50), 79 (52), 77 (44), 71 (17), 69 (28), 68 (15), 67 (48), 65 (17), 57 (19), 55 (94), 53 (34), 43 (46), 41 (73), 39 (32). Kovats' index 1700, EIMS (70 eV) m/z: 220 [M]+ (<1), 202 (15), 189 (15), 187 (21), 159 (20), 147 (22), 145 (23), 137 (17), 134 (21), 133 (28), 131 (26), 123 (22), 122 (15), 121 (100), 120 (28), 119 (91), 117 (15), 109 (36), 108 (18), 107 (52), 106 (23), 105 (77), 95 (45), 94 (24), 93 (86), 92 (21), 91 (80), 81 (61), 79 (66), 77 (53), 71 (21), 69 (32), 68 (18), 67 (55), 65 (21), 57 (32), 55 (69), 53 (43), 43 (62), 41 (91), 39 (42). Presumably both methyl groups in the isopropenyl side chain of germacrene B are hydroxylated yielding almost identical products. Hydroxylation at any other position is unlikely, because they would probably also have been observed for (+)-germacrene A. The products are measured as their Cope-rearrangement products and lowering the injection port temperature from 250° C. to 150° C. yielded faint broadened peaks due to on-column Cope-rearrangement.
- (+)-Ledene
- Incubation of (+)-ledene yielded an unknown sesquiterpene alcohol. EIMS (70 eV) m/z: 220 [M]+ (12), 187 (25), 159 (42), 151 (29), 147 (32), 145 (32), 133 (26), 131 (25), 121 (31), 119 (62), 107 (86), 105 (100), 95 (40), 93 (74), 91 (82), 81 (53), 79 (54), 77 (39), 55 (38), 43 (33), 41 (47).
- Neointermedeol
- Neointermedeol is presumably hydroxylated in the isopropenyl side chain like β-selinene, yielding 4β-H-eudesm-11(13)-ene, 4,12-diol. EIMS (70 eV) m/z: 238 [M]+ (<1), 223 (46), 135 (76), 93 (47), 81 (39), 79 (47), 71 (47), 55 (39), 43 (100), 41 (40).
- Competitive Inhibition Experiments
- The microsomal pellets that were used in the experiments do not exclusively contain the (+)-germacrene A hydroxylase, but also other membrane bound enzymes that are present in chicory roots. Hence, some of the conversion described in Table I might as well be catalysed by other oxidising enzymes than the (+)-germacrene A hydroxylase. To investigate this, incubations of the different substrates were done in the presence of 50, μM (+)-germacrene A. Incubations were also carried out with 50 μM (−)-α-cubebene instead, a sesquiterpene that is not hydroxylated (
FIG. 6 ), to test the effect of the addition of any arbitrary sesquiterpene olefin on enzyme activity (see Table II). - The results presented in Table II show that all enzymatic hydroxylations were inhibited to 90% by the addition of (+)-germacrene A, except for β-selinene and neointermedeol whose hydroxylation was inhibited by 60 and 68%, respectively. The relatively small inhibition of β-costol formation agrees with the observation that it is nearly as well hydroxylated as (+)-germacrene A (Table I); the structural correlation between β-selinene and neointermedeol possibly also explains the small effect of (+)-germacrene A upon the formation of 4β-H-eudesm-11(13)-ene-4,12-diol. More surprisingly is that (+)-germacrene A also inhibits the formation of sesquiterpene alcohols in which no isopropenyl or isopropylidene side chain is involved, like ledene alcohol.
- Hydroxylation of the sesquiterpenes is not dramatically influenced by the addition of (−)-α-cubebene, except for the formation of alloisolongifolene alcohol, a product that already under normal assay conditions is only formed in small quantities.
- Effect on Enzyme Activity of Organic Solvents
- Before experiments as described in this example were started, it was tested which organic solvent could be best used to dissolve the substrate. Stock solutions of 10 mM γ-gurjunene were prepared in hexane, pentane, iso-propanol, ethanol, and DMSO, and 5 μL of these solutions was added to the incubation-mixture. On the basis of the results of Table III ethanol was chosen as solvent for the substrates in all experiments, instead of the commonly used pentane (e.g. Karp et al., 1990).
- Conclusions
- A microsomal enzyme preparation from chicory roots can hydroxylate sesquiterpene olefins that are not present in chicory in the presence of NADPH (Table I). Most of these hydroxylations occur at the isopropenyl or isopropylidene side chain, yielding in some cases sesquiterpene alcohols that have not previously been described, e.g. amorpha-4,11-dien-12-ol and alloisolongifolene alcohol. The novelty of the formed sesquiterpene alcohols in some cases hampered their identification, and the structure assignment of the hydroxylation products of germacrene B, (+)-γ-gurjunene and neointermedeol is tentative or, like for (+)-ledene, not possible at all. Unfortunately, these compounds were not yet produced in sufficient amount to isolate them for structure elucidation by 1H NMR. The substrates for hydroxylation preferably do not contain any polar group, according the observation that neointermedeol is 15-fold less efficiently hydroxylated than β-selinene and the observation that germacrone is not hydroxylated whereas germacrene B is. The size of the substrate is also of importance as hydroxylation of limonene, a smaller monoterpene, did hardly occur. In the case of amorpha-4,11-diene two distinct sesquiterpene alcohol products were formed.
- Hydroxylations occurring at isopropenyl side chains and—less efficiently—at isopropylidene side chains are catalysed by the (+)-germacrene A hydroxylase that is present in the microsomal pellet of chicory roots. Accordingly, these hydroxylations could be competitively inhibited by (+)-germacrene A (Table II). Hydroxylations of various non-natural substrates by a cytochrome P450 enzyme of plant secondary metabolism contradicts the common belief that enzymes of plant secondary metabolism have a narrow substrate specificity. (Donaldson and Luster, 1991; Halkier, 1996; Schuler, 1996; Mihaliak et al., 1993; Karp et al., 1990).
- Formation of the unknown ledene alcohol and the unknown amorpha-4,11-diene alcohol (KI 1720) cannot have occurred in an isopropenyl/isopropylidene side chain, nevertheless these reactions are also inhibited by (+)-germacrene A. Although hard to understand, it suggests the involvement of the (+)-germacrene A hydroxylase in these reaction as well. Notably, the rate of competitive inhibition by (+)-germacrene A of the formation of amorpha-4,11-diene-12-ol and the unknown amorpha-4,11-diene alcohol is the same.
- The hydroxylation of amorphadiene-4,11-diene in the isopropenyl side chain is interesting as well. It was hypothesised to be an important step in the formation of the anti-malarial drug artemisinin in Artemisia annua but has not yet been reported for this plant (Bouwmeester et al., 1999a).
- Generally, the production of new materials for the flavor and fragrance industry has been a powerful driving force in the research on the hydroxylation of terpenes by micro-organisms. Although in some cases successful, these microbiological conversions often yield a broad spectrum of products, including epoxides and diols (Lamare and Furstoss, 1990; Drauz and Waldmann, 1995; Faber, 2000) and the oxidations often occur at double bonds. In contrast, the hydroxylations catalysed by the microsomal pellet of chicory yield one, sometimes two products, and occur more regiospecifically. Illustrative is the case of (+)-γ-gurjunene: incubation with the plant pathogenic fungus Glomerella cingulata yields (1S,4S,7R, 10R)-5-guaien-11,13-diol and (1S,4S,7R, 10S)-5-guaien-10,11,13-triol (Miyazawa et al., 1998), whereas incubation with the microsomal pellet of chicory yielded (1S,4S,7R,10R)-5,11(13)-guaiadien-12-ol (
FIG. 7 ). - (+)-Costunolide is the most rudimentary structure of a germacranolide and considered to be the parent-compound of all germacrene-derived sesquiterpene lactones, among them the guaianolides, eudesmanolides and germacranolides of chicory. It is very likely that this compound is formed from FPP through (+)-germacrene A, germacra-1(10),4,11(13)-trien-12-ol, and germacra-1(10),4,11(13)-trien-12-oic acid (4) (
FIG. 2 ) (De Kraker et al., 1998, 2001 a). Thisgermacrane acid 4 is thought to be hydroxylated at the C6-position by a cytochrome P450 enzyme after which lactonisation yields (+)-costunolide (5) (FIG. 8 ) Germacrene acid was isolated from fresh costus roots (De Kraker et al., 2001b), which makes it possible to investigate this last step in formation of the lactone ring of sesquiterpene lactones (Geissman, 1973; Fischer et al., 1979; Fischer, 1990). - (+)-Costunolide is considered to be a branching point in the biosynthesis of sesquiterpene lactones from where pathways for the formation of guaianolides, eudesmanolides and germacranohdes divide. It has been postulated by various authors that cyclisation of (+)-costunolide to either guaianolides or eudesmanolides is mediated by respectively C4-C5 epoxidation or C1-C10 epoxidation, respectively (Brown et al., 1975; Fischer 1990; Teisseire, 1994; Piet et al., 1995). Alternatively, the necessity of a C3-hydroxylation of the germacrenolide for formation of a guaianolide has been proposed (Piet et al., 1996).
- Materials and Methods
- Fresh roots of cultivated chicory (Cichorittm intybus L., cv Focus) were harvested during late summer and obtained from a grower (J. de Mik) in Veenendaal, the Netherlands. The chicory roots were cut into small pieces, frozen in liquid nitrogen and stored at −80° C. Germacra-1(10), 4,11(13)-trien-12-oic acid (4), (+)-costunolide (5), and dehydrocostus lactone (
FIGS. 9, 18 ) were isolated from costus roots (De Kraker et al., 2001b). Synthesis of a mixture of α- and γ-costic acid is described by De Kraker et al. (2001b), whereas the synthesis of elema-1,3,11(13)-trien-12-oic acid (9) is described in (de Kraker et al., 2001a). A sample of leucodin (22) was kindly provided both by Prof. M. Ando (Niigata University, Japan; Ando et al., 1994) and Dr. Shi Yong Ryu (Korea Research Institute of Chemical Technology, Yusung, Taejon, Korea), who also provided its C11-epimer achillin (Ho et al., 1998). 11,13-Dihydro-dehydrocostus lactone (mokko lactone) was a gift of Prof. Y. Asakawa (Tokushima Bunri University, Japan). Parthenolide (17) was purchased from Sigma, cis-nerolidol from Fluka. Ether (diethyl ether) and pentane were redistilled before use. - A GC-standard of 11(S),13-dihydro-costunolide (20) was prepared from 2 mg of (+)-costunolide (5) that was dissolved in 1.5 mL ethyl acetate and stirred with 1.5 mg of NaBH4 at 0° C., a procedure described for the reduction of the C11-C13 exocyclic double bond of various sesquiterpene lactones (Asakawa et al., 1980; Asakawa, 1982; Seto et al., 1988). After 45 minutes the reaction was stopped by the addition of 1% HAc and 2 ml extra ethyl acetate. The organic phase was filtered through a glass-wool plugged Pasteur pipette that contained 0.45 g of silica and a little anhydrous MgSO4. GC-MS analysis of the filtrate showed that half of the (+)-costunolide was converted into 11(S),13-dihydro-costunolide, whereas no trace of its C11-epimer was detected.
- Enzyme Isolation and Assay for (+)-Costunolide Synthase Activity
- A cell free extract of chicory roots was prepared from the frozen material in the same way as described for isolation of the germacrene A hydroxylase (Example 1), but MgCl2 was not added to the extraction buffer since the accompanying (+)-germacrene A synthase activity was not essential for the detection of (+)-costunolide synthase activity. The prepared 20,000 g supernatant was desalted with an Econo-
Pac 10 DG column (Biorad) to an assay buffer consisting of 25 mM Tris (pH 7.5), 1 mM ascorbic acid, 5 μM FAD, 5 μM FMN and 10% (v/v) glycerol. DTT was omitted from the assay buffer, because SH-groups present in DTT might undergo an “Michael-type addition” to the C11-C13 exocyclic double bond of (+)-costunolide (Kupchan et al., 1970). A 1-ml aliquot of the desalted supernatant was incubated with 3 μL of a 15 mM solution of germacrene acid (4) in tert-butylmethylether and a 1 mM NADPH-regenerating system, which consists of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase (all from Sigma). Incubations were also done with boiled desalted supernatant and in the absence of NADPH. The experiments were repeated with elema-1,3,11(13)-trien-12-oic acid (FIGS. 2, 9 ) and a mixture of α- and γ-costic acid (14) that might serve as substrate analogues for the germacrene acid (4). After 1 h of incubation at 30° C., the reactions were stored in the freezer. - The incubations were extracted three times with 1 mL of 20% (v/v) ether in pentane, after the addition of a 0.2 mM cis-nerolidol solution in ethanol that serves as internal standard. The organic phase was filtered through a glass-wool plugged (dimethyl chlorosilane-treated glasswool; Chrompack) Pasteur pipette that contained 0.45 g of silica and a little anhydrous MgSO4. The column was washed with 1.5 ml of ether and the extract was carefully concentrated to approximately 50 μL under a stream of nitrogen. Samples of 2 μL were analysed by GC-MS using an injection port temperature of 320° C. to provoke Cope rearrangement of (+)-costunolide (5). Mass spectra were recorded at 70 eV scanning from 35 to 300 atomic mass units; the GC oven temperature was programmed as described before (de Kraker et al., 1998).
- Characterisation of (+)-Costunolide Synthase Activity
- To determine whether the formation of (+)-costunolide (5) from germacrene acid (4) was catalysed by a cytochrome P450-enzyme, the effect of various established cytochrome P450-inhibitors (cytochrome C, metyrapone, clotrimazole, micozanole, and amino-benzotriazole) on this reaction were tested, as well as the effect of CO or an argon atmosphere. The cofactor dependence was also investigated, i.e. NAD(P)+ or NADH was added instead of NADPH. Experiments were carried out in a similar manner as described for the germacrene A hydroxylase in Example 1 using a 20,000 g supernatant and 5 μL of 0.2 mM cis-nerolidol as internal standard. Blue-light reversal of CO-inhibition was investigated with gas-mixtures of 10% O2 plus 90% N2 (blank) and 10% O2 plus 90% CO.
- Incorporation of oxygen was investigated with 18O2 (99% pure; Icon Services, Mt. Marlon, N.Y., USA). One ml of incubation mixture, placed in a (vented) septum-capped 4,5-mL vial, was first bubbled with nitrogen to remove air and next with oxygen-18. The mass spectra of the formed compounds were compared with those formed in the standard enzyme assays with air.
- Investigation of Subsequent Conversions of (+)-Costunolide
- Incubations as described for the germacrene acid were also done with (+)-costunolide (30 μM) to test whether any further enzymatic conversion of this compound would occur during the incubation of germacrene acid. Parthenolide (20 mM) (
FIGS. 9, 17 ) was incubated as well since it might be an intermediate in the formation of guaianolides. Dehydrocostus lactone (20 ∥M)(18) was incubated as a model compound for reductions that occurred at the C11-C13 exocyclic double bond of (+)-costunolide. The effect of established cytochrome P450 inhibitors and CO on the conversion of (+) costunolide was studied, just as the effect of various pyridine nucleotide cofactors and an argon atmosphere. - Conversion of Germacrene Acid into Sesquiterpene Lactones
- GC-MS analyses of the pentane-ether extract from the incubation of a 20,000 g chicory root supernatant with germacra-1(10),4,11(13)-trien-12-oic acid (4) in the presence of an NADPH-regenerating system showed three products that were not detected in incubations without NADPH or in incubations with boiled supernatant (
FIG. 10 A+B). The major peak co-eluted with a standard of (+)-costunolide (5) that at an injection-port temperature of 320° C. is detected as its Cope-rearrangement product dehydrosaussurea lactone (10) (FIG. 3C ). The substrate germacrene acid was also measured as it Cope-rearrangement product(s), i.e. elemene acid (9) and diastereomeric elemene acid (de Kraker et al., 2001b). - The two other products were identified as 11(S), 13-dihydrocostunolide (20) that is Cope-rearranged into saussurea lactone (21), and leucodin (22) (
FIG. 11 ). Both 11(S),13-dihydrocostunolide and leucodin are enzymatically formed from (+)-costunolide and accordingly they also appeared in incubations of (+)-costunolide with the 20,000 g supernatant and NADPH. It cannot be excluded that even more products are formed during the incubation of germacrene acid, because higher oxygenated sesquiterpene lactones are likely not volatile enough for detection by gas chromatography. Furthermore, the presence of fatty acids in chicory extracts (Sannai et al., 1982) complicates the GC-analysis, because they yield big peaks () under which smaller product peaks might “disappear”. - There was no detectable conversion of the substrate analogues α- and γ-costic acid (14) and elema-1,3,11(13)-trien-12-oic acid (9).
- Characterisation of the (+)-Costunolide Synthase
- For characterisation of the (+)-costunolide synthase the response of the GC-MS to different concentrations of (+)-costunolide should preferably be linear. Yet, at the used injection port temperature of 320° C., the GC-trace of costunolide (
FIG. 10C ) does not show a sharp peak of dehydrosaussurea lactone (19)—but a tailing peak that contains minor peaks of costunolide-related products like α- and β-cyclocostunolide. Apparently (+)-costunolide is more resistant to Cope-rearrangement than for instance germacrene acid (4). In literature it has also been noticed that a lactone ring has a strong influence on the thermal stability of germacrenes, and that Cope-rearrangement of (+)-costunolide is reversible (Jain et al., 1970; Minnaard, 1997). Therefore, on a GC-column dehydrosaussurea lactone (19) might even undergo to some extent the reverse reaction towards (+)-costunolide (Grieco and Nishazwa, 1977). Avoiding Cope-rearrangement in the injection port by lowering the injection port temperature would nevertheless result in Cope-rearrangement of (+)-costunolide during its migration through the column and yielded a broad hump (similar to the one shown for germacrene aldehyde in Example 1) instead of a clear (+)-costunolide peak. Despite the poor quality of the dehydrosaussurea lactone GC-peak, it is linear with injected (+)-costunolide concentrations in the range of 5 μM to 50 μM. The response factor relative to cis-nerolidol is 0.15, and concentrations below 5 μM are not measurable which means that (+)-costunolide concentrations below 0.25 μM in the incubation mixture, i.e. 0.25 nmol, are not detected. - More of a problem for characterisation of the (+)-costunolide synthase is that almost certainly not all subsequent conversion products of costunolide are detected. Hence, the given enzyme activities are a summation of the peaks of dehydrosaussurea lactone (19), saussurea lactone (21) and leucodin (22) and are consequently more an indication than an absolute value of costunolide synthase activity. Quantitative measurement of the elemene acid peak (substrate peak) was not an option, because it is not linear with concentration and, more generally, acid peaks on GC are of poor quality.
- Table IV shows that the costunolide synthase is dependent on oxygen and NADPH, whereas NADH was much less effective as a reductant. This suggests the involvement of a cytochrome P450 enzyme, which was confirmed by the effect of various established cytochrome P450 inhibitors (West, 1980; Mihaliak et al., 1993). In the presence of cytochrome C (100 μM), no enzymatic products of germacrene acid (4) were measured; miconazole (100 μM) reduced the amount of measurable products with 71%, aminobenzotriazole (100 μM) with 44%, metyrapone (1 mM) with 78%, and clotrimazole (100, μM) with 97%.
- The strongest proof for the involvement of a cytochrome P450 enzyme is blue-light reversible inhibition of enzyme activity by CO (West 1980; Mihaliak et al., 1993). The results depicted in
FIG. 12 show an inhibitory effect of CO on the produced sum of (+)-costunolide, 11 (S),13-dihydrocostunolide and leucodin that could be reversed by blue light, to some extent. - Characterisation of the Subsequent Conversions of (+)-Costunolide
- Incubation of (+)-costunolide with a 20,000 g supernatant chicory root supernatant in the presence of NADPH yielded 11(S),13-dihydrocostunolide (20) and leucodin (22). No other products were detected upon GC-MS analyses of the incubation, but comparison of the decrease in peak height of dehydrosaussurea lactone with the intensity of the products peaks products strongly suggested the formation of other products that are not detected on GC. The enzyme activity that catalyses the reduction of the 11 (S), 13-exocyclic double bond of costunolide was not capable of doing the same with dehydrocostus lactone (18). Incubation of parthenolide (17) did not give leucodin (22), but conversion of parthenolide into other not-measurable sesquiterpene lactones cannot be excluded. Parthenolide itself disintegrates upon GC-analyses in a number of peaks and hence no quantitative determination was done on the amount of parthenolide present in after incubation.
- To test which type(s) of enzymes might catalyse the formation of 11(S),13-dihydrocostunolide (20) and leucodin (22) the pyridine nucleotide cofactors were varied (Table V). Formation of both compounds is dependent upon NADPH, but a part of the (+)-costunolide reductase activity is retained in the absence of any cofactor.
- Table VI shows that formation of leucodin from (+)-costunolide is dependent upon oxygen, whereas the formation of 11,13-dihydrocostunolide is not. Formation of leucodin is strongly inhibited by CO which suggests the involvement of a cytochrome P450 enzyme. Accordingly it is also inhibited by all of the tested cytochrome P450 inhibitors except amino-benzotriazole.
- Incorporation of Oxygen-18
- Incubation of germacrene acid (4) in the presence oxygen-18 gave the incorporation of one atom of 18O into (+)-costunolide (5). The molecular ion peak in the mass spectrum of dehydrosaussurea lactone (19) was raised from 232 to 234 amu (
FIG. 13 ). Similar changes were observed in the mass spectrum of saussurea lactone (21), the Cope rearrangement product of 11(S),13-dihydrocostunolide (20). Its ion peak was shifted from 234 to 236 amu whereas the [M-Me]+ peak was shifted from 219 to 222 amu. Bubbling of the enzyme assay with oxygen-18 (99%) had not any measurable negative effect on enzyme activity. - The mass spectra of leucodin showed the incorporation of two atoms of 18O and the mass of the ion peak was clearly raised with 4 units from 246 to 250 amu (
FIG. 14 ). Unfortunately, in the enzyme assay the GC-peak of leucodin is superpositioned on the tailing peak of linoleic acid (FIG. 10A ) which contaminates the mass spectrum of leucodin particular in the lower mass range. - Conclusions
- The present results show that chicory contains an enzyme that converts germacra-1(10), 4,11(13)-trien-12-oic acid (4) into (+)-costunolide (5), yielding the lactone ring present in sesquiterpene lactones. This step is the final proof for the postulated pathway from FPP through (+)-germacrene A, germacra-1(10),4,11(13)-trien-12-ol, and germacra-1(10),4,11(13)-trien-12-oic acid (4) to the germacrene-derived sesquiterpene lactones (Geissman, 1973; Fischer et al., 1979; Fischer, 1990).
- The (+)-costunolide synthase is a cytochrome P450 enzyme that is dependent upon NADPH and O2 and is accordingly inhibited by various established cytochrome P450 inhibitors (West, 1980; Mihaliak et al., 1993). Blue light reversible CO-inhibition of enzyme activity could be demonstrated as well, although the results were somewhat disturbed by subsequent enzymatic conversions of (+)-costunolide. Incubation in the presence of oxygen-18 showed the incorporation of one atom of 18O into (+)-costunolide, another typical feature of cytochrome P-450 enzymes (West, 1980; Mihaliak et al., 1993). It also confirms the mechanism in which germacrene acid is first hydroxylated at the C6-position (Fischer et al., 1979) after which this hydroxyl group attacks, presumably enzyme-mediated, the carboxyl group at C12. During the resulting lactonisation it so happens that the oxygen isotope is incorporated in the lactone ring (
FIG. 15 ). - The (+)-costunolide synthase is not capable of converting the substrate analogues α-costic acid (
FIGS. 2, 14 ), or elema-1,3,11(13)-trien-12-oic acid (9) which is not unexpected, because the C6-position is not allylic. However, γ-costic acid (13), in which the C6-position is allylic, was not converted either, so apparently the geometry of the cyclodecadiene ring system is necessary for reaction. - (+)-Costunolide (5) is in incubations with NADPH and the 20,000 g supernatant of chicory roots subsequently converted into 11(S),13-dihydrocostunolide (20) and leucodin (22) (
FIG. 16 ). Formation of 11(S),13-dihydrocostunolide is not dependent upon oxygen, but is strongly enhanced in the presence of NADPH whereas a small enzyme activity of 15% is retained in its absence. The reduction of the C11-C13 exocyclic double bond is similar to the type of reactions catalysed by enoate reductases, a group of iron-sulphur flavoproteins that has been isolated from Clostridium and catalyses the reduction of the olefinic bond of α, β-unsaturated carboxylic acids under anaerobic conditions in the presence of reducing agents (Holland, 1992). The reduction of the C11-C13 exocyclic double bond in costunolide occurs stereoselectively and yields only the 11(8),13-stereoisomer is formed. The stereochemistry at C11 is identical to that of the 11(S),13-dihydro sesquiterpene lactones present in chicory (Seto et al., 1988; van Beek et al., 1990). In contrast to chicory, some other plant species contain C11-epimers like achillin which is the 11(R)-epimer of leucodin (Martinez et al., 1988; Ho et al., 1998), indicating that an enantioselective enzyme that synthesises these C11-epimers should exist in these other species. The enzyme exhibits at least some substrate specificity because the C11-C13 exocyclic double bond of dehydrocostuslacton (18) was not reduced. - The formation of leucodin (22) proves that guaianolides originate from (+)-costunolide. Their formation likely involves more than one enzyme. It was not investigated whether leucodin originates from 11(S),13-dihydrocostunolide (20). Parthenolide (17) is not involved in leucodin biosynthesis, but it cannot be excluded that 11(S), 13-dihydroparthenohde is. Various authors have suggested that either 4,5-epoxide or C3-hydroxylation is necessary to direct cyclisation of (+)-costunolide towards a guaiane framework (Brown et al., 1975; Fischer 1990; Teisseire, 1994; Piet et al., 1995, Piet et al., 1996).
- Formation of leucodin from (+)-costunolide could be inhibited by the addition of established cytochrome P450 inhibitors or CO, whereas formation of 11(S), 13-dihydrocostunolide (20) could not. Furthermore experiments with oxygen-18 demonstrated that the oxygen atom of the keto group also originates from molecular oxygen, which at least suggest the involvement of a cytochrome P450-enzyme in leucodin biosynthesis (West, 1980; Mihaliak et al., 1993).
- Leucodin can be regarded as a precursor of 11(S),13-dihydro-8-deoxylactucin, a minor sesquiterpene lactone of chicory (van Beek et al, 1990). Possibly this sesquiterpene lactone is also formed during the executed incubations, but it is not detected in GC-MS measurement due to its polarity/lesser volatility. (+)-Costunolide and possibly 11 (S),13-dihydrocostunolide (20) are likely to be involved in the biosynthesis of the other bitter tasting sesquiterpene lactones of chicory. To detect and analyse these compounds in enzymatic reaction mixtures will involve derivatisation and/or the use of other chromatographic techniques like HPLC.
- Because of the presence of a cytochrome P450 hydroxylating a sesquiterpenoid skeleton at the C2 position and a dehydrogenase activity that could further oxidize this hydroxy group to form a ketone as demonstrated in Example 2, we decided to investigate the oxidation of the sesquiterpene valencene to study whether nootkatone would be formed.
- Synthesis of Reference Compounds
- β-Nootkatol was prepared by reduction of 190 mg nootkatone (Fluka) with 20 mg of LiAlH4 in 5 mL dry ether (diethyl-ether) (Shoji et al., 1984). After stirring the grey suspension for one night, the reaction was stopped by careful addition of Na2SO4.10H2O. The mixture was stirred for an additional 30 minutes, and dried by the addition of MgSO4. The solids were filtered off and the ether was washed with distilled water. After drying and evaporation of the solvent, 140 mg of a crude oil was obtained that besides β-nootkatol contained 4% of α-nootkatol, EIMS (70 eV) m/z: 220 [M]+ (33), 177 (77), 161 (40), 145 (52), 131 (77), 119 (100), 109 (41), 107 (50), 105 (59), 95 (46), 93 (60), 91 (43), 81 (45), 79 (80), 77 (64), 69 (47), 67 (52), 55 (58), 43 (55), 41 (94), 39 (54). After flash chromatography of 50 mg from this crude oil on silica with ether-pentane (2:1), fractions devoid of any trace of a-nootkatol were pooled yielding 3.6 mg of β-nootkatol. 1H NMR (200 MHz, C6D6) δ 0.83 (d, 3H, J=3 Hz), δ 0.95 (s, 3H), δ 0.96-1.47 (m, 7H), δ 1.75 (m, 3H), δ 1.93 (dt, 1H, J=12.7 and 2.7 Hz), δ 2.07 (m, 1H), δ 2.20-2.33 (m, 2H), δ 4.19-4.26 (m, 1H), δ 4.88 (br s, 2H), 5.44 (br d, 1H). 13C NMR (100 MHz, DEPT, CDCl3) δ 15.7 (q), δ 18.4 (q), δ 21.1 (q), δ 32.8 (t), δ 33.4 (t), δ 37.8 (t), δ 38.5 (s), δ 39.8 (d), δ 141.3 (d), δ 45.1 (t), δ 68.1 (d), δ 109.2 (t), 125.9 (d), δ 144.9 (s), δ 150.2 (s). EIMS (70 eV) m/z: 220 M+ (56), 177 (100), 145 (31), 135 (51), 131 (43), 123 (38), 121 (91), 119 (81), 109 (42), 107 (66), 105 (62), 95 (49), 93 (69), 91 (87), 81 (39), 79 (60), 77 (56), 69 (45), 67 (51) 55 (62), 53 (42), 43 (52), 41 (100), 39 (55).
- A mixture of trans, trans-farnesal and cis, trans-farnesal was prepared by dissolving trans, trans-farnesol (Sigma) in pentane and stirring with MnO2. Farnesal was oxidised to a mixture of cis, trans- and trans, trans-farnesoic acid with silver oxide (Caliezi and Schinz, 1947).
- Incubations with Microsomal Pellets
- Microsomal pellets that contain (+)-germacrene A hydroxylase activity and an enzyme suspension were prepared from deep frozen chicory cubes as described in Example 1. The enzyme suspension was divided in 1 mL aliquots and incubated with 50 μM (+)-valencene in the presence of a 1 mM NADPH-regenerating system that consisted of 1 mM NADPH, 5 mM glucose-6-phosphate, and 1.2 IU glucose-6-phosphate dehydrogenase. The initial concentration of substrate in each assay was 45 μM and all experiments were done in duplicate. To the blank assays no NADPH regenerating system was added, so that cytochrome P450 enzymes (including the (+)-germacrene A hydroxylase) were not active. After 60 minutes the incubations were stopped by storing them at −20° C. in a freezer. The enzyme assays were analysed as described in Example 1.
- Results
- Incubation of (+)-valencene with a microsomal pellet from chicory roots and NADPH yielded (
FIG. 17 ) only a trace of the expected valencene-12-ol ([+]-2-[2R]-2-[1,2,3,4,6,7,8,8a-octahydro-8α,8aβ-dimethyl-2α-napthalenyl]-2-propen-1-ol) that was identified by comparison of its mass spectrum with a mass spectrum kindly provided by Dr. R. Naf (Firmenich S A, Geneva, Switzerland). EIMS (70 eV) m/z: 220 [M]+ (22), 189 (52), 187 (41), 161 (80), 145 (54), 131 (49), 21 (41), 119 (58), 117 (39), 107 (55), 105 (84), 95 (44), 93 (73), 91 (100), 81 (47), 79 (84), 77 (51), 67 (39), 55 (48), 41 (63). The major product was nootkatone (Table VII), whereas in most experiments the corresponding β-nootkatol was detected in amounts smaller than the valencene-12-ol (the chromatogram depicted inFIG. 17 is an exception!). - It was assumed that this β-nootkatol is an intermediate in the formation of nootkatone. For this reason incubations of 100 μM (β-nootkatol were performed at
pH 10 with NAD(P)+ and a 150,000 g supernatant of chicory roots, such as described for the conversion of (−)-elema-1,3, 11(13)-12-ol and germacra-1(10),4,11(13)-trien-12-ol by NADP+-dependent dehydrogenases by De Kraker et al. (2001). During incubation the added β-nootkatol was converted for more than 60% into nootkatone in the presence of either 1 mM NADP+ or 1 mM NAD+. In the absence of these cofactors conversion still amounted to 25%, whereas the boiled enzyme extract gave no conversion of β-nootkatol. At pH 7.5, enzyme activity was slightly lower, whereas a 150,000 g pellet, as expected, yielded 3-fold less dehydrogenase activity than the corresponding supernatant. Incubations with a mixture of α- and β-nootkatol showed that only β-nootkatol was converted (FIG. 18 ). - To get some more information about the substrate specificity of the dehydrogenase(s) present in chicory roots, incubations with the 150,000 g supernatant were also performed with 100, μM trans, trans-farnesol as substrate (
FIG. 19 ) in the presence of either NAD+ or NADP+. Trans, trans-farnesol was converted up to 60% into a mixture of trans, trans-farnesal and cis,trans-farnesal, and small amounts of farnesoic acid were observed as well. - Various pH-values were tested between 7.5 and 11.0 with Tris, glycine and CAPS buffers; the highest conversion of farnesol into farnesal was observed at
pH 10 decreasing to 30% of maximum enzyme activity at pH 7.0. - Conclusion
- A chicory enzyme extract efficiently catalysed the conversion of (+)-valencene via nootkatol into nootkatone (
FIGS. 17 and 18 ). Possibly these reactions are catalysed by the same enzymes that are involved in the biosynthesis of leucodin from (+)-costunolide (FIG. 20 ; Example 2). On basis of its structural resemblance with leucodin, the same might have occurred to (+)-ledene (see Example 2, Table I), but this compound was only hydroxylated and not converted into a ketone. - Formation of nootkatone catalysed by enzymes of chicory proceeds via β-nootkatol that is subsequently oxidised to nootkatone by NAD(P)+-dependent dehydrogenase(s). These dehydrogenases are operationally soluble enzymes, but apparently partially end up in the microsomal pellet, just as the germacrene alcohol dehydrogenase(s). The dehydrogenase(s) involved in formation of nootkatone have a strong preference for β-nootkatol over α-nootkatol and this may indicate the involvement of a specific enzyme that perhaps in planta is responsible for the oxidation of the alcohol precursor of leucodin. In general the dehydrogenase(s) present in a 150,000 g supernatant of chicory do not seem to act with a high substrate specificity. In addition to the conversion of germacrene alcohol and elemene alcohol/aldehyde (Example 1) they are also capable of converting trans, trans-farnesol into farnesal an farnesoic acid. NAD(P)+-dependent oxidation of farnesol to farnesal, including the observed isomerisation of farnesal, has also been reported for other crude plant extracts, (Chayet et al., 1973; Overton and Roberts, 1974). Whether in vivo the isolated dehydrogenase activities are exclusively involved in sesquiterpene lactone biosynthesis or have (also) a different function is uncertain.
- Nootkatone is a much sought-after aromatic substance with a distinctive flavor of grapefruit that is widely used in the flavor and fragrance and food industry.
- Nootkatone was also shown to be an important constituent of anti-ulcer medication (Yamahara et al., 1990). For this reason the possibilities for conversion of the less valuable (+)-valencene has intensively been studied, but the yields obtained by either chemical methods or microbiological methods were not satisfying or too laborious (Dhavlikar and Albroscheit, 1973; Kunst et al. 1975; Lamare and Furstoss, 1990). Remarkably, there is not yet any direct proof that in grapefruit, the source of valencene and nootkatone, a biochemical pathway exists for the conversion of (+)-valencene via β-nootkatol into nootkatone (del Rio et al., 1992).
- Generally, the production of new materials for flavors and fragrances has been a powerful driving force in the research on the hydroxylation of terpenes by micro-organisms. Although in some cases successful, these microbiological conversions often yield a broad spectrum of products, including epoxides and diols (Lamare and Furstoss, 1990; Drauz and Waldmann, 1995; Faber, 2000) and the oxidations often occur at double bonds. This is in strong contrast to the highly specific oxidation of valencene to nootkatone as catalysed by the chicory enzyme extract.
- Carboxylic acids are important flavours and fragrances. For instance, fatty acids of various chain lengths are very characteristic for the flavour of cheese (West, 1996), whereas higher fatty acids contribute to the taste and smell of peanuts (Hashim et al., 1993). Branched chain fatty acids are important flavour notes in mutton and sheep cheese (Heinsman, 2000; Heinsman et al., submitted). The chicory dehydrogenases responsible for the conversion of germacrene alcohol to germacrene acid have a rather low substrate specificity. Therefore we have investigated whether these dehydrogenases are capable of oxidising other kinds of terpene alcohols and aldehydes as well as linear and branched aliphatic alcohols and aldehydes.
- A chicory enzyme preparation or extract containing the dehydrogenases is made according to De Kraker et al. (2001a). Incubation with an alcohol or aldehyde, for instance amorpha-4,11-diene-12-ol or the corresponding aldehyde, in the presence of NADP+ at
pH 10 leads to the formation of the corresponding carboxylic acid in high yield. In case of amorpha-4,11-diene-12-ol, a mixture of artemisinic and dihydroartemisinic acid are produced. Apparently, the dehydrogenases are not only capable of oxidising amorphadiene to artemisinic acid but also the reductase responsible for the reduction of the double bond in the isopropenyl group in the pathway after costunolide (Example 2) is capable of reducing artemisinic acid to dihydroartemisinic acid. As the conversion of dihydroartemisinic acid to artemisinin is supposed to proceed non-enzymatically, chicory may be a suitable production organism for artemisinin, or a source of genes that can be used to produce artemisinin in other organisms. - In the same way, octanol or octanal and 4-methyloctanol or 4-methyloctanal are oxidised to the corresponding octanoic acid and 4-methyloctanoic acid, respectively. Since 4-methyloctanoic acid is chiral, we checked the stereochemical composition of the product, which appears to contain the R-enantiomer in preference.
- Preparation of Immobilised Enzymes
- Fresh roots of cultivated chicory are processed as described in Example 1, and the 150,000 g pellets are used for the following experiment. Two grams of pellets are suspended in 50 ml of demineralised water containing 25 mM Tris pH 7.5, 10% glycerol, 1 mM ascorbic acid and 2 mM DTT. To this is added 10 U of an NADPH-regenerating enzyme like glucose 6-phosphate dehydrogenase, hydrogenase, or, preferably, formate dehydrogenase (Seelbach et al., 1996) and 100 g of a solid support like DEAE-Sepharose, polyacrylamide or, preferably, Accurel beads. The mixture is stirred overnight at 4° C. after which the immobilised enzymes are filtered, washed with demineralised water containing 25 mM Tris pH 7.5, 10% glycerol and 1 mM ascorbic acid, and stored at 4° C. until usage. Alternatively, the mixture of chicory enzymes and cofactor-recycling enzyme is brought into contact with a hydrophobic membrane (flat membrane or hollow fibre unit) for one night at 4° C., after which the membrane is washed and the membrane (containing the immobilised enzymes) is stored at 4° C. until usage.
- Reaction of Immobilised Enzymes with Sesquiterpenes
- The immobilised enzyme is placed in a bioreactor and suspended in 500 ml of demineralised water containing 25 mM Tris pH 7.5, 10% glycerol, and 1 mM ascorbic acid, at room temperature. To this mixture, NADPH is added up to 0.3 mM, together with a suitable amount of cosubstrate, for cofactor recycling. Typically, 1.5 mM of glucose 6-phosphate is added as a cosubstrate when using glucose 6-phosphate dehydrogenase for the recycling of NADPH, whereas 100 mM of formic acid/sodium formate pH 7.5 is added when formate dehydrogenase is the enzyme of choice. Then, the sesquiterpene substrate (100 mM in ethanol) is pumped into the bioreactor at a speed of 0.1 ml/min, under continuous gentle stirring. At the same time, oxygen is pumped into the bioreactor using a thin-walled silicon tube which allows bubble-free aeration (Rissom et al., 1997). This system is chosen since it is known that gas-liquid interfaces (like air bubbles) frequently cause inactivation of monooxygenases. Pumping is stopped when 50 ml of substrate solution (5 mmol, about 1 g of sesquiterpene) has been added, and the reaction mixture is stirred at room temperature until the concentration of product does no longer increase (as monitored by off-line GC). At that time, the immobilised enzyme is filtered off and the product is obtained by extraction of the aqueous medium with pentane, followed by chromatography over silica (using petroleum ether/ethyl acetate mixtures as the solvents). In this way, 0.5 g of pure hydroxylated sesquiterpene can be obtained, but higher yields are possible, depending on the substrate used. Also nootkatone can be obtained in this way in yields around 50% or higher, using valencene as the substrate. The immobilised enzymes are washed with buffer and can be reused many times. Enzymatic reactions at temperatures higher than ambient are possible but lead to a decreased lifetime of the enzyme preparation.
- In case of hydrogenase, more advantageous results are obtained when this enzyme is immobilised separately from the chicory enzymes, and a two-compartment bioreactor is used. The two compartments are separated by a highly porous membrane which is permeable for the NADP(H) cofactor used. One compartment contains immobilised hydrogenase and a thin-walled silicon tube, through which hydrogen gas is pumped. The other compartment contains the immobilised chicory enzymes and a thin-walled silicon tube, through which oxygen gas is pumped. In this way, both enzymes have access to their substrates and cofactors whereas the hydrogenase does not suffer from inactivation by oxygen.
- Alternatively, enzymes that are co-immobilised on solid beads can be used in a fed-batch bioreactor where the outlet is equipped with a hydrophobic membrane such that the product is able to pass whereas the cofactors and the enzymes remain inside the reactor. For this purpose, a membrane reactor in which both enzyme preparations are immobilised on the membrane is most advantageous. Using this system, the enzymes can be used continuously since they are stable for a prolonged period, allowing the facile preparation of several hundred grams of hydroxylated sesquiterpenes or nootkaton.
- Cultures of de-differentiated cells or callus, hairy roots, shoots and other tissues have been used extensively for the bioconversion of a wide range of substrates. For example cell suspension cultures of grape were able to convert citral to nerol, geraniol and geranylacetate. Also Asteraceae species are suitable for this approach. Hairy root and cell cultures of chicory are obtained using standard protocols (hairy root cultures: Song et al., 1995; cell cultures: Dubois et al., 1988). The cultures are supplied with sesquiterpenes such as valencene, α-gurjunene, amorpha-4,11-diene and α-trans-bergamotene at 200 mg/l. After one week of growth in the presence of the sesquiterpenes, the reaction products are extracted from the culture medium and the hairy roots/cells using pentane/ether. The reaction products are characterised using GC-MS. Incubations with valencene yield an efficient conversion to nootkatone. Incubations with α-gurjunene, amorphadiene and α-trans-bergamotene yield an efficient conversion to the corresponding alcohols with a high regioselectivity: hydroxylation occurs only in the isopropenyl group.
- Recently we have demonstrated that the sesquiterpenoid backbone of the sesquiterpene lactones in chicory is formed by a (+)-germacrene A synthase which cyclizes FPP to (+)-germacrene A (de Kraker et al., 1998; Bouwmeester et al., 1999b). These so called terpene synthases catalyse the first committed step in all terpenoid biosynthetic pathways. The terpene synthases are a large group of enzymes that all convert the ubiquitous substrates geranyl diphosphate (to the monoterpenes), farnesyl diphosphate (to the sesquiterpenes), geranylgeranyl diphosphate (to the diterpenes) or squalene epoxide (to the triterpenes) (Bohlmann et al, 1998). The sesquiterpenes exhibit an exceptional large structural diversity, and over 7000 different compounds have been described. Like the other terpene synthases (leading to mono-, di- and triterpenes), sesquiterpene synthases exhibit a fair degree of sequence similarity, which allows them—in most cases—to be recognized as a sesquiterpene synthase, and enables the design of degenerate primers to be used in PCR to generate fragments that can be used to screen libraries or can be extended using RACE-PCR to obtain the full-length cDNAs (Bohlmann et al, 1998). Particularly in specialised tissues or enriched libraries also random sequencing may be used to obtain these (sesqui)terpene synthases (Bohlmann et al., 1998).
- The valencene synthase gene is isolated from grapefruit, orange, pomelo and Claamaecyparis nootkatensis using PCR with degenerate primers based on the sequence homology existing between sesquiterpene synthases (see for example Bouwmeester et al., 1999b) or using the sequence information of the putative sesquiterpene synthase isolated from grapefruit, as published in Genbank (AF411120).
- a) Isolation of mRNA. Total RNA is isolated from grapefruit, orange and pomelo albedo and C. nootkatensis using the purescript RNA isolation kit (Biozym). DNase I (Deoxyribonuclease I, RNase free) is used to remove DNA from the RNA isolate. The DNase I is removed with a phenol/chloroform extraction after which the RNA is precipitated (ethanol precipitation with NaAc). Poly (A)+ RNA is extracted from 20 μg of total RNA using 2 μg poly-d(T)25V oligonucleotides coupled to 1 mg paramagnetic beads (Dynal A. S.). The poly(A)+ RNA is resuspended in 20 μl H2O.
- b) cDNA synthesis. The reverse transcription reaction is carried out in a 50 μl reaction containing 10 μl poly (A)+ mixture, 0.3 μg oligo (dT)25V, 1 mM each dATP, dTTP, dCTP and dGTP, 50 mM Tris-HCl pH 8.3, 80 mM KCl, 10 mM MgCl2 and catalyzed with 12 U AMV reverse transcriptase (Pharmacia). After an incubation for 2 h at 42° C. the reaction is stopped and the cDNA purified with the Wizard PCR Preps DNA purification system (Promega). The cDNA is resuspended in 50 μl H2O.
- c) PCR-Based Probe Generation.
- Based on comparison of sequences of terpenoid synthases, two degenerated primers were designed for two conserved regions: sense primer: 5′-GAY GAR AAY GGI AAR TTY AAR GA-3′; anti-sense primer: 5′-CC RTA IGC RTC RAA IGT RTC RTC-3′ (Wallaart et al., 2001) (primers from Eurogentec, Seraing, Belgium) (Bouwmeester et al., 1999b; Wallaart et al., 2001).
- PCR is performed in a total volume of 50 μl containing 0.5 μM of each of the two primers, 0.2 mM dNTP, 1 U Super Taq polymerase/1×PCR buffer (HT Biotechnology LTD, Cambridge, England) and 10 μl cDNA. The reaction mixture is incubated in a thermocycler (Robocycler, Stratagene) with 1 min denaturation at 94° C., 1.5 min annealing at 42° C. and 1 min elongation at 72° C. during 40 cycles. Agarose gel electrophoresis revealed a single specific PCR product of 550 bp that BLAST comparison shows to have homology with sesquiterpene synthases. The PCR product is purified using the Wizard PCR Preps DNA purification system (Promega) and subcloned using the pGEMT system. E. coli JM101 is transformed with this construct. The full length cDNA is obtained using RACE-PCR.
- For functional expression, the cDNA clone is subcloned in frame into the expression vector pET 11d (Stratagene). The construct and pET 11d without an insert (as negative control) are transformed to E. coli BL 21 (DE3) (Stratagene), and grown overnight on LB agar plates supplemented with ampicillin at 37° C. Cultures of 50 ml LB medium supplemented with ampicillin (100 μg/ml) and 0.25 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) are occulated with these over night cultures to A600=0.5 and grown for 3 h at 27° C. The cells are harvested by centrifugation during 8 minutes at 2000 g and resuspended in 1.2 ml buffer containing 15 mM Mopso (pH 7.0), 10% (v/v) glycerol, 10 mM MgC12, 1 mM sodium ascorbate and 2 mM DTT (buffer A). The resuspended cells are sonicated on ice during 4 min (5 sec on, 30 sec off), centrifuged for 5 minutes at 4° C. (14.000 rpm) and the supernatant used for assays.
- For determination of product identity, 20 μM [3H]-FDP is added to 0.5 mL of the enzyme preparations diluted 1:1 with buffer A containing 0.1% tween-20. After the addition of a 1-mL redistilled pentane overlay, the tubes are carefully mixed and incubated for 1 h at 30° C. Following the assay, the tubes are mixed, the organic layer is removed and passed over a short column of aluminum oxide overlaid with anhydrous MgSO4. The assay is re-extracted with 1 mL of pentane:diethyl ether (80:20), which is also passed over the aluminum oxide column, and the column washed with 1.5 mL of pentane:diethyl ether (80:20). The extract is analysed using radio-GLC and GC-MS (Bouwmeester et al., 1999a, b). Radio-GLC analysis shows that the cDNA formed a functionally active protein catalysing the formation of one radiolabelled sesquiterpene from [3H]-FDP. The negative control (vector without insert) produced no radioactivity. The samples are also analysed by GC-MS using a HP 5890 series II gas chromatograph equipped with an HP5-MS column (30 m×0.25 mm i.d., 0.25 μm df) and HP 5972A Mass Selective Detector (Hewlett-Packard). The oven is programmed at an initial temperature of 70° C. for 1 min, with a ramp of 5° C. min−1 to 210° C. and final time of 5 min. The injection port (splitless mode), interface and MS source temperatures are 150, 290 and 180° C., respectively, and the He inlet pressure is controlled by electronic pressure control to achieve a constant column flow of 1.0 mL min−1. Ionization potential is set at 70 eV, and scanning is performed from 30-250 amu. The negative control produced no sesquiterpenes, whereas in assays with the expression products valencene is the major product. The identity of the latter is confirmed by analysis of an authentic standard and comparison of the mass spectra with the authentic standard.
- Two strategies are used to isolate the sesquiterpene hydroxylases and dehydrogenase from chicory. One is based on the presence of sequence homology between P450 genes on the one hand and dehydrogenases on the other. The other method uses random sequencing of a C. intybus root cDNA library which has been shown to be a powerful tool for the isolation of biosynthetic genes (Aharoni, et al., 2000).
- a) Isolation of mRNA. Total RNA is isolated from chicory chicons using the purescript RNA isolation kit (Biozym). DNase I (Deoxyribonuclease I, RNase free) is used to remove DNA from the RNA isolate. The DNase I is removed with a phenol/chloroform extraction after which the RNA is precipitated (ethanol precipitation with NaAc). Poly (A)+ RNA is extracted from 20 μg of total RNA using 2 μg poly-d(T)25V oligonucleotides coupled to 1 mg paramagnetic beads (Dynal A. S.). The poly(A)+ RNA is resuspended in 20 μl H2O.
- b) cDNA synthesis. The reverse transcription reaction is carried out in a 50 μl reaction containing 10 μl poly (A)+ mixture, 0.3 μg oligo (dT)25V, 1 mM each dATP, dTTP, dCTP and dGTP, 50 mM Tris-HCl pH 8.3, 80 mM KCl, 10 mM MgCl2 and catalyzed with 12 U AMV reverse transcriptase (Pharmacia). After an incubation for 2 h at 42° C. the reaction is stopped and the cDNA purified with the Wizard PCR Preps DNA purification system (Promega). The cDNA is resuspended in 50 μl H2O
- c) PCR-based probe generation. Based on comparison of sequences of cytochrome P450 and dehydrogenase enzymes, degenerate primers are designed for conserved regions such as the ER targeting signal, the heme-binding domain, the central region of helix I and the PERF-motif. PCR is performed in a total volume of 50 μl containing 0.5 μM of each of the two primers, 0.2 mM dNTP, 1 U Super Taq polymerase/1× PCR buffer (HT Biotechnology LTD, Cambridge, England) and 10 μl cDNA. The reaction mixture is incubated in a thermocycler (Robocycler, Stratagene) with 1 min denaturation at 94° C., 1.5 min annealing at 42° C. and 1 min elongation at 72° C. during 40 cycles. Agarose gel electrophoresis revealed a single specific PCR product.
- d) cDNA library construction and screening. A cDNA library is constructed using the UniZap XR custom cDNA library service (Stratagene). For
library screening 200 ng of the PCR amplified probes are gel-purified, randomly labelled with [α-32P]dCTP, according to manufacturer's recommendation (Ready-To-Go DNA labelling beads (−dCTP), Pharmacia) and used to screen replica filters of 104 plaques of the cDNA library plated on E. coli XL1-Blue MRF (Stratagene). The plaque lifting and hybridization are carried out according to standard protocols. Positive clones are isolated using a second and third round of hybridization. In vivo excision of the pBluescript phagemid from the Uni-Zap vector is performed according to manufacturer's instructions (Stratagene). - In addition, 1500 clones from the cDNA library are randomly sequenced and compared to sequences in the databases using BLAST. Promising P450 and dehydrogenase-like sequences were found and are further characterised by heterologous expression.
- Expression of the isolated genes in E. coli and yeast. For functional expression, the cDNA clones are subcloned into suitable expression vectors and transformed to a suitable expression host. Induced cells are harvested by centrifugation during 8 minutes at 2000 g and resuspended in 1 ml assay buffer. The resuspended cells are either sonicated on ice during 4 min (5 sec on, 30 sec off), centrifuged for 5 minutes at 4° C. (14.000 rpm) and the supernatant used for assays or used as intact cells. In both systems germacrene A, valencene and nootkatol are used as substrates. Ether extracts of the assays are analysed using GC-MS (see Example 7). The negative control produced no germacrene A alcohol, nootkatol, or nootkatone, whereas in assays with the expression products of both genes conversion of germacrene A to germacrene A alcohol, valencene to nootkatol and of nootkatol to nootkatone, respectively, occurred.
- Chicory transformation. Chicory is transformed as described in PCT/EP00/02130 (Bouwmeester et al., 1999b) with a construct harboring the valencene or amorphadiene synthase. After regeneration, transgenic plants are screened for the activity of the introduced gene by examining sesquiterpene synthase activity in enzyme extracts. Hereto, 100 mg of tissue, ground in liq N2, is extracted in a 2-ml Eppendorf vial, using a plastic probe to further homogenize the tissue, in 1.0 ml of extraction buffer containing 50 mM Mopso (pH 6.8), 20% (v/v) glycerol, 50 mM sodium ascorbate, 50 mM NaHSO3, 1% PVβ-40, 10 mM MgCl2 and 5 mM DTT. After extraction, the samples are centrifuged for 20 min at 20,000 g at 4° C. 0.5 mL of the supernatant are diluted 2-fold with buffer A (Example 7) also containing 6 mM sodium orthovanadate (an inhibitor of phosphohydrolase activity). After addition of 20 μM 3H-FPP and a 1 mL redistilled pentane overlay, the tubes are carefully mixed and incubated for 1 h at 30° C. The assays are extracted and analysed using radio-GC and GC-MS as described for Example 7.
- The wildtype and GUS-construct controls all exhibit a similar sesquiterpene synthase activity, which is due to the presence of endogenous germacrene A synthase activity. The transformants exhibit an altered sesquiterpene profile, with varying amounts of valencene and amorphadiene, respectively in addition to germacrene A. For some transformants 90% of the in vitro produced sesquiterpene is valencene.
- Extracts of the transgenic plants that were analysed using GC-MS showed the presence of valencene, nootkatol and nootkatone on the one hand and artemisinic acid, dihydroartemisinic acid and artemisinin on the other hand, respectively.
- Saccharomyces cerevisiae and Pichia pastoris are transformed using the S. cerevisae EasyComp™ transformation kit (Invitrogen) according to manufacturer's instructions with constructs harboring:
- 1. the valencene hydroxylase and a general, commercial or chicory dehydrogenase
- 2. the valencene synthase and valencene hydroxylase
- 3. the valencene synthase, valencene hydroxylase and general, commercial or chicory dehydrogenase
- Transgenic cells are grown in a reactor, and products of the cells are analysed after extraction.
- Transgenic yeast
cells harboring constructs cells harboring construct 1 produce nootkatone upon feeding of valencene. - Saccharomyces cerevisiae and Pichia pastoris are transformed using the S. cerevisae EasyComp™ transformation kit (Invitrogen) according to manufacturer's instructions with a construct harboring a sesquiterpene synthase, such as, but not limited to, amorphadiene synthase, (−)-α-trans-bergamotene synthase, alloisolongifolene synthase, γ-gurjunene synthase and a sesquiterpene hydroxylase cDNA (obtained as described in Example 8).
- Transgenic cells are grown in a reactor, and products of the cells are analysed after extraction.
- Transgenic yeast cells are harboring the constructs produce amorphadien-12-ol, (E)-trans-bergamota-2,12-dien-14-ol; alloisologifolene alcohol; and 5,11(13)-guaiadiene-12-ol, respectively.
-
- Ando M, Ibayashi K, Minami N, Nakamura T, Isogai K (1994) Studies on the synthesis of sesquiterpene lactones, 16. The synthesis of 11β, 13-dihydrokauniolide, estafiatin, isodehydrocostuslactone, 2-oxodesoxyligustrin, arborescin, 1,10-epiaborescin, 11β, 13-dihydroludartin, 8-desoxy-11β, 13-dihydrorupicolin B, 8-deoxyrupicolin B, 3,4-epiludartin, ludartin, kauniolide, dehydroleucodin and leucodin. J Nat Prod 57: 443-445
- Aharoni A, Keizer L C P, Bouwmeester H J, Zhongkui Sun, Alvarez-Huerta M, Verhoeven H A, Blaas J, van Houwelingen A M M L, de Vos R C H, van der Voet H, Jansen R C, Guis M, Davis R W, Schena M, van Tunen A J, O'Connell A P (2000) Identification of the SAA T gene involved in strawberry flavor biogenesis by using DNA microarrays. The Plant Cell 12: 1-16.
- Asakawa Y (1982) Chemical constituents of hepaticae. In W Herz, H Grisebach, G W Kirby, eds, Progress in the Chemistry of Organic Natural Products Vol. 42. Springer Verlag, Wien-New York
- Asakawa Y, Matsuda R, Takemoto T (1980) Mono and sesquiterpenoids from Wiesnerella denudate. Phytochemistry 19: 567-569.
- Balkrishna B L, Childers W E, Pinnick J R, Pinnick H W (1981) Oxidation of α, β-unsaturated aldehydes. Tetrahedron 37: 2091-2096
- Barton D H R, Moss G P, Whittle J A (1968) Investigations on the biosynthesis of steroids and terpenoids part I: A preliminary study of the biosynthesis of santonin. J Chem Soc (C) 1813-1818
- Bawdekar A S, Kelkar G R (1965) Terpenoids-LXVIII: Structure and absolute configuration of costic acid-a new sesquiterpene acid from costus root oil. Tetrahedron 21: 1521-1528
- Bawdekar A S, Kelkar G R, Bhattacharyya S C (1967) Terpenoids-CIV: Costol fraction of costus root oil. Tetrahedron 23: 1993-1996
- Birch A J (1974) Dihydrobenzenes in synthesis in terpenen related areas. J Agric Food Chem 22: 162-167
- Bohlman F, Ates N, Jakupovic J (1983) Hirsutinolides from South African Vernonia species. Phytochemistry 22: 1159-1162
- Bohlmann J, Meyer-Gauen G, Croteau R (1998) Plant terpenoid synthases: Molecular biology and phylogenetic analysis. Proceedings of the National Academy of Science, USA 95: 4126-4133
- Bouwmeester H J, Wallaart T E, Janssen M H A, van Loo B, Jansen B J M, Posthumus M A, Schmidt C O, de Kraker J-W, König W A, Franssen M C R (1999a) Amorpha-4,11-diene synthase catalyses the first probable step in artemisinin biosynthesis. Phytochemistry 52: 843-854
- Bouwmeester H J, Kodde J, de Kraker J W (1999b) Sesquiterpenoid synthase genes and their use for influencing bitterness and resistance in plants. Patent PCT/EP00/02130
- Brown E D, Sutherland J K, Sam T W (1975) Medium-
ring 1,5-dienes. Part III. Cyclization of germacra-1(10),4,7-(11)-triene oxides. J ChemSoc Perkin Trans 1, 2332-2336 - Caliezi A, Schinz H (1947) Zur Kenntnis der Sesquiterpene und Azulene: die Cyclisation der Farnesylsaure. Helv Chim Acta 32: 2556-2560
- Chayet L, Pont-Lezica R, George-Nascimiento C, Cori 0 (1973) Biosynthesis of sesquiterpene alcohols and aldehydes by cell free extracts from orange flavedo. Phytochemistry 12: 95-101
- Cordell G A (1976) Biosynthesis of sesquiterpenes. Chem Rev 76: 425-460
- De Kraker J W, Franssen M C R, de Groot Ae, König W A, Bouwmeester H J (1998) (+)-Germacrene A biosynthesis. The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiol. 117: 1381-1392.
- De Kraker J W, Franssen M C R, Dalm M C F, de Groot Ae, Bouwmeester H J (2001a) Biosynthesis of germacrene A carboxylic acid in chicory: Demonstration of a cytochrome P450 (+)-germacrene A hydroxylase and NADP+/NAD+-dependent sesquiterpenoid dehydrogenase (s) involved in sesquiterpene lactone biosynthesis. Plant Physiol. 125: 1930-1940.
- De Kraker J W, Franssen M C R, de Groot Ae, Shibata T, Bouwmeester H J (2001b) Germacrenes from fresh costus roots. Plwytochemistry, 58: 481-487.
- del Rio J A, Ortuno A, Garcia-Puig D, Porras I, Garcia-Lidón A, Sabater F (1992) Variations of nootkatone and valencene levels during the development of grapefruit. J Agric Food Chem 40: 1488-1490
- Dhavalikar R S, Rangachari P N, Bhattacharyya P K (1966) Microbiological transformations of terpenes: Part IX-Pathways of degradation of limonen in a soil pseudomonad. Indian J Biochem 3: 158-164
- Dhavlikar R S, Albroscheit G (1973) Microbiologische Umsetzung von Terpenen: Valencen. Dragoco Report 12: 250-258
- Donaldson R P, Luster D G (1991) Multiple forms of plant cytochromes P-450. Plant Physiol 96: 669-674
- Drauz K, Waldmann H (1995) Enzyme Catalysis in Organic Synthesis-A Comprehensive Handbook. V C H, Weinheim, 667-701
- Faber K (2000) Biotransformations in Organic Chemistry. 42nd ed, Springer-Verlag, Berlin, 453 pages.
- Fischer N H (1990) Sesquiterpene lactones: Biogenesis and biomimetic transformations. In G Towers and H Towers, eds, Biochemistry of the Mevalonic Acid Pathway to Terpenoids. Plenum Press, New York, pp 161-201
- Fischer N H, Olivier E J, Fischer H D (1979) The biogenesis and chemistry of sesquiterpene lactones. In W Herz, H Grisebach, G W Kirby, eds, Progress in the Chemistry of Organic Natural Products Vol. 38. Springer Verlag, Wien-New York
- Franssen M C R, Walton N J (1999) Biotransformations. In NJ Walton, DE Brown eds, Chemicals from Plants, World Scientific Publishers, London, 277-325
- Geissman T A (1973) The biogenesis of sesquiterpene lactones of the compositae. In V C Runeckles, T J Marby, eds, Recent Advances in Phytochemistry,
Vol 6, Academic Press, New York and Londen, pp 65-95 - Genderen, H van, Schoonhoven L M, Fuchs A (1996) Chemisch-ecologische flora van Nederland en Belgie. Een inleiding over aard en ecologische betekenis van secundaire plantenstoffen, H van Genderen, L M Schoonhoven, A Fuchs, eds. KNNV Uitgeverij, Utrecht, 298 pp
- Grieco P A, Nishazawa M (1977) Total synthesis of (+)-costunolide. J Org Chem 42: 1717-1720
- Halkier B A (1996) Catalytic reactivities and structure/function relationships of cytochrome P450 enzymes. Phytochemistry 34: 1-21
- Harbome J B, Baxter H, Moss G P (1999) Phytochemical Dictionary. A handbook of bioactive compounds from plants, 2nd edition. Taylor & Francis
- Hashim I B, Koehler P E, Kvien C K (1993) Fatty acid composition, mineral content, and flavor quality of southern runner peanuts treated with herbicides and fungicides. Peanut Sci. 20: 106-111
- Heinsman N W T J (2000) Lipase-catalyzed kinetic resolution of branched chain fatty acids and their esters. PhD thesis, Wageningen University
- Heinsman N W J T, Franssen M C R, van der Padt A, Boom R M, van't Riet K, de Groot Ae Lipase-mediated resolution of branched chain fatty acids. Biocatal. Biotransform., submitted
- Herz W (1977) Sesquiterpene lactones in the compositae. In V H Heywood, J B Harborne, B L Turner, eds, The Biology and Chemistry of the Compositae. Academic Press, London, pp 337-357
- Ho C, Choi E J, Yoo G S, Kim K M, Ryu S Y (1998) Desacetylmatricin, an anti-allergic component from Taraxacum platycarpum. Planta Med 64: 577-578
- Holland H L (1992) Organic Synthesis with Enzymes. VCH Publishers, New York, pp 29-31
- Hunter G L K, Brogden W B Jr (1965) Conversion of valencene to nootkatone. J Food Sci 30: 876-878
- Jain T C, Banks C M, McCloskey J E (1970) Dehydrosaussurea lactone and reversibility in the germacranolide-cope reaction. Tetrahedron Lett 11: 841-844 Jerussi A R (1970) Selective oxidations with selenium dioxide. In Selective Organic Transformations. Wiley-Interscience, p. 301-313.
- Karp F, Mihaliak C A, Harris J L, Croteau R (1990) Monoterpene biosynthesis: specificity of the hydroxylations of (−)-limonene by enzyme preparations from peppermint (Mentha piperita), spearmint (Mentha spicata) and perilla (Perilla frutescens) leaves. Arch Biochem Biophys 276: 219-226
- Kesselmans R P W (1992) Total synthesis of all stereoisomers of eudesm-11-en-14-ol. PhD thesis, Wageningen University
- Konst W M B, van der Linde L M, Witteveen J G (1975) Recent developments in the chemistry of eremophilanes. International Flavours and Food Additives 6: 121-125
- Kupchan S M, Fessler D C, Eakin M A, Giacobbe T J (1970) Reactions of alpha methylene lactone tumor inhibitors with model biological nucleophils. Science 168: 376-377
- Lamare V, Furstoss R (1990) Bioconversion of sesquiterpenes. Tetrahedron 46: 4109-4132
- March J (2001) Advanced Organic Chemistry: reactions, mechanisms and structure. 5thed, Wiley-Interscience, New York, N.Y., 2083 pages
- Martinez M, Munoz-Zamora A, Joseph-Nathan P (1988). Conformational analysis of achillin and leukodin. J Nat Prod 51: 221-228
- Mathews C K, Van Holde K E (1996) Biochemistry. 2nd ed, Oregon State University, The Benjamin/Cummings Publishing Company
- Maurer B, Grieder A (1977) Sesquiterpenoids from costus root oil (Saussurea lappa Clarke). Helv Chim Acta 60: 2177-2190
- Meijer A H (1993) Cytochrome P-450 and secondary metabolism in Catharanthus roseus. Ph. D. thesis, Leiden University
- Mihaliak C A, Karp F, Croteau (1993) Cytochrome β-450 terpene hydroxylases. In P. J. Lea ed, Methods in Plant Biochemistry, Enzymes of Secondary Metabolism,
Vol 9. Academic Press, Londen, pp 261-279 - Minnaard (1997) Germacrene sesquiterpenes: synthesis and role in biosynthesis. PhD thesis. Wageningen University.
- Miyazawa M, Honjo Y, Kameoka H (1998) Bioatransforamtion of the sesquiterpenoid (+)-γ-gurjunene using a plant pathogenic fungus Glomerella cingulata, as a biocatalyst. Phytochemstry 49: 1283-1285
- Overton K H, Roberts F M (1974) Interconversion of trans, trans and cis, trans farnesol by enzymes from Andographis. Phytochemistry 13: 95-101
- Paul A, Bawdekar A S, Joshi R S, Somesekar Roa A, Kelkar G R, Bhattacharyya S C (1960) Terpenoids XX: examination of costus root oil. Perf and Ess Oil Rec 15: 115-120
- Pesaro M, Bozzato G, Schudel P (1968) The total synthesis of racemic nootkatone. Chem Commun 1152-1154
- Petersen M, Seitz H U (1988) Reconstitution of cytochrome P-450-dependent digitoxin 12β-hydroxylase from cell cultures of foxglove (Digitalis lanata EHRH.). Biochem J 252: 537-543
- Petersen M, Alfermann A W, Reinhard E, Seitz H U (1987) Immobilization of digitoxin 12β-hydroxylase, a cytochrome β-45-dependent enzyme from cell cultures of Digitalis lanata EHRH. Plant Cell Rep 6: 200-203
- Petit F, Furstoss R (1995) Synthesis of (1S,5R)-2,8-dioxabicyclo [3,3.0]octan-3-one from its enantiomer: a subunit of clerodane derivatives. Synthesis 1517-1520
- Picman A K (1986) Review article number 7: biological activities of sesquiterpene lactones. Biochem Syst Ecol 14: 255-281
- Piet D P, Franssen M C R, de Groot Ae (1996) Biotransformation of allylically activated (E, E)-cyclodeca-1,6-dienols by Cichorium intybus. Tetrahedron 52: 11273-11280
- Piet D P, Schrijvers R, Franssen M C R, de Groot Ae (1995) Biotransformation of germacrene epoxides by Cichorium intybus L. Tetrahedron 51: 6303-6314
- Price K R, DuPont M S, Shepherd R, Chan H W-S, Fenwick G R (1990) Relationship between the chemical and sensory properties of exotic salad crops-colored lettuce (Lactuca sativa) and chicory (Cichorium intybus). J Sci Food Agric 53: 185-192
- Pyrek J S T (1985) Sesquiterpene lactones of Cichorium intybus and Leontodon autumnalis. Phytochemistry 24: 186-188
- Reichardt P B, Anderson B J, Clausen T P, Hoskins L C (1988) Thermal instability of germacrone: implications for gas chromatographic analysis of thermally unstable analytes. Can J Chem 67: 1174-1177
- Rissom S, Schwarz-Linek U, Vogel M, Tishkov V I, Kragl U (1997) Synthesis of chiral ε-lactones in a two-enzyme system of cyclohexanone mono-oxygenase and formate dehydrogenase with integrated bubble-free aeration. Tetrahedron: Asymmetry 8: 2523-2526
- Sannai A, Fujimori T, Kato K (1982) Studies on flavor components of roasted chicory root. Agric Biol Chem 46: 429-433
- Schuler M A (1996) Plant cytochrome P450 monooxygenases. Crit. Rev Plant Sci 15: 235-284
- Seaman F C (1982) Sesquiterpene lactones as taxonomic characters in the Asteraceae. Bot Rev 48: 124-145
- Seelbach K, Riebel B, Hummel W, Kula M R, Tishkov V I, Egorov A M, Wandrey C, Kragl U (1996) A Novel, Efficient Regenerating Method of NADPH Using a New Formate Dehydrogenase. Tetrahedron Lett 37: 1377-1380
- Seigler D S (1995) Plant Secondary Metabolism. Kluwer Academic Publishers, Boston/Dordrecht/London, 759 pp
- Seto M, Miyase T, Umehara K, Ueno A, Hirano Y, Otani N (1988) Sesquiterpene lactones from Cichorium endivia Li and C. intybus L and cytotoxic activity. Chem Pharm Bull 36: 2423-2429
- Shoji N, Umeyama A, Asakawa Y, Takemoto T, Nomoto K, Ohizumi Y (1984) Structural determination of nootkatol, a new sesquiterpene isolated from Alpina oxyphylla Miquel possessing calcium-antagonistic activity. J Pharm Sc 73: 843-844
- Somasekar Roa A, Kelkar G R, Bhattacharyya S C (1960) Terpenoids-XXI: the structure of costunolide, a new sesquiterpene lactone from costus root oil. Tetrahedron 9: 275-283
- Song Q, Gomez-Barrios M L, Hopper E L, Hjortso M A, Fischer N H (1995) Biosynthetic studies of lactucin derivatives in hairy root cultures of Lactucafloridana. Phytochemistry 40: 1659-1665
- Suga, T. and Hirata, T. (1990) Biotransformation of exogenous substrates by plant cell cultures. Phytochemistry 29: 2393-2406.
- Takasugi M, Okinaka S, Katsui N, Masamune T, Shirata A, Ohuchi M (1985) Isolation and structure of lettucinin A, a novel guaianolide phytoalexin from Lactuca satina var. capitata (Compositae). J Chem Soc Chem Commun 621-622
- Takeda, K (1974) Stereospecific Cope rearrangement of the germacrene-type sesquiterpenes. Tetrahedron 30: 1525-1534
- Teisseire P J (1994) Chemistry of Fragrant Substances. VCH Publishers Inc., New York, pp 193-289
- Umbreit M A. Sharpless K B (1977) Allylic oxidation of olefins by catalytic and stoichiometric selenium dioxide with tert-butyl hydroperoxide. J Am Chem Soc 99: 5526-5528
- van Beek T A, Maas P, King B M, Leclercq E, Voragen A G J, de Groot Ae (1990) Bitter sesquiterpene lactones from chicory roots. J Agric Food Chem 38: 1035-1038
- Vogel G, Hartman H D, Krahnstöver K (1994) Handbuch des speziellen Gemusebaues. Ulmer, Stuttgart, pp 84-144
- Wallaart T E, Bouwmeester H J, Hille J, Popping a L, Maijers N C A (2001) Amorpha-4,11-diene synthase: cloning and functional expression of a key enzyme in the biosynthetic pathway of the novel antimalarial drug artemisinin. Planta 212: 460-465.
- Walton N J, Brown D E (1999) eds, Chemicals from plants: perspectives on plant secondary metabolism. World Scientific Publishers, Singapore, 425 pages
- Weeda E J, Westra R, Westra C H, Westra C (1991) Nederlandse oecologische flora: wilde planten en
hun relaties 4. IVN, Amsterdam, pp 152-154 - West C A (1980) Hydroxylases, monooxygenases, and cytochrome β-450. In DD Davis, ed, The Biochemistry of Plants,
Vol 2. Academic Press, Londen, pp 317-342 - West S (1996) Flavour production with enzymes. In: Industrial Enzymology, Godfrey T and
- West S, eds, 2nd ed, Macmillan Press Ltd, London, UK, p. 209-225.
- Wilson C W III, Shaw P E (1978) Synthesis of nootkatone from valencene. J Agric Food Chem 26: 1430-1432
- Yamahara J, Hao Y, Tamai Y (1990) Anti-ulcer effect in rats of bitter cardamom constituents. Chem Pharm Bull 38: 3053-3054
Claims (12)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/796,503 US20070300327A1 (en) | 2001-09-17 | 2007-04-27 | Plant enzymes for bioconversion |
US11/998,036 US20080124772A1 (en) | 2001-09-17 | 2007-11-28 | Plant enzymes for bioconversion |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01203519 | 2001-09-17 | ||
EP1203519.2 | 2001-09-17 | ||
PCT/NL2002/000591 WO2003025193A1 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
US10/489,762 US7214507B2 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
US11/796,503 US20070300327A1 (en) | 2001-09-17 | 2007-04-27 | Plant enzymes for bioconversion |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2002/000591 Division WO2003025193A1 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
US10/489,762 Division US7214507B2 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/998,036 Division US20080124772A1 (en) | 2001-09-17 | 2007-11-28 | Plant enzymes for bioconversion |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070300327A1 true US20070300327A1 (en) | 2007-12-27 |
Family
ID=8180937
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/489,762 Expired - Fee Related US7214507B2 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
US11/796,503 Abandoned US20070300327A1 (en) | 2001-09-17 | 2007-04-27 | Plant enzymes for bioconversion |
US11/998,036 Abandoned US20080124772A1 (en) | 2001-09-17 | 2007-11-28 | Plant enzymes for bioconversion |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/489,762 Expired - Fee Related US7214507B2 (en) | 2001-09-17 | 2002-09-17 | Plant enzymes for bioconversion |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/998,036 Abandoned US20080124772A1 (en) | 2001-09-17 | 2007-11-28 | Plant enzymes for bioconversion |
Country Status (5)
Country | Link |
---|---|
US (3) | US7214507B2 (en) |
EP (2) | EP1427838A1 (en) |
JP (1) | JP2005503163A (en) |
CN (1) | CN1589327A (en) |
WO (1) | WO2003025193A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10000773B2 (en) | 2011-11-01 | 2018-06-19 | Firmenich Sa | Cytochrome P450 and use thereof for the enzymatic oxidation of terpenes |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003025193A1 (en) * | 2001-09-17 | 2003-03-27 | Plant Research International B.V. | Plant enzymes for bioconversion |
US7442785B2 (en) | 2003-07-24 | 2008-10-28 | The University Of Kentucky Research Foundation | Sesquiterpene synthase gene and protein |
ATE424460T1 (en) * | 2003-11-26 | 2009-03-15 | Firmenich & Cie | SESQUITERPENE SYNTHASES FROM PATCHOULI |
US20090031455A1 (en) * | 2004-10-14 | 2009-01-29 | Plant Research International B.V. | Terpene hydroxylation |
DK1919514T3 (en) | 2005-07-05 | 2012-08-20 | Univ California | Polynucleotides encoding isoprenoid-modifying enzymes and methods for their use |
JP5148970B2 (en) * | 2007-11-02 | 2013-02-20 | 学校法人近畿大学 | Novel β-serinene derivative and acetylcholinesterase activity inhibitor containing the derivative |
DE102010000168A1 (en) * | 2010-01-22 | 2011-07-28 | Universität des Saarlandes Campus Saarbrücken Gebäude A1 1, 66123 | Biocatalyst for hydroxylation and / or epoxidation |
WO2011121456A2 (en) * | 2010-03-16 | 2011-10-06 | Uti Limited Partnership | Nucleic acids and protein sequences of costunolide synthase |
WO2012058636A1 (en) | 2010-10-29 | 2012-05-03 | Allylix, Inc. | Modified valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof |
EP2537926A1 (en) * | 2011-06-21 | 2012-12-26 | Isobionics B.V. | Valencene synthase |
WO2014031790A1 (en) | 2012-08-23 | 2014-02-27 | Allylix, Inc. | Nootkatone as an insecticide and insect repellent |
ES2647828T3 (en) | 2013-03-14 | 2017-12-26 | Evolva, Inc. | Valencene synthase polypeptides, nucleic acid molecules that encode them, and uses thereof |
WO2015040197A1 (en) * | 2013-09-19 | 2015-03-26 | Laurent Daviet | Method for producing fragrant alcohols |
US10785982B2 (en) | 2015-10-05 | 2020-09-29 | Philip Morris Products S.A. | Crisps and syrup made from low bitter chicory products |
MA40995A (en) | 2014-10-06 | 2017-09-26 | Blue Prairie Brands Inc | LOW BITTER CHICORY PRODUCTS |
CN108714117B (en) * | 2018-07-06 | 2021-04-27 | 浙江丽芙秀化妆品有限公司 | Long-acting perfume and preparation method thereof |
CN111995629B (en) * | 2019-05-11 | 2021-06-01 | 普济生物科技(台州)有限公司 | Germacrene leaf derivative, pharmaceutical composition thereof and application thereof in medicine |
CN114630905A (en) * | 2019-07-10 | 2022-06-14 | 弗门尼舍有限公司 | Biocatalytic process for controlled degradation of terpene compounds |
KR102261069B1 (en) | 2019-12-17 | 2021-06-04 | 건국대학교 산학협력단 | Decomposing enzyme fixation device using nickel and zeolite and its method |
CN118064392A (en) * | 2024-02-28 | 2024-05-24 | 四川大学 | Application of cytochrome P450 monooxygenase LsDHLS |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6200786B1 (en) * | 1999-09-08 | 2001-03-13 | Givaudan S.A. | Process for the preparation of nootkatone by laccase catalysis |
US6451576B1 (en) * | 1998-01-22 | 2002-09-17 | Washington State University Research Foundation | Sesquiterpene synthases from grand fir (Abies grandis), and methods of use |
US7091027B1 (en) * | 1998-08-27 | 2006-08-15 | Genoclipp Biotechnology B.V. | Transgenic amorpha-4,11-diene synthesis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003025193A1 (en) * | 2001-09-17 | 2003-03-27 | Plant Research International B.V. | Plant enzymes for bioconversion |
-
2002
- 2002-09-17 WO PCT/NL2002/000591 patent/WO2003025193A1/en active Application Filing
- 2002-09-17 US US10/489,762 patent/US7214507B2/en not_active Expired - Fee Related
- 2002-09-17 CN CNA028228227A patent/CN1589327A/en active Pending
- 2002-09-17 EP EP02758947A patent/EP1427838A1/en not_active Withdrawn
- 2002-09-17 EP EP07121764.0A patent/EP1916307B1/en not_active Expired - Lifetime
- 2002-09-17 JP JP2003529966A patent/JP2005503163A/en active Pending
-
2007
- 2007-04-27 US US11/796,503 patent/US20070300327A1/en not_active Abandoned
- 2007-11-28 US US11/998,036 patent/US20080124772A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451576B1 (en) * | 1998-01-22 | 2002-09-17 | Washington State University Research Foundation | Sesquiterpene synthases from grand fir (Abies grandis), and methods of use |
US7091027B1 (en) * | 1998-08-27 | 2006-08-15 | Genoclipp Biotechnology B.V. | Transgenic amorpha-4,11-diene synthesis |
US6200786B1 (en) * | 1999-09-08 | 2001-03-13 | Givaudan S.A. | Process for the preparation of nootkatone by laccase catalysis |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10000773B2 (en) | 2011-11-01 | 2018-06-19 | Firmenich Sa | Cytochrome P450 and use thereof for the enzymatic oxidation of terpenes |
Also Published As
Publication number | Publication date |
---|---|
EP1427838A1 (en) | 2004-06-16 |
US7214507B2 (en) | 2007-05-08 |
EP1916307B1 (en) | 2014-02-26 |
US20080124772A1 (en) | 2008-05-29 |
CN1589327A (en) | 2005-03-02 |
WO2003025193A1 (en) | 2003-03-27 |
EP1916307A1 (en) | 2008-04-30 |
US20050019882A1 (en) | 2005-01-27 |
JP2005503163A (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070300327A1 (en) | Plant enzymes for bioconversion | |
Hansen et al. | Plant cytochrome P450 plasticity and evolution | |
Hallahan | Monoterpenoid biosynthesis in glandular trichomes of labiate plants | |
Luo et al. | Molecular cloning and functional identification of (+)‐δ‐cadinene‐8‐hydroxylase, a cytochrome P450 mono‐oxygenase (CYP706B1) of cotton sesquiterpene biosynthesis | |
Bouwmeester et al. | Biosynthesis of the monoterpenes limonene and carvone in the fruit of caraway: I. Demonstration of enzyme activities and their changes with development | |
de Kraker et al. | Biosynthesis of germacrene A carboxylic acid in chicory roots. Demonstration of a cytochrome P450 (+)-germacrene a hydroxylase and NADP+-dependent sesquiterpenoid dehydrogenase (s) involved in sesquiterpene lactone biosynthesis | |
Cankar et al. | A chicory cytochrome P450 mono-oxygenase CYP71AV8 for the oxidation of (+)-valencene | |
Ramirez et al. | Biosynthesis of sesquiterpene lactones in pyrethrum (Tanacetum cinerariifolium) | |
Pateraki et al. | Cytochromes P450 for terpene functionalisation and metabolic engineering | |
Ilc et al. | Monoterpenol oxidative metabolism: role in plant adaptation and potential applications | |
US7541172B2 (en) | Transgenic amorpha-4, 11-diene synthesis | |
Lücker et al. | Metabolic engineering of monoterpene biosynthesis: two‐step production of (+)‐trans‐isopiperitenol by tobacco | |
de Kraker et al. | Hydroxylation of sesquiterpenes by enzymes from chicory (Cichorium intybus L.) roots | |
KR101878899B1 (en) | 1-deoxy-d-xylulose 5-phosphate synthase alleles responsible for enhanced terpene biosynthesis | |
Aleu et al. | Biotransformations by Botrytis species | |
Crocoll | Biosynthesis of the phenolic monoterpenes, thymol and carvacrol, by terpene synthases and cytochrome P450s in oregano and thyme | |
Iijima et al. | Biosynthesis of geranial, a potent aroma compound in ginger rhizome (Zingiber officinale): molecular cloning and characterization of geraniol dehydrogenase | |
Narnoliya et al. | Biotechnological avenues for fruit juices debittering | |
Villa-Ruano et al. | Cytochrome P450 from plants: platforms for valuable phytopharmaceuticals | |
Huang et al. | Overexpression of hydroperoxide lyase, peroxygenase and epoxide hydrolase in tobacco for the biotechnological production of flavours and polymer precursors | |
Keeling et al. | Plant terpenoids | |
Banthorpe et al. | The biosynthesis of C 5—C 20 terpenoid compounds | |
de Kraker | The biosynthesis of sesquiterpene lactones in chicory (Cichorium intybus L.) roots | |
Lücker | Metabolic engineering of monoterpene biosynthesis in plants | |
EP4015626A1 (en) | Enzymes and methods for fermentative production of monoterpene esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DAFRA PHARMA RESEARCH & DEVELOPMENT BVBA, BELGIUM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PLANT RESEARCH INTERNATIONAL B.V.;REEL/FRAME:021462/0747 Effective date: 20080818 |
|
XAS | Not any more in us assignment database |
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PLANT RESEARCH INTERNATIONAL B.V.;REEL/FRAME:021462/0747 |
|
AS | Assignment |
Owner name: PLANT RESEARCH INTERNATIONAL B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOUWMEESTER, HENDRIK JAN;DE DRAKER, JAN WILLEM;SCHURINK, MARLOES;AND OTHERS;REEL/FRAME:023667/0870;SIGNING DATES FROM 20040316 TO 20040330 Owner name: PLANT RESEARCH INTERNATIONAL B.V.,NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOUWMEESTER, HENDRIK JAN;DE KRAKER, JAN WILLEM;SCHURINK, MARLOES;AND OTHERS;SIGNING DATES FROM 20040316 TO 20040330;REEL/FRAME:023667/0870 Owner name: PLANT RESEARCH INTERNATIONAL B.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOUWMEESTER, HENDRIK JAN;DE KRAKER, JAN WILLEM;SCHURINK, MARLOES;AND OTHERS;SIGNING DATES FROM 20040316 TO 20040330;REEL/FRAME:023667/0870 |
|
AS | Assignment |
Owner name: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK,NETHERLA Free format text: MERGER;ASSIGNOR:PLANT RESEARCH INTERNATIONAL B.V.;REEL/FRAME:024238/0755 Effective date: 20100118 Owner name: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK, NETHERL Free format text: MERGER;ASSIGNOR:PLANT RESEARCH INTERNATIONAL B.V.;REEL/FRAME:024238/0755 Effective date: 20100118 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |